id	sid	tid	token	lemma	pos
ecj-12528	1	1	hrev_master	hrev_master	NOUN
ecj-12528	2	1	[	[	X
ecj-12528	2	2	page	page	NOUN
ecj-12528	2	3	94	94	NUM
ecj-12528	2	4	]	]	PUNCT
ecj-12528	3	1	[	[	X
ecj-12528	3	2	emergency	emergency	NOUN
ecj-12528	3	3	care	care	NOUN
ecj-12528	3	4	journal	journal	PROPN
ecj-12528	3	5	2024	2024	NUM
ecj-12528	3	6	;	;	PUNCT
ecj-12528	3	7	20:12528	20:12528	NUM
ecj-12528	3	8	]	]	X
ecj-12528	3	9	emergency	emergency	NOUN
ecj-12528	3	10	care	care	NOUN
ecj-12528	3	11	journal	journal	PROPN
ecj-12528	3	12	2024	2024	NUM
ecj-12528	3	13	volume	volume	NOUN
ecj-12528	3	14	20:12528	20:12528	NUM
ecj-12528	3	15	abstract	abstract	NOUN
ecj-12528	3	16	covid-19	covid-19	PROPN
ecj-12528	3	17	can	can	AUX
ecj-12528	3	18	cause	cause	VERB
ecj-12528	3	19	a	a	DET
ecj-12528	3	20	wide	wide	ADJ
ecj-12528	3	21	range	range	NOUN
ecj-12528	3	22	of	of	ADP
ecj-12528	3	23	effects	effect	NOUN
ecj-12528	3	24	on	on	ADP
ecj-12528	3	25	patients	patient	NOUN
ecj-12528	3	26	,	,	PUNCT
ecj-12528	3	27	from	from	ADP
ecj-12528	3	28	asymptomatic	asymptomatic	ADJ
ecj-12528	3	29	cases	case	NOUN
ecj-12528	3	30	to	to	ADP
ecj-12528	3	31	mortality	mortality	NOUN
ecj-12528	3	32	.	.	PUNCT
ecj-12528	4	1	many	many	ADJ
ecj-12528	4	2	factors	factor	NOUN
ecj-12528	4	3	can	can	AUX
ecj-12528	4	4	affect	affect	VERB
ecj-12528	4	5	the	the	DET
ecj-12528	4	6	prognosis	prognosis	NOUN
ecj-12528	4	7	of	of	ADP
ecj-12528	4	8	the	the	DET
ecj-12528	4	9	disease	disease	NOUN
ecj-12528	4	10	.	.	PUNCT
ecj-12528	5	1	our	our	PRON
ecj-12528	5	2	study	study	NOUN
ecj-12528	5	3	aims	aim	VERB
ecj-12528	5	4	to	to	PART
ecj-12528	5	5	evaluate	evaluate	VERB
ecj-12528	5	6	the	the	DET
ecj-12528	5	7	predictive	predictive	ADJ
ecj-12528	5	8	power	power	NOUN
ecj-12528	5	9	of	of	ADP
ecj-12528	5	10	the	the	DET
ecj-12528	5	11	systemic	systemic	ADJ
ecj-12528	5	12	inflammatory	inflammatory	ADJ
ecj-12528	5	13	index	index	NOUN
ecj-12528	5	14	(	(	PUNCT
ecj-12528	5	15	sii	sii	PROPN
ecj-12528	5	16	)	)	PUNCT
ecj-12528	5	17	and	and	CCONJ
ecj-12528	5	18	systemic	systemic	ADJ
ecj-12528	5	19	inflammatory	inflammatory	ADJ
ecj-12528	5	20	response	response	NOUN
ecj-12528	5	21	index	index	NOUN
ecj-12528	5	22	(	(	PUNCT
ecj-12528	5	23	siri	siri	NOUN
ecj-12528	5	24	)	)	PUNCT
ecj-12528	5	25	in	in	ADP
ecj-12528	5	26	determining	determine	VERB
ecj-12528	5	27	prognosis	prognosis	NOUN
ecj-12528	5	28	and	and	CCONJ
ecj-12528	5	29	mortality	mortality	NOUN
ecj-12528	5	30	in	in	ADP
ecj-12528	5	31	patients	patient	NOUN
ecj-12528	5	32	.	.	PUNCT
ecj-12528	6	1	patients	patient	NOUN
ecj-12528	6	2	who	who	PRON
ecj-12528	6	3	tested	test	VERB
ecj-12528	6	4	positive	positive	ADJ
ecj-12528	6	5	for	for	ADP
ecj-12528	6	6	covid-19	covid-19	PROPN
ecj-12528	6	7	by	by	ADP
ecj-12528	6	8	polymerase	polymerase	NOUN
ecj-12528	6	9	chain	chain	NOUN
ecj-12528	6	10	reaction	reaction	NOUN
ecj-12528	6	11	and	and	CCONJ
ecj-12528	6	12	presented	present	VERB
ecj-12528	6	13	to	to	ADP
ecj-12528	6	14	the	the	DET
ecj-12528	6	15	emergency	emergency	NOUN
ecj-12528	6	16	department	department	PROPN
ecj-12528	6	17	of	of	ADP
ecj-12528	6	18	mersin	mersin	PROPN
ecj-12528	6	19	hospital	hospital	PROPN
ecj-12528	6	20	between	between	ADP
ecj-12528	6	21	september	september	PROPN
ecj-12528	6	22	1	1	NUM
ecj-12528	6	23	,	,	PUNCT
ecj-12528	6	24	2020	2020	NUM
ecj-12528	6	25	,	,	PUNCT
ecj-12528	6	26	and	and	CCONJ
ecj-12528	6	27	august	august	PROPN
ecj-12528	6	28	31	31	NUM
ecj-12528	6	29	,	,	PUNCT
ecj-12528	6	30	2021	2021	NUM
ecj-12528	6	31	,	,	PUNCT
ecj-12528	6	32	were	be	AUX
ecj-12528	6	33	included	include	VERB
ecj-12528	6	34	in	in	ADP
ecj-12528	6	35	the	the	DET
ecj-12528	6	36	study	study	NOUN
ecj-12528	6	37	.	.	PUNCT
ecj-12528	7	1	the	the	DET
ecj-12528	7	2	data	datum	NOUN
ecj-12528	7	3	of	of	ADP
ecj-12528	7	4	the	the	DET
ecj-12528	7	5	patients	patient	NOUN
ecj-12528	7	6	were	be	AUX
ecj-12528	7	7	retrospectively	retrospectively	ADV
ecj-12528	7	8	analyzed	analyze	VERB
ecj-12528	7	9	.	.	PUNCT
ecj-12528	8	1	a	a	DET
ecj-12528	8	2	total	total	NOUN
ecj-12528	8	3	of	of	ADP
ecj-12528	8	4	446	446	NUM
ecj-12528	8	5	patients	patient	NOUN
ecj-12528	8	6	were	be	AUX
ecj-12528	8	7	included	include	VERB
ecj-12528	8	8	in	in	ADP
ecj-12528	8	9	our	our	PRON
ecj-12528	8	10	study	study	NOUN
ecj-12528	8	11	.	.	PUNCT
ecj-12528	9	1	the	the	DET
ecj-12528	9	2	rate	rate	NOUN
ecj-12528	9	3	of	of	ADP
ecj-12528	9	4	patients	patient	NOUN
ecj-12528	9	5	with	with	ADP
ecj-12528	9	6	severe	severe	ADJ
ecj-12528	9	7	disease	disease	NOUN
ecj-12528	9	8	was	be	AUX
ecj-12528	9	9	55.6	55.6	NUM
ecj-12528	9	10	%	%	NOUN
ecj-12528	9	11	,	,	PUNCT
ecj-12528	9	12	and	and	CCONJ
ecj-12528	9	13	the	the	DET
ecj-12528	9	14	mortality	mortality	NOUN
ecj-12528	9	15	rate	rate	NOUN
ecj-12528	9	16	was	be	AUX
ecj-12528	9	17	30.5	30.5	NUM
ecj-12528	9	18	%	%	NOUN
ecj-12528	9	19	.	.	PUNCT
ecj-12528	10	1	it	it	PRON
ecj-12528	10	2	was	be	AUX
ecj-12528	10	3	found	find	VERB
ecj-12528	10	4	that	that	SCONJ
ecj-12528	10	5	mortality	mortality	NOUN
ecj-12528	10	6	increased	increase	VERB
ecj-12528	10	7	with	with	ADP
ecj-12528	10	8	age	age	NOUN
ecj-12528	10	9	(	(	PUNCT
ecj-12528	10	10	p<0.001	p<0.001	PROPN
ecj-12528	10	11	)	)	PUNCT
ecj-12528	10	12	.	.	PUNCT
ecj-12528	11	1	sii	sii	PROPN
ecj-12528	11	2	and	and	CCONJ
ecj-12528	11	3	siri	siri	NOUN
ecj-12528	11	4	levels	level	NOUN
ecj-12528	11	5	were	be	AUX
ecj-12528	11	6	found	find	VERB
ecj-12528	11	7	to	to	PART
ecj-12528	11	8	be	be	AUX
ecj-12528	11	9	higher	high	ADJ
ecj-12528	11	10	in	in	ADP
ecj-12528	11	11	patients	patient	NOUN
ecj-12528	11	12	who	who	PRON
ecj-12528	11	13	died	die	VERB
ecj-12528	11	14	or	or	CCONJ
ecj-12528	11	15	had	have	VERB
ecj-12528	11	16	severe	severe	ADJ
ecj-12528	11	17	disease	disease	NOUN
ecj-12528	11	18	(	(	PUNCT
ecj-12528	11	19	p<0.001	p<0.001	PROPN
ecj-12528	11	20	)	)	PUNCT
ecj-12528	11	21	.	.	PUNCT
ecj-12528	12	1	it	it	PRON
ecj-12528	12	2	was	be	AUX
ecj-12528	12	3	determined	determine	VERB
ecj-12528	12	4	that	that	SCONJ
ecj-12528	12	5	the	the	DET
ecj-12528	12	6	severity	severity	NOUN
ecj-12528	12	7	level	level	NOUN
ecj-12528	12	8	increased	increase	VERB
ecj-12528	12	9	in	in	ADP
ecj-12528	12	10	covid-19	covid-19	PROPN
ecj-12528	12	11	patients	patient	NOUN
ecj-12528	12	12	when	when	SCONJ
ecj-12528	12	13	the	the	DET
ecj-12528	12	14	siri	siri	NOUN
ecj-12528	12	15	value	value	NOUN
ecj-12528	12	16	was	be	AUX
ecj-12528	12	17	above	above	ADP
ecj-12528	12	18	1.648	1.648	NUM
ecj-12528	12	19	(	(	PUNCT
ecj-12528	12	20	p<0.0001	p<0.0001	NOUN
ecj-12528	12	21	,	,	PUNCT
ecj-12528	12	22	auc=0.689	auc=0.689	PROPN
ecj-12528	12	23	)	)	PUNCT
ecj-12528	12	24	,	,	PUNCT
ecj-12528	12	25	and	and	CCONJ
ecj-12528	12	26	the	the	DET
ecj-12528	12	27	mortality	mortality	NOUN
ecj-12528	12	28	rate	rate	NOUN
ecj-12528	12	29	increased	increase	VERB
ecj-12528	12	30	when	when	SCONJ
ecj-12528	12	31	the	the	DET
ecj-12528	12	32	siri	siri	NOUN
ecj-12528	12	33	value	value	NOUN
ecj-12528	12	34	was	be	AUX
ecj-12528	12	35	above	above	ADP
ecj-12528	12	36	2.057	2.057	NUM
ecj-12528	12	37	(	(	PUNCT
ecj-12528	12	38	p<0.0001	p<0.0001	NOUN
ecj-12528	12	39	,	,	PUNCT
ecj-12528	12	40	auc=0.640	auc=0.640	ADJ
ecj-12528	12	41	)	)	PUNCT
ecj-12528	12	42	.	.	PUNCT
ecj-12528	13	1	it	it	PRON
ecj-12528	13	2	was	be	AUX
ecj-12528	13	3	determined	determine	VERB
ecj-12528	13	4	that	that	SCONJ
ecj-12528	13	5	the	the	DET
ecj-12528	13	6	severity	severity	NOUN
ecj-12528	13	7	level	level	NOUN
ecj-12528	13	8	increased	increase	VERB
ecj-12528	13	9	in	in	ADP
ecj-12528	13	10	covid-19	covid-19	PROPN
ecj-12528	13	11	patients	patient	NOUN
ecj-12528	13	12	when	when	SCONJ
ecj-12528	13	13	the	the	DET
ecj-12528	13	14	sii	sii	PROPN
ecj-12528	13	15	value	value	NOUN
ecj-12528	13	16	was	be	AUX
ecj-12528	13	17	above	above	ADP
ecj-12528	13	18	867.834	867.834	NUM
ecj-12528	13	19	(	(	PUNCT
ecj-12528	13	20	p<0.0001	p<0.0001	NOUN
ecj-12528	13	21	,	,	PUNCT
ecj-12528	13	22	auc=0.744	auc=0.744	ADJ
ecj-12528	13	23	)	)	PUNCT
ecj-12528	13	24	,	,	PUNCT
ecj-12528	13	25	and	and	CCONJ
ecj-12528	13	26	the	the	DET
ecj-12528	13	27	mortality	mortality	NOUN
ecj-12528	13	28	rate	rate	NOUN
ecj-12528	13	29	increased	increase	VERB
ecj-12528	13	30	when	when	SCONJ
ecj-12528	13	31	it	it	PRON
ecj-12528	13	32	was	be	AUX
ecj-12528	13	33	above	above	ADP
ecj-12528	13	34	1370.353	1370.353	NUM
ecj-12528	13	35	(	(	PUNCT
ecj-12528	13	36	p<0.0001	p<0.0001	NOUN
ecj-12528	13	37	,	,	PUNCT
ecj-12528	13	38	auc=0.682	auc=0.682	ADJ
ecj-12528	13	39	)	)	PUNCT
ecj-12528	13	40	.	.	PUNCT
ecj-12528	14	1	in	in	ADP
ecj-12528	14	2	patients	patient	NOUN
ecj-12528	14	3	diagnosed	diagnose	VERB
ecj-12528	14	4	with	with	ADP
ecj-12528	14	5	covid-19	covid-19	PROPN
ecj-12528	14	6	,	,	PUNCT
ecj-12528	14	7	it	it	PRON
ecj-12528	14	8	was	be	AUX
ecj-12528	14	9	found	find	VERB
ecj-12528	14	10	that	that	SCONJ
ecj-12528	14	11	sii	sii	ADJ
ecj-12528	14	12	and	and	CCONJ
ecj-12528	14	13	siri	siri	NOUN
ecj-12528	14	14	parameters	parameter	NOUN
ecj-12528	14	15	could	could	AUX
ecj-12528	14	16	predict	predict	VERB
ecj-12528	14	17	the	the	DET
ecj-12528	14	18	severity	severity	NOUN
ecj-12528	14	19	and	and	CCONJ
ecj-12528	14	20	mortality	mortality	NOUN
ecj-12528	14	21	of	of	ADP
ecj-12528	14	22	the	the	DET
ecj-12528	14	23	disease	disease	NOUN
ecj-12528	14	24	.	.	PUNCT
ecj-12528	15	1	further	further	ADJ
ecj-12528	15	2	comprehensive	comprehensive	ADJ
ecj-12528	15	3	studies	study	NOUN
ecj-12528	15	4	are	be	AUX
ecj-12528	15	5	needed	need	VERB
ecj-12528	15	6	to	to	PART
ecj-12528	15	7	determine	determine	VERB
ecj-12528	15	8	the	the	DET
ecj-12528	15	9	future	future	ADJ
ecj-12528	15	10	roles	role	NOUN
ecj-12528	15	11	of	of	ADP
ecj-12528	15	12	these	these	DET
ecj-12528	15	13	indices	index	NOUN
ecj-12528	15	14	.	.	PUNCT
ecj-12528	16	1	introduction	introduction	NOUN
ecj-12528	16	2	the	the	DET
ecj-12528	16	3	pathogenesis	pathogenesis	NOUN
ecj-12528	16	4	,	,	PUNCT
ecj-12528	16	5	clinical	clinical	ADJ
ecj-12528	16	6	features	feature	NOUN
ecj-12528	16	7	,	,	PUNCT
ecj-12528	16	8	and	and	CCONJ
ecj-12528	16	9	pathological	pathological	ADJ
ecj-12528	16	10	changes	change	NOUN
ecj-12528	16	11	of	of	ADP
ecj-12528	16	12	coronavirus	coronavirus	NOUN
ecj-12528	16	13	disease	disease	NOUN
ecj-12528	16	14	2019	2019	NUM
ecj-12528	16	15	(	(	PUNCT
ecj-12528	16	16	covid-19	covid-19	PROPN
ecj-12528	16	17	)	)	PUNCT
ecj-12528	16	18	,	,	PUNCT
ecj-12528	16	19	characterized	characterize	VERB
ecj-12528	16	20	by	by	ADP
ecj-12528	16	21	diffuse	diffuse	ADJ
ecj-12528	16	22	inflammatory	inflammatory	ADJ
ecj-12528	16	23	changes	change	NOUN
ecj-12528	16	24	in	in	ADP
ecj-12528	16	25	the	the	DET
ecj-12528	16	26	lungs	lung	NOUN
ecj-12528	16	27	in	in	ADP
ecj-12528	16	28	patients	patient	NOUN
ecj-12528	16	29	with	with	ADP
ecj-12528	16	30	severe	severe	ADJ
ecj-12528	16	31	disease	disease	NOUN
ecj-12528	16	32	status	status	NOUN
ecj-12528	16	33	,	,	PUNCT
ecj-12528	16	34	are	be	AUX
ecj-12528	16	35	still	still	ADV
ecj-12528	16	36	under	under	ADP
ecj-12528	16	37	investigation.1	investigation.1	PROPN
ecj-12528	16	38	the	the	DET
ecj-12528	16	39	world	world	PROPN
ecj-12528	16	40	health	health	NOUN
ecj-12528	16	41	organization	organization	NOUN
ecj-12528	16	42	has	have	AUX
ecj-12528	16	43	reported	report	VERB
ecj-12528	16	44	that	that	SCONJ
ecj-12528	16	45	13.8	13.8	NUM
ecj-12528	16	46	%	%	NOUN
ecj-12528	16	47	of	of	ADP
ecj-12528	16	48	infected	infected	ADJ
ecj-12528	16	49	people	people	NOUN
ecj-12528	16	50	have	have	VERB
ecj-12528	16	51	severe	severe	ADJ
ecj-12528	16	52	infections	infection	NOUN
ecj-12528	16	53	and	and	CCONJ
ecj-12528	16	54	6.1	6.1	NUM
ecj-12528	16	55	%	%	NOUN
ecj-12528	16	56	have	have	VERB
ecj-12528	16	57	critical	critical	ADJ
ecj-12528	16	58	illnesses	illness	NOUN
ecj-12528	16	59	.	.	PUNCT
ecj-12528	17	1	it	it	PRON
ecj-12528	17	2	has	have	AUX
ecj-12528	17	3	also	also	ADV
ecj-12528	17	4	been	be	AUX
ecj-12528	17	5	reported	report	VERB
ecj-12528	17	6	that	that	SCONJ
ecj-12528	17	7	approximately	approximately	ADV
ecj-12528	17	8	26.1	26.1	NUM
ecj-12528	17	9	-	-	SYM
ecj-12528	17	10	32.0	32.0	NUM
ecj-12528	17	11	%	%	NOUN
ecj-12528	17	12	of	of	ADP
ecj-12528	17	13	confirmed	confirm	VERB
ecj-12528	17	14	cases	case	NOUN
ecj-12528	17	15	may	may	AUX
ecj-12528	17	16	develop	develop	VERB
ecj-12528	17	17	into	into	ADP
ecj-12528	17	18	severe	severe	ADJ
ecj-12528	17	19	or	or	CCONJ
ecj-12528	17	20	critical	critical	ADJ
ecj-12528	17	21	cases	case	NOUN
ecj-12528	17	22	,	,	PUNCT
ecj-12528	17	23	with	with	ADP
ecj-12528	17	24	mortality	mortality	NOUN
ecj-12528	17	25	rates	rate	NOUN
ecj-12528	17	26	of	of	ADP
ecj-12528	17	27	4.3	4.3	NUM
ecj-12528	17	28	-	-	PUNCT
ecj-12528	17	29	11%.2	11%.2	NUM
ecj-12528	17	30	-	-	PUNCT
ecj-12528	17	31	4	4	NUM
ecj-12528	17	32	given	give	VERB
ecj-12528	17	33	that	that	SCONJ
ecj-12528	17	34	markers	marker	NOUN
ecj-12528	17	35	of	of	ADP
ecj-12528	17	36	inflammation	inflammation	NOUN
ecj-12528	17	37	are	be	AUX
ecj-12528	17	38	so	so	ADV
ecj-12528	17	39	prevalent	prevalent	ADJ
ecj-12528	17	40	,	,	PUNCT
ecj-12528	17	41	identifying	identify	VERB
ecj-12528	17	42	risk	risk	NOUN
ecj-12528	17	43	factors	factor	NOUN
ecj-12528	17	44	in	in	ADP
ecj-12528	17	45	the	the	DET
ecj-12528	17	46	blood	blood	NOUN
ecj-12528	17	47	associated	associate	VERB
ecj-12528	17	48	with	with	ADP
ecj-12528	17	49	disease	disease	NOUN
ecj-12528	17	50	severity	severity	NOUN
ecj-12528	17	51	and	and	CCONJ
ecj-12528	17	52	early	early	ADJ
ecj-12528	17	53	intervention	intervention	NOUN
ecj-12528	17	54	to	to	PART
ecj-12528	17	55	improve	improve	VERB
ecj-12528	17	56	mortality	mortality	NOUN
ecj-12528	17	57	is	be	AUX
ecj-12528	17	58	vital	vital	ADJ
ecj-12528	17	59	.	.	PUNCT
ecj-12528	18	1	biomarkers	biomarker	NOUN
ecj-12528	18	2	,	,	PUNCT
ecj-12528	18	3	together	together	ADV
ecj-12528	18	4	with	with	ADP
ecj-12528	18	5	some	some	DET
ecj-12528	18	6	clinical	clinical	ADJ
ecj-12528	18	7	factors	factor	NOUN
ecj-12528	18	8	,	,	PUNCT
ecj-12528	18	9	may	may	AUX
ecj-12528	18	10	help	help	VERB
ecj-12528	18	11	predict	predict	VERB
ecj-12528	18	12	adverse	adverse	ADJ
ecj-12528	18	13	outcomes	outcome	NOUN
ecj-12528	18	14	among	among	ADP
ecj-12528	18	15	covid-19	covid-19	PROPN
ecj-12528	18	16	patients	patient	NOUN
ecj-12528	18	17	.	.	PUNCT
ecj-12528	19	1	identifying	identify	VERB
ecj-12528	19	2	early	early	ADJ
ecj-12528	19	3	biomarkers	biomarker	NOUN
ecj-12528	19	4	of	of	ADP
ecj-12528	19	5	disease	disease	NOUN
ecj-12528	19	6	severity	severity	NOUN
ecj-12528	19	7	can	can	AUX
ecj-12528	19	8	facilitate	facilitate	VERB
ecj-12528	19	9	early	early	ADJ
ecj-12528	19	10	implementation	implementation	NOUN
ecj-12528	19	11	of	of	ADP
ecj-12528	19	12	aggressive	aggressive	ADJ
ecj-12528	19	13	treatment	treatment	NOUN
ecj-12528	19	14	,	,	PUNCT
ecj-12528	19	15	improve	improve	VERB
ecj-12528	19	16	hospital	hospital	NOUN
ecj-12528	19	17	resource	resource	NOUN
ecj-12528	19	18	utilization	utilization	NOUN
ecj-12528	19	19	,	,	PUNCT
ecj-12528	19	20	and	and	CCONJ
ecj-12528	19	21	reduce	reduce	VERB
ecj-12528	19	22	mortality.5	mortality.5	PROPN
ecj-12528	19	23	-	-	PUNCT
ecj-12528	19	24	7	7	NUM
ecj-12528	19	25	a	a	DET
ecj-12528	19	26	complete	complete	ADJ
ecj-12528	19	27	blood	blood	NOUN
ecj-12528	19	28	count	count	NOUN
ecj-12528	19	29	is	be	AUX
ecj-12528	19	30	cheap	cheap	ADJ
ecj-12528	19	31	and	and	CCONJ
ecj-12528	19	32	easy	easy	ADJ
ecj-12528	19	33	to	to	PART
ecj-12528	19	34	perform	perform	VERB
ecj-12528	19	35	.	.	PUNCT
ecj-12528	20	1	hematologic	hematologic	NOUN
ecj-12528	20	2	markers	marker	NOUN
ecj-12528	20	3	,	,	PUNCT
ecj-12528	20	4	including	include	VERB
ecj-12528	20	5	platelets	platelet	NOUN
ecj-12528	20	6	,	,	PUNCT
ecj-12528	20	7	lymphocytes	lymphocyte	NOUN
ecj-12528	20	8	,	,	PUNCT
ecj-12528	20	9	neutrophils	neutrophil	NOUN
ecj-12528	20	10	,	,	PUNCT
ecj-12528	20	11	and	and	CCONJ
ecj-12528	20	12	monocytes	monocyte	NOUN
ecj-12528	20	13	,	,	PUNCT
ecj-12528	20	14	and	and	CCONJ
ecj-12528	20	15	their	their	PRON
ecj-12528	20	16	ratios	ratio	NOUN
ecj-12528	20	17	to	to	ADP
ecj-12528	20	18	each	each	DET
ecj-12528	20	19	other	other	ADJ
ecj-12528	20	20	,	,	PUNCT
ecj-12528	20	21	have	have	AUX
ecj-12528	20	22	been	be	AUX
ecj-12528	20	23	proposed	propose	VERB
ecj-12528	20	24	as	as	ADP
ecj-12528	20	25	indicators	indicator	NOUN
ecj-12528	20	26	to	to	PART
ecj-12528	20	27	aid	aid	VERB
ecj-12528	20	28	in	in	ADP
ecj-12528	20	29	the	the	DET
ecj-12528	20	30	diagnosis	diagnosis	NOUN
ecj-12528	20	31	,	,	PUNCT
ecj-12528	20	32	early	early	ADJ
ecj-12528	20	33	warning	warning	NOUN
ecj-12528	20	34	,	,	PUNCT
ecj-12528	20	35	and	and	CCONJ
ecj-12528	20	36	risk	risk	NOUN
ecj-12528	20	37	stratification	stratification	NOUN
ecj-12528	20	38	of	of	ADP
ecj-12528	20	39	infectious	infectious	ADJ
ecj-12528	20	40	diseases.8	diseases.8	PROPN
ecj-12528	20	41	the	the	DET
ecj-12528	20	42	neutrophil	neutrophil	ADJ
ecj-12528	20	43	-	-	PUNCT
ecj-12528	20	44	tolymphocyte	tolymphocyte	NOUN
ecj-12528	20	45	ratio	ratio	NOUN
ecj-12528	20	46	(	(	PUNCT
ecj-12528	20	47	nlr	nlr	PROPN
ecj-12528	20	48	)	)	PUNCT
ecj-12528	20	49	,	,	PUNCT
ecj-12528	20	50	platelet	platelet	NOUN
ecj-12528	20	51	-	-	PUNCT
ecj-12528	20	52	to	to	ADP
ecj-12528	20	53	-	-	PUNCT
ecj-12528	20	54	lymphocyte	lymphocyte	ADJ
ecj-12528	20	55	ratio	ratio	NOUN
ecj-12528	20	56	(	(	PUNCT
ecj-12528	20	57	plr	plr	NOUN
ecj-12528	20	58	)	)	PUNCT
ecj-12528	20	59	,	,	PUNCT
ecj-12528	20	60	and	and	CCONJ
ecj-12528	20	61	systemic	systemic	ADJ
ecj-12528	20	62	inflammation	inflammation	NOUN
ecj-12528	20	63	index	index	NOUN
ecj-12528	20	64	(	(	PUNCT
ecj-12528	20	65	sii	sii	PROPN
ecj-12528	20	66	)	)	PUNCT
ecj-12528	20	67	have	have	AUX
ecj-12528	20	68	recently	recently	ADV
ecj-12528	20	69	been	be	AUX
ecj-12528	20	70	shown	show	VERB
ecj-12528	20	71	to	to	PART
ecj-12528	20	72	be	be	AUX
ecj-12528	20	73	useful	useful	ADJ
ecj-12528	20	74	for	for	ADP
ecj-12528	20	75	the	the	DET
ecj-12528	20	76	assessment	assessment	NOUN
ecj-12528	20	77	of	of	ADP
ecj-12528	20	78	the	the	DET
ecj-12528	20	79	severity	severity	NOUN
ecj-12528	20	80	of	of	ADP
ecj-12528	20	81	covid-19	covid-19	PROPN
ecj-12528	20	82	patients	patient	NOUN
ecj-12528	20	83	.	.	PUNCT
ecj-12528	21	1	however	however	ADV
ecj-12528	21	2	,	,	PUNCT
ecj-12528	21	3	there	there	PRON
ecj-12528	21	4	are	be	VERB
ecj-12528	21	5	few	few	ADJ
ecj-12528	21	6	studies	study	NOUN
ecj-12528	21	7	evaluating	evaluate	VERB
ecj-12528	21	8	the	the	DET
ecj-12528	21	9	prognostic	prognostic	ADJ
ecj-12528	21	10	correspondence	correspondence	NOUN
ecj-12528	21	11	:	:	PUNCT
ecj-12528	21	12	akif	akif	PROPN
ecj-12528	21	13	yarkaç	yarkaç	PROPN
ecj-12528	21	14	,	,	PUNCT
ecj-12528	21	15	emergency	emergency	NOUN
ecj-12528	21	16	medicine	medicine	PROPN
ecj-12528	21	17	department	department	PROPN
ecj-12528	21	18	,	,	PUNCT
ecj-12528	21	19	mersin	mersin	PROPN
ecj-12528	21	20	university	university	PROPN
ecj-12528	21	21	medical	medical	ADJ
ecj-12528	21	22	faculty	faculty	PROPN
ecj-12528	21	23	,	,	PUNCT
ecj-12528	21	24	mersin	mersin	PROPN
ecj-12528	21	25	,	,	PUNCT
ecj-12528	21	26	turkey	turkey	PROPN
ecj-12528	21	27	.	.	PUNCT
ecj-12528	22	1	tel	tel	PROPN
ecj-12528	22	2	.	.	PUNCT
ecj-12528	22	3	:	:	PUNCT
ecj-12528	23	1	+90.5542812788	+90.5542812788	VERB
ecj-12528	23	2	fax	fax	NOUN
ecj-12528	23	3	:	:	PUNCT
ecj-12528	23	4	+90.324.2410098	+90.324.2410098	PUNCT
ecj-12528	23	5	e-mail:akifyarkac@hotmail.com	e-mail:akifyarkac@hotmail.com	X
ecj-12528	23	6	key	key	ADJ
ecj-12528	23	7	words	word	NOUN
ecj-12528	23	8	:	:	PUNCT
ecj-12528	23	9	covid-19	covid-19	PROPN
ecj-12528	23	10	,	,	PUNCT
ecj-12528	23	11	systemic	systemic	ADJ
ecj-12528	23	12	immune	immune	NOUN
ecj-12528	23	13	-	-	PUNCT
ecj-12528	23	14	inflammation	inflammation	NOUN
ecj-12528	23	15	index	index	NOUN
ecj-12528	23	16	,	,	PUNCT
ecj-12528	23	17	systemic	systemic	ADJ
ecj-12528	23	18	inflammation	inflammation	ADJ
ecj-12528	23	19	response	response	NOUN
ecj-12528	23	20	index	index	NOUN
ecj-12528	23	21	.	.	PUNCT
ecj-12528	24	1	contributions	contribution	NOUN
ecj-12528	24	2	:	:	PUNCT
ecj-12528	24	3	literature	literature	NOUN
ecj-12528	24	4	search	search	NOUN
ecj-12528	24	5	:	:	PUNCT
ecj-12528	24	6	at	at	ADP
ecj-12528	24	7	,	,	PUNCT
ecj-12528	24	8	çsb	çsb	PROPN
ecj-12528	24	9	,	,	PUNCT
ecj-12528	24	10	sb	sb	PROPN
ecj-12528	24	11	;	;	PUNCT
ecj-12528	24	12	data	data	NOUN
ecj-12528	24	13	collection	collection	NOUN
ecj-12528	24	14	:	:	PUNCT
ecj-12528	24	15	çsb	çsb	PROPN
ecj-12528	24	16	,	,	PUNCT
ecj-12528	24	17	sb	sb	PROPN
ecj-12528	24	18	,	,	PUNCT
ecj-12528	24	19	ay	ay	PROPN
ecj-12528	24	20	;	;	PUNCT
ecj-12528	24	21	study	study	NOUN
ecj-12528	24	22	design	design	NOUN
ecj-12528	24	23	:	:	PUNCT
ecj-12528	24	24	at	at	ADP
ecj-12528	24	25	,	,	PUNCT
ecj-12528	24	26	ak	ak	PROPN
ecj-12528	24	27	,	,	PUNCT
ecj-12528	24	28	se	se	X
ecj-12528	24	29	;	;	PUNCT
ecj-12528	24	30	analysis	analysis	NOUN
ecj-12528	24	31	of	of	ADP
ecj-12528	24	32	data	datum	NOUN
ecj-12528	24	33	:	:	PUNCT
ecj-12528	24	34	se	se	X
ecj-12528	24	35	,	,	PUNCT
ecj-12528	24	36	ay	ay	INTJ
ecj-12528	24	37	,	,	PUNCT
ecj-12528	24	38	çsb	çsb	PROPN
ecj-12528	24	39	;	;	PUNCT
ecj-12528	24	40	manuscript	manuscript	NOUN
ecj-12528	24	41	preparation	preparation	NOUN
ecj-12528	24	42	:	:	PUNCT
ecj-12528	24	43	ay	ay	PROPN
ecj-12528	24	44	,	,	PUNCT
ecj-12528	24	45	sb	sb	PROPN
ecj-12528	24	46	,	,	PUNCT
ecj-12528	24	47	ak	ak	PROPN
ecj-12528	24	48	;	;	PUNCT
ecj-12528	24	49	review	review	NOUN
ecj-12528	24	50	of	of	ADP
ecj-12528	24	51	manuscript	manuscript	NOUN
ecj-12528	24	52	:	:	PUNCT
ecj-12528	24	53	ak	ak	PROPN
ecj-12528	24	54	,	,	PUNCT
ecj-12528	24	55	se	se	X
ecj-12528	24	56	.	.	PUNCT
ecj-12528	25	1	conflict	conflict	NOUN
ecj-12528	25	2	of	of	ADP
ecj-12528	25	3	interest	interest	NOUN
ecj-12528	25	4	:	:	PUNCT
ecj-12528	25	5	the	the	DET
ecj-12528	25	6	authors	author	NOUN
ecj-12528	25	7	declare	declare	VERB
ecj-12528	25	8	no	no	DET
ecj-12528	25	9	potential	potential	ADJ
ecj-12528	25	10	conflict	conflict	NOUN
ecj-12528	25	11	of	of	ADP
ecj-12528	25	12	interest	interest	NOUN
ecj-12528	25	13	,	,	PUNCT
ecj-12528	25	14	and	and	CCONJ
ecj-12528	25	15	all	all	DET
ecj-12528	25	16	authors	author	NOUN
ecj-12528	25	17	confirm	confirm	VERB
ecj-12528	25	18	accuracy	accuracy	NOUN
ecj-12528	25	19	.	.	PUNCT
ecj-12528	26	1	ethics	ethic	NOUN
ecj-12528	26	2	approval	approval	NOUN
ecj-12528	26	3	:	:	PUNCT
ecj-12528	26	4	our	our	PRON
ecj-12528	26	5	study	study	NOUN
ecj-12528	26	6	was	be	AUX
ecj-12528	26	7	conducted	conduct	VERB
ecj-12528	26	8	after	after	ADP
ecj-12528	26	9	the	the	DET
ecj-12528	26	10	approval	approval	NOUN
ecj-12528	26	11	of	of	ADP
ecj-12528	26	12	mersin	mersin	PROPN
ecj-12528	26	13	university	university	PROPN
ecj-12528	26	14	clinical	clinical	ADJ
ecj-12528	26	15	research	research	NOUN
ecj-12528	26	16	ethics	ethic	NOUN
ecj-12528	26	17	committee	committee	NOUN
ecj-12528	26	18	(	(	PUNCT
ecj-12528	26	19	28/09/2022	28/09/2022	NUM
ecj-12528	26	20	dated	date	VERB
ecj-12528	26	21	and	and	CCONJ
ecj-12528	26	22	2022/646	2022/646	NUM
ecj-12528	26	23	numbered	number	VERB
ecj-12528	26	24	)	)	PUNCT
ecj-12528	26	25	.	.	PUNCT
ecj-12528	27	1	the	the	DET
ecj-12528	27	2	study	study	NOUN
ecj-12528	27	3	is	be	AUX
ecj-12528	27	4	conformed	conform	VERB
ecj-12528	27	5	with	with	ADP
ecj-12528	27	6	the	the	DET
ecj-12528	27	7	helsinki	helsinki	PROPN
ecj-12528	27	8	declaration	declaration	NOUN
ecj-12528	27	9	of	of	ADP
ecj-12528	27	10	1964	1964	NUM
ecj-12528	27	11	,	,	PUNCT
ecj-12528	27	12	as	as	SCONJ
ecj-12528	27	13	revised	revise	VERB
ecj-12528	27	14	in	in	ADP
ecj-12528	27	15	2013	2013	NUM
ecj-12528	27	16	,	,	PUNCT
ecj-12528	27	17	concerning	concern	VERB
ecj-12528	27	18	human	human	ADJ
ecj-12528	27	19	and	and	CCONJ
ecj-12528	27	20	animal	animal	NOUN
ecj-12528	27	21	rights	right	NOUN
ecj-12528	27	22	.	.	PUNCT
ecj-12528	28	1	informed	informed	ADJ
ecj-12528	28	2	consent	consent	NOUN
ecj-12528	28	3	:	:	PUNCT
ecj-12528	28	4	all	all	DET
ecj-12528	28	5	patients	patient	NOUN
ecj-12528	28	6	participating	participate	VERB
ecj-12528	28	7	in	in	ADP
ecj-12528	28	8	this	this	DET
ecj-12528	28	9	study	study	NOUN
ecj-12528	28	10	signed	sign	VERB
ecj-12528	28	11	a	a	DET
ecj-12528	28	12	written	write	VERB
ecj-12528	28	13	informed	inform	VERB
ecj-12528	28	14	consent	consent	NOUN
ecj-12528	28	15	form	form	NOUN
ecj-12528	28	16	for	for	ADP
ecj-12528	28	17	participating	participate	VERB
ecj-12528	28	18	in	in	ADP
ecj-12528	28	19	this	this	DET
ecj-12528	28	20	study	study	NOUN
ecj-12528	28	21	.	.	PUNCT
ecj-12528	29	1	patient	patient	ADJ
ecj-12528	29	2	consent	consent	NOUN
ecj-12528	29	3	for	for	ADP
ecj-12528	29	4	publication	publication	NOUN
ecj-12528	29	5	:	:	PUNCT
ecj-12528	29	6	written	write	VERB
ecj-12528	29	7	informed	informed	ADJ
ecj-12528	29	8	consent	consent	NOUN
ecj-12528	29	9	was	be	AUX
ecj-12528	29	10	obtained	obtain	VERB
ecj-12528	29	11	from	from	ADP
ecj-12528	29	12	a	a	DET
ecj-12528	29	13	legally	legally	ADV
ecj-12528	29	14	authorized	authorize	VERB
ecj-12528	29	15	representative(s	representative(s	NOUN
ecj-12528	29	16	)	)	PUNCT
ecj-12528	29	17	for	for	ADP
ecj-12528	29	18	anonymized	anonymize	VERB
ecj-12528	29	19	patient	patient	ADJ
ecj-12528	29	20	information	information	NOUN
ecj-12528	29	21	to	to	PART
ecj-12528	29	22	be	be	AUX
ecj-12528	29	23	published	publish	VERB
ecj-12528	29	24	in	in	ADP
ecj-12528	29	25	this	this	DET
ecj-12528	29	26	article	article	NOUN
ecj-12528	29	27	.	.	PUNCT
ecj-12528	30	1	availability	availability	NOUN
ecj-12528	30	2	of	of	ADP
ecj-12528	30	3	data	datum	NOUN
ecj-12528	30	4	and	and	CCONJ
ecj-12528	30	5	materials	material	NOUN
ecj-12528	30	6	:	:	PUNCT
ecj-12528	30	7	all	all	DET
ecj-12528	30	8	data	datum	NOUN
ecj-12528	30	9	generated	generate	VERB
ecj-12528	30	10	or	or	CCONJ
ecj-12528	30	11	analyzed	analyze	VERB
ecj-12528	30	12	during	during	ADP
ecj-12528	30	13	this	this	DET
ecj-12528	30	14	study	study	NOUN
ecj-12528	30	15	are	be	AUX
ecj-12528	30	16	included	include	VERB
ecj-12528	30	17	in	in	ADP
ecj-12528	30	18	this	this	DET
ecj-12528	30	19	published	publish	VERB
ecj-12528	30	20	article	article	NOUN
ecj-12528	30	21	.	.	PUNCT
ecj-12528	31	1	received	receive	VERB
ecj-12528	31	2	:	:	PUNCT
ecj-12528	31	3	30	30	NUM
ecj-12528	31	4	march	march	NOUN
ecj-12528	31	5	2024	2024	NUM
ecj-12528	31	6	.	.	PUNCT
ecj-12528	32	1	accepted	accept	VERB
ecj-12528	32	2	:	:	PUNCT
ecj-12528	32	3	4	4	NUM
ecj-12528	32	4	june	june	PROPN
ecj-12528	32	5	2024	2024	NUM
ecj-12528	32	6	.	.	PUNCT
ecj-12528	33	1	early	early	ADJ
ecj-12528	33	2	view	view	NOUN
ecj-12528	33	3	:	:	PUNCT
ecj-12528	33	4	18	18	NUM
ecj-12528	33	5	july	july	PROPN
ecj-12528	33	6	2024	2024	NUM
ecj-12528	33	7	.	.	PUNCT
ecj-12528	34	1	this	this	DET
ecj-12528	34	2	work	work	NOUN
ecj-12528	34	3	is	be	AUX
ecj-12528	34	4	licensed	license	VERB
ecj-12528	34	5	under	under	ADP
ecj-12528	34	6	a	a	DET
ecj-12528	34	7	creative	creative	ADJ
ecj-12528	34	8	commons	common	NOUN
ecj-12528	34	9	attribution	attribution	NOUN
ecj-12528	34	10	4.0	4.0	NUM
ecj-12528	34	11	license	license	NOUN
ecj-12528	34	12	(	(	PUNCT
ecj-12528	34	13	by	by	ADP
ecj-12528	34	14	-	-	PUNCT
ecj-12528	34	15	nc	nc	PROPN
ecj-12528	34	16	4.0	4.0	NUM
ecj-12528	34	17	)	)	PUNCT
ecj-12528	34	18	.	.	PUNCT
ecj-12528	35	1	©	©	PROPN
ecj-12528	35	2	copyright	copyright	NOUN
ecj-12528	35	3	:	:	PUNCT
ecj-12528	35	4	the	the	DET
ecj-12528	35	5	author(s	author(s	PROPN
ecj-12528	35	6	)	)	PUNCT
ecj-12528	35	7	,	,	PUNCT
ecj-12528	35	8	2024	2024	NUM
ecj-12528	35	9	licensee	licensee	NOUN
ecj-12528	35	10	pagepress	pagepress	NOUN
ecj-12528	35	11	,	,	PUNCT
ecj-12528	35	12	italy	italy	PROPN
ecj-12528	35	13	emergency	emergency	PROPN
ecj-12528	35	14	care	care	PROPN
ecj-12528	35	15	journal	journal	PROPN
ecj-12528	35	16	2024	2024	NUM
ecj-12528	35	17	;	;	PUNCT
ecj-12528	35	18	20:12528	20:12528	NUM
ecj-12528	35	19	doi:10.4081	doi:10.4081	NOUN
ecj-12528	35	20	/	/	SYM
ecj-12528	35	21	ecj.2024.12528	ecj.2024.12528	PROPN
ecj-12528	35	22	publisher	publisher	NOUN
ecj-12528	35	23	's	's	PART
ecj-12528	35	24	note	note	NOUN
ecj-12528	35	25	:	:	PUNCT
ecj-12528	35	26	all	all	DET
ecj-12528	35	27	claims	claim	NOUN
ecj-12528	35	28	expressed	express	VERB
ecj-12528	35	29	in	in	ADP
ecj-12528	35	30	this	this	DET
ecj-12528	35	31	article	article	NOUN
ecj-12528	35	32	are	be	AUX
ecj-12528	35	33	solely	solely	ADV
ecj-12528	35	34	those	those	PRON
ecj-12528	35	35	of	of	ADP
ecj-12528	35	36	the	the	DET
ecj-12528	35	37	authors	author	NOUN
ecj-12528	35	38	and	and	CCONJ
ecj-12528	35	39	do	do	AUX
ecj-12528	35	40	not	not	PART
ecj-12528	35	41	necessarily	necessarily	ADV
ecj-12528	35	42	represent	represent	VERB
ecj-12528	35	43	those	those	PRON
ecj-12528	35	44	of	of	ADP
ecj-12528	35	45	their	their	PRON
ecj-12528	35	46	affiliated	affiliated	ADJ
ecj-12528	35	47	organizations	organization	NOUN
ecj-12528	35	48	,	,	PUNCT
ecj-12528	35	49	or	or	CCONJ
ecj-12528	35	50	those	those	PRON
ecj-12528	35	51	of	of	ADP
ecj-12528	35	52	the	the	DET
ecj-12528	35	53	publisher	publisher	NOUN
ecj-12528	35	54	,	,	PUNCT
ecj-12528	35	55	the	the	DET
ecj-12528	35	56	editors	editor	NOUN
ecj-12528	35	57	and	and	CCONJ
ecj-12528	35	58	the	the	DET
ecj-12528	35	59	reviewers	reviewer	NOUN
ecj-12528	35	60	.	.	PUNCT
ecj-12528	36	1	any	any	DET
ecj-12528	36	2	product	product	NOUN
ecj-12528	36	3	that	that	PRON
ecj-12528	36	4	may	may	AUX
ecj-12528	36	5	be	be	AUX
ecj-12528	36	6	evaluated	evaluate	VERB
ecj-12528	36	7	in	in	ADP
ecj-12528	36	8	this	this	DET
ecj-12528	36	9	article	article	NOUN
ecj-12528	36	10	or	or	CCONJ
ecj-12528	36	11	claim	claim	NOUN
ecj-12528	36	12	that	that	PRON
ecj-12528	36	13	may	may	AUX
ecj-12528	36	14	be	be	AUX
ecj-12528	36	15	made	make	VERB
ecj-12528	36	16	by	by	ADP
ecj-12528	36	17	its	its	PRON
ecj-12528	36	18	manufacturer	manufacturer	NOUN
ecj-12528	36	19	is	be	AUX
ecj-12528	36	20	not	not	PART
ecj-12528	36	21	guaranteed	guarantee	VERB
ecj-12528	36	22	or	or	CCONJ
ecj-12528	36	23	endorsed	endorse	VERB
ecj-12528	36	24	by	by	ADP
ecj-12528	36	25	the	the	DET
ecj-12528	36	26	publisher	publisher	NOUN
ecj-12528	36	27	.	.	PUNCT
ecj-12528	37	1	prognostic	prognostic	ADJ
ecj-12528	37	2	importance	importance	NOUN
ecj-12528	37	3	of	of	ADP
ecj-12528	37	4	the	the	DET
ecj-12528	37	5	systemic	systemic	ADJ
ecj-12528	37	6	inflammatory	inflammatory	ADJ
ecj-12528	37	7	index	index	NOUN
ecj-12528	37	8	and	and	CCONJ
ecj-12528	37	9	the	the	DET
ecj-12528	37	10	systemic	systemic	ADJ
ecj-12528	37	11	inflammatory	inflammatory	ADJ
ecj-12528	37	12	response	response	NOUN
ecj-12528	37	13	index	index	NOUN
ecj-12528	37	14	in	in	ADP
ecj-12528	37	15	covid-19	covid-19	PROPN
ecj-12528	37	16	patients	patient	NOUN
ecj-12528	37	17	alikemal	alikemal	ADJ
ecj-12528	37	18	topal,1	topal,1	DET
ecj-12528	37	19	akif	akif	ADV
ecj-12528	37	20	yarkaç,1	yarkaç,1	ADJ
ecj-12528	37	21	seyran	seyran	ADJ
ecj-12528	37	22	bozkurt,1	bozkurt,1	NOUN
ecj-12528	37	23	çağrı	çağrı	PROPN
ecj-12528	37	24	safa	safa	PROPN
ecj-12528	37	25	buyurgan,1	buyurgan,1	PROPN
ecj-12528	37	26	ataman	ataman	PROPN
ecj-12528	37	27	köse,1	köse,1	PROPN
ecj-12528	37	28	semra	semra	PROPN
ecj-12528	37	29	erdoğan2	erdoğan2	PROPN
ecj-12528	38	1	1emergency	1emergency	NUM
ecj-12528	38	2	medicine	medicine	NOUN
ecj-12528	38	3	department	department	PROPN
ecj-12528	38	4	,	,	PUNCT
ecj-12528	38	5	mersin	mersin	PROPN
ecj-12528	38	6	university	university	PROPN
ecj-12528	38	7	medical	medical	ADJ
ecj-12528	38	8	faculty	faculty	NOUN
ecj-12528	38	9	,	,	PUNCT
ecj-12528	38	10	mersin	mersin	PROPN
ecj-12528	38	11	;	;	PUNCT
ecj-12528	38	12	2department	2department	NUM
ecj-12528	38	13	of	of	ADP
ecj-12528	38	14	biostatistics	biostatistic	NOUN
ecj-12528	38	15	and	and	CCONJ
ecj-12528	38	16	medical	medical	ADJ
ecj-12528	38	17	informatics	informatics	PROPN
ecj-12528	38	18	,	,	PUNCT
ecj-12528	38	19	mersin	mersin	PROPN
ecj-12528	38	20	university	university	PROPN
ecj-12528	38	21	medical	medical	ADJ
ecj-12528	38	22	faculty	faculty	PROPN
ecj-12528	38	23	,	,	PUNCT
ecj-12528	38	24	mersin	mersin	PROPN
ecj-12528	38	25	,	,	PUNCT
ecj-12528	38	26	turkey	turkey	PROPN
ecj-12528	38	27	non	non	PROPN
ecj-12528	38	28	-co	-co	PROPN
ecj-12528	38	29	mmerc	mmerc	PROPN
ecj-12528	38	30	ial	ial	PROPN
ecj-12528	38	31	us	us	PROPN
ecj-12528	38	32	e	e	NOUN
ecj-12528	38	33	o	o	NOUN
ecj-12528	38	34	nly	nly	ADV
ecj-12528	38	35	capacity	capacity	NOUN
ecj-12528	38	36	of	of	ADP
ecj-12528	38	37	these	these	DET
ecj-12528	38	38	indices	index	NOUN
ecj-12528	38	39	,	,	PUNCT
ecj-12528	38	40	and	and	CCONJ
ecj-12528	38	41	these	these	PRON
ecj-12528	38	42	are	be	AUX
ecj-12528	38	43	limited	limit	VERB
ecj-12528	38	44	to	to	ADP
ecj-12528	38	45	nlr	nlr	PROPN
ecj-12528	38	46	and	and	CCONJ
ecj-12528	38	47	plr.9	plr.9	PROPN
ecj-12528	38	48	in	in	ADP
ecj-12528	38	49	our	our	PRON
ecj-12528	38	50	study	study	NOUN
ecj-12528	38	51	,	,	PUNCT
ecj-12528	38	52	we	we	PRON
ecj-12528	38	53	aimed	aim	VERB
ecj-12528	38	54	to	to	PART
ecj-12528	38	55	evaluate	evaluate	VERB
ecj-12528	38	56	the	the	DET
ecj-12528	38	57	prognostic	prognostic	ADJ
ecj-12528	38	58	effect	effect	NOUN
ecj-12528	38	59	of	of	ADP
ecj-12528	38	60	sii	sii	PROPN
ecj-12528	38	61	and	and	CCONJ
ecj-12528	38	62	the	the	DET
ecj-12528	38	63	systemic	systemic	ADJ
ecj-12528	38	64	inflammation	inflammation	ADJ
ecj-12528	38	65	response	response	NOUN
ecj-12528	38	66	index	index	NOUN
ecj-12528	38	67	(	(	PUNCT
ecj-12528	38	68	siri	siri	NOUN
ecj-12528	38	69	)	)	PUNCT
ecj-12528	38	70	in	in	ADP
ecj-12528	38	71	covid-19	covid-19	PROPN
ecj-12528	38	72	patients	patient	NOUN
ecj-12528	38	73	.	.	PUNCT
ecj-12528	39	1	materials	material	NOUN
ecj-12528	39	2	and	and	CCONJ
ecj-12528	39	3	methods	method	NOUN
ecj-12528	39	4	study	study	NOUN
ecj-12528	39	5	design	design	NOUN
ecj-12528	39	6	patients	patient	NOUN
ecj-12528	39	7	aged	age	VERB
ecj-12528	39	8	18	18	NUM
ecj-12528	39	9	years	year	NOUN
ecj-12528	39	10	and	and	CCONJ
ecj-12528	39	11	over	over	ADP
ecj-12528	39	12	who	who	PRON
ecj-12528	39	13	applied	apply	VERB
ecj-12528	39	14	to	to	ADP
ecj-12528	39	15	the	the	DET
ecj-12528	39	16	emergency	emergency	NOUN
ecj-12528	39	17	department	department	PROPN
ecj-12528	39	18	of	of	ADP
ecj-12528	39	19	mersin	mersin	PROPN
ecj-12528	39	20	university	university	PROPN
ecj-12528	39	21	hospital	hospital	NOUN
ecj-12528	39	22	between	between	ADP
ecj-12528	39	23	september	september	PROPN
ecj-12528	39	24	1	1	NUM
ecj-12528	39	25	,	,	PUNCT
ecj-12528	39	26	2020	2020	NUM
ecj-12528	39	27	,	,	PUNCT
ecj-12528	39	28	and	and	CCONJ
ecj-12528	39	29	august	august	PROPN
ecj-12528	39	30	31	31	NUM
ecj-12528	39	31	,	,	PUNCT
ecj-12528	39	32	2021	2021	NUM
ecj-12528	39	33	,	,	PUNCT
ecj-12528	39	34	and	and	CCONJ
ecj-12528	39	35	had	have	VERB
ecj-12528	39	36	a	a	DET
ecj-12528	39	37	positive	positive	ADJ
ecj-12528	39	38	covid-19	covid-19	PROPN
ecj-12528	39	39	polymerase	polymerase	NOUN
ecj-12528	39	40	chain	chain	NOUN
ecj-12528	39	41	reaction	reaction	NOUN
ecj-12528	39	42	(	(	PUNCT
ecj-12528	39	43	pcr	pcr	NOUN
ecj-12528	39	44	)	)	PUNCT
ecj-12528	39	45	test	test	NOUN
ecj-12528	39	46	were	be	AUX
ecj-12528	39	47	included	include	VERB
ecj-12528	39	48	in	in	ADP
ecj-12528	39	49	the	the	DET
ecj-12528	39	50	study	study	NOUN
ecj-12528	39	51	.	.	PUNCT
ecj-12528	40	1	information	information	NOUN
ecj-12528	40	2	including	include	VERB
ecj-12528	40	3	age	age	NOUN
ecj-12528	40	4	,	,	PUNCT
ecj-12528	40	5	gender	gender	NOUN
ecj-12528	40	6	,	,	PUNCT
ecj-12528	40	7	complaint	complaint	NOUN
ecj-12528	40	8	at	at	ADP
ecj-12528	40	9	presentation	presentation	NOUN
ecj-12528	40	10	,	,	PUNCT
ecj-12528	40	11	vital	vital	ADJ
ecj-12528	40	12	signs	sign	NOUN
ecj-12528	40	13	,	,	PUNCT
ecj-12528	40	14	comorbid	comorbid	NOUN
ecj-12528	40	15	diseases	disease	NOUN
ecj-12528	40	16	,	,	PUNCT
ecj-12528	40	17	laboratory	laboratory	NOUN
ecj-12528	40	18	and	and	CCONJ
ecj-12528	40	19	radiological	radiological	ADJ
ecj-12528	40	20	examination	examination	NOUN
ecj-12528	40	21	results	result	NOUN
ecj-12528	40	22	,	,	PUNCT
ecj-12528	40	23	emergency	emergency	NOUN
ecj-12528	40	24	department	department	NOUN
ecj-12528	40	25	(	(	PUNCT
ecj-12528	40	26	hospitalization	hospitalization	NOUN
ecj-12528	40	27	,	,	PUNCT
ecj-12528	40	28	discharge	discharge	NOUN
ecj-12528	40	29	,	,	PUNCT
ecj-12528	40	30	death	death	NOUN
ecj-12528	40	31	)	)	PUNCT
ecj-12528	40	32	,	,	PUNCT
ecj-12528	40	33	and	and	CCONJ
ecj-12528	40	34	hospital	hospital	NOUN
ecj-12528	40	35	outcome	outcome	NOUN
ecj-12528	40	36	(	(	PUNCT
ecj-12528	40	37	discharge	discharge	NOUN
ecj-12528	40	38	,	,	PUNCT
ecj-12528	40	39	death	death	NOUN
ecj-12528	40	40	)	)	PUNCT
ecj-12528	40	41	were	be	AUX
ecj-12528	40	42	recorded	record	VERB
ecj-12528	40	43	on	on	ADP
ecj-12528	40	44	a	a	DET
ecj-12528	40	45	preprepared	preprepare	VERB
ecj-12528	40	46	data	data	NOUN
ecj-12528	40	47	form	form	NOUN
ecj-12528	40	48	.	.	PUNCT
ecj-12528	41	1	patient	patient	ADJ
ecj-12528	41	2	data	datum	NOUN
ecj-12528	41	3	were	be	AUX
ecj-12528	41	4	analyzed	analyze	VERB
ecj-12528	41	5	retrospectively	retrospectively	ADV
ecj-12528	41	6	through	through	ADP
ecj-12528	41	7	the	the	DET
ecj-12528	41	8	hospital	hospital	NOUN
ecj-12528	41	9	’s	’s	PART
ecj-12528	41	10	electronic	electronic	ADJ
ecj-12528	41	11	information	information	NOUN
ecj-12528	41	12	management	management	NOUN
ecj-12528	41	13	system	system	NOUN
ecj-12528	41	14	.	.	PUNCT
ecj-12528	42	1	exclusion	exclusion	NOUN
ecj-12528	42	2	criteria	criterion	NOUN
ecj-12528	42	3	patients	patient	NOUN
ecj-12528	42	4	younger	young	ADJ
ecj-12528	42	5	than	than	ADP
ecj-12528	42	6	18	18	NUM
ecj-12528	42	7	years	year	NOUN
ecj-12528	42	8	of	of	ADP
ecj-12528	42	9	age	age	NOUN
ecj-12528	42	10	,	,	PUNCT
ecj-12528	42	11	patients	patient	NOUN
ecj-12528	42	12	with	with	ADP
ecj-12528	42	13	a	a	DET
ecj-12528	42	14	negative	negative	ADJ
ecj-12528	42	15	pcr	pcr	ADJ
ecj-12528	42	16	test	test	NOUN
ecj-12528	42	17	at	at	ADP
ecj-12528	42	18	emergency	emergency	NOUN
ecj-12528	42	19	department	department	NOUN
ecj-12528	42	20	admission	admission	NOUN
ecj-12528	42	21	,	,	PUNCT
ecj-12528	42	22	patients	patient	NOUN
ecj-12528	42	23	with	with	ADP
ecj-12528	42	24	incomplete	incomplete	ADJ
ecj-12528	42	25	data	datum	NOUN
ecj-12528	42	26	,	,	PUNCT
ecj-12528	42	27	patients	patient	NOUN
ecj-12528	42	28	with	with	ADP
ecj-12528	42	29	a	a	DET
ecj-12528	42	30	history	history	NOUN
ecj-12528	42	31	of	of	ADP
ecj-12528	42	32	active	active	ADJ
ecj-12528	42	33	malignancy	malignancy	NOUN
ecj-12528	42	34	,	,	PUNCT
ecj-12528	42	35	patients	patient	NOUN
ecj-12528	42	36	with	with	ADP
ecj-12528	42	37	hematological	hematological	ADJ
ecj-12528	42	38	disorders	disorder	NOUN
ecj-12528	42	39	(	(	PUNCT
ecj-12528	42	40	leukemia	leukemia	NOUN
ecj-12528	42	41	,	,	PUNCT
ecj-12528	42	42	lymphoma	lymphoma	NOUN
ecj-12528	42	43	)	)	PUNCT
ecj-12528	42	44	,	,	PUNCT
ecj-12528	42	45	patients	patient	NOUN
ecj-12528	42	46	who	who	PRON
ecj-12528	42	47	have	have	AUX
ecj-12528	42	48	received	receive	VERB
ecj-12528	42	49	chemotherapy	chemotherapy	NOUN
ecj-12528	42	50	in	in	ADP
ecj-12528	42	51	the	the	DET
ecj-12528	42	52	last	last	ADJ
ecj-12528	42	53	month	month	NOUN
ecj-12528	42	54	,	,	PUNCT
ecj-12528	42	55	and	and	CCONJ
ecj-12528	42	56	patients	patient	NOUN
ecj-12528	42	57	who	who	PRON
ecj-12528	42	58	received	receive	VERB
ecj-12528	42	59	blood	blood	NOUN
ecj-12528	42	60	transfusions	transfusion	NOUN
ecj-12528	42	61	within	within	ADP
ecj-12528	42	62	the	the	DET
ecj-12528	42	63	last	last	ADJ
ecj-12528	42	64	3	3	NUM
ecj-12528	42	65	months	month	NOUN
ecj-12528	42	66	before	before	ADP
ecj-12528	42	67	admission	admission	NOUN
ecj-12528	42	68	were	be	AUX
ecj-12528	42	69	excluded	exclude	VERB
ecj-12528	42	70	from	from	ADP
ecj-12528	42	71	the	the	DET
ecj-12528	42	72	study	study	NOUN
ecj-12528	42	73	.	.	PUNCT
ecj-12528	43	1	severity	severity	NOUN
ecj-12528	43	2	status	status	NOUN
ecj-12528	43	3	i	i	NOUN
ecj-12528	43	4	)	)	PUNCT
ecj-12528	43	5	oxygen	oxygen	NOUN
ecj-12528	43	6	saturation	saturation	NOUN
ecj-12528	43	7	≤	≤	NOUN
ecj-12528	43	8	93	93	NUM
ecj-12528	43	9	%	%	NOUN
ecj-12528	43	10	at	at	ADP
ecj-12528	43	11	rest	rest	NOUN
ecj-12528	43	12	;	;	PUNCT
ecj-12528	43	13	ii	ii	X
ecj-12528	43	14	)	)	PUNCT
ecj-12528	43	15	respiratory	respiratory	ADJ
ecj-12528	43	16	distress	distress	NOUN
ecj-12528	43	17	and	and	CCONJ
ecj-12528	43	18	a	a	DET
ecj-12528	43	19	respiratory	respiratory	ADJ
ecj-12528	43	20	rate	rate	NOUN
ecj-12528	43	21	greater	great	ADJ
ecj-12528	43	22	than	than	ADP
ecj-12528	43	23	30	30	NUM
ecj-12528	43	24	/	/	SYM
ecj-12528	43	25	minute	minute	NOUN
ecj-12528	43	26	;	;	PUNCT
ecj-12528	43	27	iii	iii	X
ecj-12528	43	28	)	)	PUNCT
ecj-12528	43	29	pao2	pao2	PROPN
ecj-12528	43	30	/	/	SYM
ecj-12528	43	31	fio2	fio2	PROPN
ecj-12528	43	32	ratio	ratio	NOUN
ecj-12528	43	33	≤	≤	NUM
ecj-12528	43	34	300	300	NUM
ecj-12528	43	35	mmhg	mmhg	NOUN
ecj-12528	43	36	;	;	PUNCT
ecj-12528	43	37	iv	iv	X
ecj-12528	43	38	)	)	PUNCT
ecj-12528	43	39	short	short	ADJ
ecj-12528	43	40	-	-	PUNCT
ecj-12528	43	41	term	term	NOUN
ecj-12528	43	42	(	(	PUNCT
ecj-12528	43	43	24–48	24–48	NUM
ecj-12528	43	44	hours	hour	NOUN
ecj-12528	43	45	)	)	PUNCT
ecj-12528	43	46	>	>	PUNCT
ecj-12528	43	47	50	50	NUM
ecj-12528	43	48	%	%	NOUN
ecj-12528	43	49	progression	progression	NOUN
ecj-12528	43	50	on	on	ADP
ecj-12528	43	51	lung	lung	NOUN
ecj-12528	43	52	imaging	imaging	NOUN
ecj-12528	43	53	;	;	PUNCT
ecj-12528	43	54	v	v	X
ecj-12528	43	55	)	)	PUNCT
ecj-12528	43	56	cases	case	NOUN
ecj-12528	43	57	with	with	ADP
ecj-12528	43	58	septic	septic	ADJ
ecj-12528	43	59	shock	shock	NOUN
ecj-12528	43	60	and/or	and/or	CCONJ
ecj-12528	43	61	multiple	multiple	ADJ
ecj-12528	43	62	organ	organ	NOUN
ecj-12528	43	63	dysfunction	dysfunction	NOUN
ecj-12528	43	64	were	be	AUX
ecj-12528	43	65	considered	consider	VERB
ecj-12528	43	66	serious.2	serious.2	ADP
ecj-12528	43	67	patients	patient	NOUN
ecj-12528	43	68	were	be	AUX
ecj-12528	43	69	categorized	categorize	VERB
ecj-12528	43	70	as	as	ADP
ecj-12528	43	71	severe	severe	ADJ
ecj-12528	43	72	if	if	SCONJ
ecj-12528	43	73	at	at	ADV
ecj-12528	43	74	least	least	ADJ
ecj-12528	43	75	one	one	NUM
ecj-12528	43	76	of	of	ADP
ecj-12528	43	77	these	these	DET
ecj-12528	43	78	criteria	criterion	NOUN
ecj-12528	43	79	was	be	AUX
ecj-12528	43	80	present	present	ADJ
ecj-12528	43	81	and	and	CCONJ
ecj-12528	43	82	non	non	ADJ
ecj-12528	43	83	-	-	ADJ
ecj-12528	43	84	severe	severe	ADJ
ecj-12528	43	85	if	if	SCONJ
ecj-12528	43	86	none	none	NOUN
ecj-12528	43	87	was	be	AUX
ecj-12528	43	88	present	present	ADJ
ecj-12528	43	89	.	.	PUNCT
ecj-12528	44	1	sii	sii	ADJ
ecj-12528	44	2	,	,	PUNCT
ecj-12528	44	3	siri	siri	NOUN
ecj-12528	44	4	,	,	PUNCT
ecj-12528	44	5	and	and	CCONJ
ecj-12528	44	6	other	other	ADJ
ecj-12528	44	7	parameters	parameter	NOUN
ecj-12528	44	8	were	be	AUX
ecj-12528	44	9	compared	compare	VERB
ecj-12528	44	10	according	accord	VERB
ecj-12528	44	11	to	to	ADP
ecj-12528	44	12	the	the	DET
ecj-12528	44	13	severity	severity	NOUN
ecj-12528	44	14	of	of	ADP
ecj-12528	44	15	the	the	DET
ecj-12528	44	16	disease	disease	NOUN
ecj-12528	44	17	,	,	PUNCT
ecj-12528	44	18	survival	survival	NOUN
ecj-12528	44	19	,	,	PUNCT
ecj-12528	44	20	and	and	CCONJ
ecj-12528	44	21	mortality	mortality	NOUN
ecj-12528	44	22	.	.	PUNCT
ecj-12528	45	1	systemic	systemic	ADJ
ecj-12528	45	2	inflammatory	inflammatory	ADJ
ecj-12528	45	3	index	index	NOUN
ecj-12528	45	4	(	(	PUNCT
ecj-12528	45	5	sii	sii	PROPN
ecj-12528	45	6	)	)	PUNCT
ecj-12528	45	7	was	be	AUX
ecj-12528	45	8	calculated	calculate	VERB
ecj-12528	45	9	as	as	ADP
ecj-12528	45	10	platelet	platelet	NOUN
ecj-12528	45	11	count	count	NOUN
ecj-12528	45	12	×	×	NOUN
ecj-12528	45	13	neutrophil	neutrophil	ADJ
ecj-12528	45	14	count	count	NOUN
ecj-12528	45	15	/	/	SYM
ecj-12528	45	16	lymphocyte	lymphocyte	ADJ
ecj-12528	45	17	count	count	NOUN
ecj-12528	45	18	,	,	PUNCT
ecj-12528	45	19	systemic	systemic	ADJ
ecj-12528	45	20	inflammation	inflammation	ADJ
ecj-12528	45	21	response	response	NOUN
ecj-12528	45	22	index	index	NOUN
ecj-12528	45	23	(	(	PUNCT
ecj-12528	45	24	siri	siri	NOUN
ecj-12528	45	25	)	)	PUNCT
ecj-12528	45	26	was	be	AUX
ecj-12528	45	27	calculated	calculate	VERB
ecj-12528	45	28	as	as	ADP
ecj-12528	45	29	(	(	PUNCT
ecj-12528	45	30	neutrophil	neutrophil	ADJ
ecj-12528	45	31	count	count	VERB
ecj-12528	45	32	×	×	PROPN
ecj-12528	45	33	monocyte	monocyte	NOUN
ecj-12528	45	34	count)/lymphocyte	count)/lymphocyte	NOUN
ecj-12528	45	35	count).9,10	count).9,10	NOUN
ecj-12528	45	36	our	our	PRON
ecj-12528	45	37	study	study	NOUN
ecj-12528	45	38	was	be	AUX
ecj-12528	45	39	conducted	conduct	VERB
ecj-12528	45	40	after	after	ADP
ecj-12528	45	41	the	the	DET
ecj-12528	45	42	approval	approval	NOUN
ecj-12528	45	43	of	of	ADP
ecj-12528	45	44	mersin	mersin	PROPN
ecj-12528	45	45	university	university	PROPN
ecj-12528	45	46	clinical	clinical	ADJ
ecj-12528	45	47	research	research	NOUN
ecj-12528	45	48	ethics	ethic	NOUN
ecj-12528	45	49	committee	committee	NOUN
ecj-12528	45	50	(	(	PUNCT
ecj-12528	45	51	28/09/2022	28/09/2022	NUM
ecj-12528	45	52	dated	date	VERB
ecj-12528	45	53	and	and	CCONJ
ecj-12528	45	54	2022/646	2022/646	NUM
ecj-12528	45	55	numbered	number	VERB
ecj-12528	45	56	)	)	PUNCT
ecj-12528	45	57	.	.	PUNCT
ecj-12528	46	1	statistical	statistical	ADJ
ecj-12528	46	2	analysis	analysis	NOUN
ecj-12528	46	3	normality	normality	NOUN
ecj-12528	46	4	controls	control	NOUN
ecj-12528	46	5	for	for	ADP
ecj-12528	46	6	continuous	continuous	ADJ
ecj-12528	46	7	measurements	measurement	NOUN
ecj-12528	46	8	were	be	AUX
ecj-12528	46	9	tested	test	VERB
ecj-12528	46	10	with	with	ADP
ecj-12528	46	11	the	the	DET
ecj-12528	46	12	shapiro	shapiro	PROPN
ecj-12528	46	13	-	-	PUNCT
ecj-12528	46	14	wilk	wilk	NOUN
ecj-12528	46	15	test	test	NOUN
ecj-12528	46	16	.	.	PUNCT
ecj-12528	47	1	differences	difference	NOUN
ecj-12528	47	2	between	between	ADP
ecj-12528	47	3	continuous	continuous	ADJ
ecj-12528	47	4	measurements	measurement	NOUN
ecj-12528	47	5	of	of	ADP
ecj-12528	47	6	mortality	mortality	NOUN
ecj-12528	47	7	and	and	CCONJ
ecj-12528	47	8	severity	severity	NOUN
ecj-12528	47	9	parameters	parameter	NOUN
ecj-12528	47	10	were	be	AUX
ecj-12528	47	11	tested	test	VERB
ecj-12528	47	12	with	with	ADP
ecj-12528	47	13	the	the	DET
ecj-12528	47	14	student	student	NOUN
ecj-12528	47	15	t	t	PROPN
ecj-12528	47	16	-	-	PUNCT
ecj-12528	47	17	test	test	NOUN
ecj-12528	47	18	for	for	ADP
ecj-12528	47	19	normally	normally	ADV
ecj-12528	47	20	distributed	distribute	VERB
ecj-12528	47	21	parameters	parameter	NOUN
ecj-12528	47	22	and	and	CCONJ
ecj-12528	47	23	the	the	DET
ecj-12528	47	24	mannwhitney	mannwhitney	NOUN
ecj-12528	47	25	u	u	PROPN
ecj-12528	47	26	test	test	NOUN
ecj-12528	47	27	for	for	ADP
ecj-12528	47	28	non	non	ADJ
ecj-12528	47	29	-	-	ADJ
ecj-12528	47	30	normally	normally	ADV
ecj-12528	47	31	distributed	distribute	VERB
ecj-12528	47	32	parameters	parameter	NOUN
ecj-12528	47	33	.	.	PUNCT
ecj-12528	48	1	as	as	SCONJ
ecj-12528	48	2	descriptive	descriptive	ADJ
ecj-12528	48	3	statistics	statistic	NOUN
ecj-12528	48	4	mean	mean	VERB
ecj-12528	48	5	and	and	CCONJ
ecj-12528	48	6	standard	standard	ADJ
ecj-12528	48	7	deviation	deviation	NOUN
ecj-12528	48	8	values	value	NOUN
ecj-12528	48	9	were	be	AUX
ecj-12528	48	10	given	give	VERB
ecj-12528	48	11	for	for	ADP
ecj-12528	48	12	normally	normally	ADV
ecj-12528	48	13	distributed	distribute	VERB
ecj-12528	48	14	parameters	parameter	NOUN
ecj-12528	48	15	,	,	PUNCT
ecj-12528	48	16	and	and	CCONJ
ecj-12528	48	17	minimum	minimum	ADJ
ecj-12528	48	18	,	,	PUNCT
ecj-12528	48	19	maximum	maximum	ADJ
ecj-12528	48	20	,	,	PUNCT
ecj-12528	48	21	median	median	ADJ
ecj-12528	48	22	,	,	PUNCT
ecj-12528	48	23	and	and	CCONJ
ecj-12528	48	24	25–75	25–75	NUM
ecj-12528	48	25	%	%	NOUN
ecj-12528	48	26	percentages	percentage	NOUN
ecj-12528	48	27	were	be	AUX
ecj-12528	48	28	given	give	VERB
ecj-12528	48	29	for	for	ADP
ecj-12528	48	30	non	non	ADJ
ecj-12528	48	31	-	-	ADJ
ecj-12528	48	32	normally	normally	ADV
ecj-12528	48	33	distributed	distribute	VERB
ecj-12528	48	34	measurements	measurement	NOUN
ecj-12528	48	35	.	.	PUNCT
ecj-12528	49	1	pearson	pearson	PROPN
ecj-12528	49	2	chi	chi	PROPN
ecj-12528	49	3	-	-	PUNCT
ecj-12528	49	4	square	square	PROPN
ecj-12528	49	5	,	,	PUNCT
ecj-12528	49	6	fisher	fisher	PROPN
ecj-12528	49	7	exact	exact	ADJ
ecj-12528	49	8	chi	chi	NOUN
ecj-12528	49	9	-	-	PUNCT
ecj-12528	49	10	square	square	ADJ
ecj-12528	49	11	,	,	PUNCT
ecj-12528	49	12	and	and	CCONJ
ecj-12528	49	13	likelihood	likelihood	NOUN
ecj-12528	49	14	ratio	ratio	NOUN
ecj-12528	49	15	chi	chi	ADJ
ecj-12528	49	16	-	-	PUNCT
ecj-12528	49	17	square	square	ADJ
ecj-12528	49	18	tests	test	NOUN
ecj-12528	49	19	were	be	AUX
ecj-12528	49	20	used	use	VERB
ecj-12528	49	21	for	for	ADP
ecj-12528	49	22	differences	difference	NOUN
ecj-12528	49	23	with	with	ADP
ecj-12528	49	24	categorical	categorical	ADJ
ecj-12528	49	25	variables	variable	NOUN
ecj-12528	49	26	.	.	PUNCT
ecj-12528	50	1	numbers	number	NOUN
ecj-12528	50	2	and	and	CCONJ
ecj-12528	50	3	percentage	percentage	NOUN
ecj-12528	50	4	values	value	NOUN
ecj-12528	50	5	are	be	AUX
ecj-12528	50	6	given	give	VERB
ecj-12528	50	7	as	as	ADP
ecj-12528	50	8	descriptive	descriptive	ADJ
ecj-12528	50	9	statistics	statistic	NOUN
ecj-12528	50	10	.	.	PUNCT
ecj-12528	51	1	cut	cut	VERB
ecj-12528	51	2	-	-	PUNCT
ecj-12528	51	3	off	off	ADP
ecj-12528	51	4	points	point	NOUN
ecj-12528	51	5	for	for	ADP
ecj-12528	51	6	continuous	continuous	ADJ
ecj-12528	51	7	parameters	parameter	NOUN
ecj-12528	51	8	were	be	AUX
ecj-12528	51	9	obtained	obtain	VERB
ecj-12528	51	10	by	by	ADP
ecj-12528	51	11	using	use	VERB
ecj-12528	51	12	roc	roc	PROPN
ecj-12528	51	13	analysis	analysis	NOUN
ecj-12528	51	14	.	.	PUNCT
ecj-12528	52	1	cut	cut	VERB
ecj-12528	52	2	-	-	PUNCT
ecj-12528	52	3	off	off	ADP
ecj-12528	52	4	points	point	NOUN
ecj-12528	52	5	,	,	PUNCT
ecj-12528	52	6	sensitivity	sensitivity	NOUN
ecj-12528	52	7	,	,	PUNCT
ecj-12528	52	8	selectivity	selectivity	NOUN
ecj-12528	52	9	,	,	PUNCT
ecj-12528	52	10	and	and	CCONJ
ecj-12528	52	11	positive	positive	ADJ
ecj-12528	52	12	and	and	CCONJ
ecj-12528	52	13	negative	negative	ADJ
ecj-12528	52	14	predictive	predictive	ADJ
ecj-12528	52	15	values	value	NOUN
ecj-12528	52	16	are	be	AUX
ecj-12528	52	17	given	give	VERB
ecj-12528	52	18	as	as	ADP
ecj-12528	52	19	descriptive	descriptive	ADJ
ecj-12528	52	20	statistics	statistic	NOUN
ecj-12528	52	21	.	.	PUNCT
ecj-12528	53	1	p<0.05	p<0.05	NOUN
ecj-12528	53	2	was	be	AUX
ecj-12528	53	3	taken	take	VERB
ecj-12528	53	4	as	as	ADP
ecj-12528	53	5	statistical	statistical	ADJ
ecj-12528	53	6	significance	significance	NOUN
ecj-12528	53	7	.	.	PUNCT
ecj-12528	54	1	results	result	VERB
ecj-12528	54	2	our	our	PRON
ecj-12528	54	3	study	study	NOUN
ecj-12528	54	4	included	include	VERB
ecj-12528	54	5	446	446	NUM
ecj-12528	54	6	patients	patient	NOUN
ecj-12528	54	7	,	,	PUNCT
ecj-12528	54	8	50.7	50.7	NUM
ecj-12528	54	9	%	%	NOUN
ecj-12528	54	10	of	of	ADP
ecj-12528	54	11	whom	whom	PRON
ecj-12528	54	12	were	be	AUX
ecj-12528	54	13	male	male	ADJ
ecj-12528	54	14	.	.	PUNCT
ecj-12528	55	1	the	the	DET
ecj-12528	55	2	mortality	mortality	NOUN
ecj-12528	55	3	rate	rate	NOUN
ecj-12528	55	4	was	be	AUX
ecj-12528	55	5	30.5	30.5	NUM
ecj-12528	55	6	%	%	NOUN
ecj-12528	55	7	,	,	PUNCT
ecj-12528	55	8	and	and	CCONJ
ecj-12528	55	9	the	the	DET
ecj-12528	55	10	rate	rate	NOUN
ecj-12528	55	11	of	of	ADP
ecj-12528	55	12	patients	patient	NOUN
ecj-12528	55	13	with	with	ADP
ecj-12528	55	14	severe	severe	ADJ
ecj-12528	55	15	disease	disease	NOUN
ecj-12528	55	16	was	be	AUX
ecj-12528	55	17	55.6	55.6	NUM
ecj-12528	55	18	%	%	NOUN
ecj-12528	55	19	.	.	PUNCT
ecj-12528	56	1	it	it	PRON
ecj-12528	56	2	was	be	AUX
ecj-12528	56	3	determined	determine	VERB
ecj-12528	56	4	that	that	SCONJ
ecj-12528	56	5	66.4	66.4	NUM
ecj-12528	56	6	%	%	NOUN
ecj-12528	56	7	of	of	ADP
ecj-12528	56	8	the	the	DET
ecj-12528	56	9	cases	case	NOUN
ecj-12528	56	10	were	be	AUX
ecj-12528	56	11	hospitalized	hospitalize	VERB
ecj-12528	56	12	,	,	PUNCT
ecj-12528	56	13	37.2	37.2	NUM
ecj-12528	56	14	%	%	NOUN
ecj-12528	56	15	of	of	ADP
ecj-12528	56	16	which	which	PRON
ecj-12528	56	17	were	be	AUX
ecj-12528	56	18	in	in	ADP
ecj-12528	56	19	intensive	intensive	ADJ
ecj-12528	56	20	care	care	NOUN
ecj-12528	56	21	.	.	PUNCT
ecj-12528	57	1	the	the	DET
ecj-12528	57	2	mean	mean	ADJ
ecj-12528	57	3	age	age	NOUN
ecj-12528	57	4	of	of	ADP
ecj-12528	57	5	deceased	deceased	ADJ
ecj-12528	57	6	and	and	CCONJ
ecj-12528	57	7	severely	severely	ADV
ecj-12528	57	8	ill	ill	ADJ
ecj-12528	57	9	patients	patient	NOUN
ecj-12528	57	10	was	be	AUX
ecj-12528	57	11	found	find	VERB
ecj-12528	57	12	to	to	PART
ecj-12528	57	13	be	be	AUX
ecj-12528	57	14	higher	high	ADJ
ecj-12528	57	15	(	(	PUNCT
ecj-12528	57	16	p	p	NOUN
ecj-12528	57	17	values	value	NOUN
ecj-12528	57	18	p<0.001	p<0.001	PROPN
ecj-12528	57	19	,	,	PUNCT
ecj-12528	57	20	respectively	respectively	ADV
ecj-12528	57	21	)	)	PUNCT
ecj-12528	57	22	(	(	PUNCT
ecj-12528	57	23	table	table	NOUN
ecj-12528	57	24	1	1	NUM
ecj-12528	57	25	)	)	PUNCT
ecj-12528	57	26	.	.	PUNCT
ecj-12528	58	1	article	article	NOUN
ecj-12528	58	2	table	table	VERB
ecj-12528	58	3	1	1	NUM
ecj-12528	58	4	.	.	PUNCT
ecj-12528	58	5	disease	disease	NOUN
ecj-12528	58	6	severity	severity	NOUN
ecj-12528	58	7	and	and	CCONJ
ecj-12528	58	8	its	its	PRON
ecj-12528	58	9	relation	relation	NOUN
ecj-12528	58	10	with	with	ADP
ecj-12528	58	11	death	death	NOUN
ecj-12528	58	12	according	accord	VERB
ecj-12528	58	13	to	to	ADP
ecj-12528	58	14	demographic	demographic	ADJ
ecj-12528	58	15	characteristics	characteristic	NOUN
ecj-12528	58	16	of	of	ADP
ecj-12528	58	17	the	the	DET
ecj-12528	58	18	patients	patient	NOUN
ecj-12528	58	19	.	.	PUNCT
ecj-12528	59	1	survival	survival	NOUN
ecj-12528	59	2	n:310	n:310	VERB
ecj-12528	59	3	death	death	NOUN
ecj-12528	59	4	n:136	n:136	NOUN
ecj-12528	59	5	p	p	NOUN
ecj-12528	59	6	non	non	ADJ
ecj-12528	59	7	-	-	ADJ
ecj-12528	59	8	severe	severe	ADJ
ecj-12528	59	9	n:198	n:198	ADJ
ecj-12528	59	10	severe	severe	ADJ
ecj-12528	59	11	n:248	n:248	NOUN
ecj-12528	59	12	p	p	NOUN
ecj-12528	59	13	number	number	NOUN
ecj-12528	59	14	(	(	PUNCT
ecj-12528	59	15	%	%	NOUN
ecj-12528	59	16	)	)	PUNCT
ecj-12528	59	17	number	number	NOUN
ecj-12528	59	18	(	(	PUNCT
ecj-12528	59	19	%	%	NOUN
ecj-12528	59	20	)	)	PUNCT
ecj-12528	59	21	number	number	NOUN
ecj-12528	59	22	(	(	PUNCT
ecj-12528	59	23	%	%	NOUN
ecj-12528	59	24	)	)	PUNCT
ecj-12528	59	25	number	number	NOUN
ecj-12528	59	26	(	(	PUNCT
ecj-12528	59	27	%	%	NOUN
ecj-12528	59	28	)	)	PUNCT
ecj-12528	59	29	gender	gender	NOUN
ecj-12528	59	30	male	male	NOUN
ecj-12528	59	31	147(47.4	147(47.4	NUM
ecj-12528	59	32	)	)	PUNCT
ecj-12528	59	33	79	79	NUM
ecj-12528	59	34	(	(	PUNCT
ecj-12528	59	35	58	58	NUM
ecj-12528	59	36	)	)	PUNCT
ecj-12528	59	37	0.038	0.038	NUM
ecj-12528	59	38	95	95	NUM
ecj-12528	59	39	(	(	PUNCT
ecj-12528	59	40	47.9	47.9	NUM
ecj-12528	59	41	)	)	PUNCT
ecj-12528	59	42	131(52.8	131(52.8	NUM
ecj-12528	59	43	)	)	PUNCT
ecj-12528	59	44	0.309	0.309	NUM
ecj-12528	59	45	female	female	ADJ
ecj-12528	59	46	163	163	NUM
ecj-12528	59	47	(	(	PUNCT
ecj-12528	59	48	52.6	52.6	NUM
ecj-12528	59	49	)	)	PUNCT
ecj-12528	59	50	57	57	NUM
ecj-12528	59	51	(	(	PUNCT
ecj-12528	59	52	42	42	NUM
ecj-12528	59	53	)	)	PUNCT
ecj-12528	59	54	103	103	NUM
ecj-12528	59	55	(	(	PUNCT
ecj-12528	59	56	52.1	52.1	NUM
ecj-12528	59	57	)	)	PUNCT
ecj-12528	59	58	117	117	NUM
ecj-12528	59	59	(	(	PUNCT
ecj-12528	59	60	47.2	47.2	NUM
ecj-12528	59	61	)	)	PUNCT
ecj-12528	59	62	age	age	NOUN
ecj-12528	59	63	(	(	PUNCT
ecj-12528	59	64	average±sd	average±sd	PROPN
ecj-12528	59	65	)	)	PUNCT
ecj-12528	59	66	59.3	59.3	NUM
ecj-12528	59	67	±	±	NUM
ecj-12528	59	68	18.8	18.8	NUM
ecj-12528	59	69	73.7	73.7	NUM
ecj-12528	59	70	±	±	NUM
ecj-12528	59	71	11.2	11.2	NUM
ecj-12528	59	72	<	<	NOUN
ecj-12528	59	73	0.001	0.001	NUM
ecj-12528	59	74	55.5	55.5	NUM
ecj-12528	59	75	±	±	NUM
ecj-12528	59	76	19.5	19.5	NUM
ecj-12528	59	77	70.3	70.3	NUM
ecj-12528	59	78	±	±	NUM
ecj-12528	59	79	13.7	13.7	NUM
ecj-12528	59	80	<	<	NOUN
ecj-12528	59	81	0.001	0.001	NUM
ecj-12528	59	82	presence	presence	NOUN
ecj-12528	59	83	of	of	ADP
ecj-12528	59	84	chronic	chronic	ADJ
ecj-12528	59	85	disease	disease	NOUN
ecj-12528	59	86	167	167	NUM
ecj-12528	59	87	(	(	PUNCT
ecj-12528	59	88	53.8	53.8	NUM
ecj-12528	59	89	)	)	PUNCT
ecj-12528	59	90	119	119	NUM
ecj-12528	59	91	(	(	PUNCT
ecj-12528	59	92	87.5	87.5	NUM
ecj-12528	59	93	)	)	PUNCT
ecj-12528	59	94	<	<	X
ecj-12528	59	95	0.001	0.001	NUM
ecj-12528	59	96	87	87	NUM
ecj-12528	59	97	(	(	PUNCT
ecj-12528	59	98	43.9	43.9	NUM
ecj-12528	59	99	)	)	PUNCT
ecj-12528	59	100	199	199	NUM
ecj-12528	59	101	(	(	PUNCT
ecj-12528	59	102	80.2	80.2	NUM
ecj-12528	59	103	)	)	PUNCT
ecj-12528	59	104	<	<	X
ecj-12528	59	105	0.001	0.001	NUM
ecj-12528	59	106	dm	dm	NUM
ecj-12528	59	107	84	84	NUM
ecj-12528	59	108	(	(	PUNCT
ecj-12528	59	109	27	27	NUM
ecj-12528	59	110	)	)	SYM
ecj-12528	59	111	60	60	NUM
ecj-12528	59	112	(	(	PUNCT
ecj-12528	59	113	44.1	44.1	NUM
ecj-12528	59	114	)	)	PUNCT
ecj-12528	59	115	<	<	X
ecj-12528	59	116	0.001	0.001	NUM
ecj-12528	59	117	36	36	NUM
ecj-12528	59	118	(	(	PUNCT
ecj-12528	59	119	18.1	18.1	NUM
ecj-12528	59	120	)	)	PUNCT
ecj-12528	59	121	108	108	NUM
ecj-12528	59	122	(	(	PUNCT
ecj-12528	59	123	43.5	43.5	NUM
ecj-12528	59	124	)	)	PUNCT
ecj-12528	59	125	<	<	X
ecj-12528	59	126	0.001	0.001	NUM
ecj-12528	59	127	ht	ht	PROPN
ecj-12528	59	128	114	114	NUM
ecj-12528	59	129	(	(	PUNCT
ecj-12528	59	130	36.7	36.7	NUM
ecj-12528	59	131	)	)	PUNCT
ecj-12528	59	132	83	83	NUM
ecj-12528	59	133	(	(	PUNCT
ecj-12528	59	134	61	61	NUM
ecj-12528	59	135	)	)	PUNCT
ecj-12528	59	136	<	<	X
ecj-12528	59	137	0.001	0.001	NUM
ecj-12528	59	138	52	52	NUM
ecj-12528	59	139	(	(	PUNCT
ecj-12528	59	140	26.2	26.2	NUM
ecj-12528	59	141	)	)	PUNCT
ecj-12528	59	142	145	145	NUM
ecj-12528	59	143	(	(	PUNCT
ecj-12528	59	144	58.4	58.4	NUM
ecj-12528	59	145	)	)	PUNCT
ecj-12528	59	146	<	<	X
ecj-12528	59	147	0.001	0.001	NUM
ecj-12528	59	148	hf	hf	NOUN
ecj-12528	59	149	25	25	NUM
ecj-12528	59	150	(	(	PUNCT
ecj-12528	59	151	8)	8)	NUM
ecj-12528	59	152	29	29	NUM
ecj-12528	59	153	(	(	PUNCT
ecj-12528	59	154	21.3	21.3	NUM
ecj-12528	59	155	)	)	PUNCT
ecj-12528	59	156	<	<	X
ecj-12528	59	157	0.001	0.001	NUM
ecj-12528	59	158	14	14	NUM
ecj-12528	59	159	(	(	PUNCT
ecj-12528	59	160	7	7	NUM
ecj-12528	59	161	)	)	PUNCT
ecj-12528	59	162	40	40	NUM
ecj-12528	59	163	(	(	PUNCT
ecj-12528	59	164	16.1	16.1	NUM
ecj-12528	59	165	)	)	PUNCT
ecj-12528	59	166	0.006	0.006	NUM
ecj-12528	59	167	cad	cad	NOUN
ecj-12528	59	168	55(17.7	55(17.7	NUM
ecj-12528	59	169	)	)	PUNCT
ecj-12528	59	170	48	48	NUM
ecj-12528	59	171	(	(	PUNCT
ecj-12528	59	172	35.3	35.3	NUM
ecj-12528	59	173	)	)	PUNCT
ecj-12528	59	174	<	<	X
ecj-12528	59	175	0.001	0.001	NUM
ecj-12528	59	176	29	29	NUM
ecj-12528	59	177	(	(	PUNCT
ecj-12528	59	178	14.6	14.6	NUM
ecj-12528	59	179	)	)	PUNCT
ecj-12528	59	180	74	74	NUM
ecj-12528	59	181	(	(	PUNCT
ecj-12528	59	182	29.8	29.8	NUM
ecj-12528	59	183	)	)	PUNCT
ecj-12528	59	184	<	<	X
ecj-12528	59	185	0.001	0.001	NUM
ecj-12528	59	186	arrhythmia	arrhythmia	NOUN
ecj-12528	59	187	13	13	NUM
ecj-12528	59	188	(	(	PUNCT
ecj-12528	59	189	4.2	4.2	NUM
ecj-12528	59	190	)	)	PUNCT
ecj-12528	59	191	14	14	NUM
ecj-12528	59	192	(	(	PUNCT
ecj-12528	59	193	10.3	10.3	NUM
ecj-12528	59	194	)	)	PUNCT
ecj-12528	59	195	0.023	0.023	NUM
ecj-12528	59	196	11	11	NUM
ecj-12528	59	197	(	(	PUNCT
ecj-12528	59	198	5.5	5.5	NUM
ecj-12528	59	199	)	)	PUNCT
ecj-12528	59	200	16	16	NUM
ecj-12528	59	201	(	(	PUNCT
ecj-12528	59	202	6.4	6.4	NUM
ecj-12528	59	203	)	)	PUNCT
ecj-12528	59	204	0.846	0.846	NUM
ecj-12528	59	205	ckf	ckf	NOUN
ecj-12528	59	206	19	19	NUM
ecj-12528	59	207	(	(	PUNCT
ecj-12528	59	208	6.1	6.1	NUM
ecj-12528	59	209	)	)	PUNCT
ecj-12528	59	210	19	19	NUM
ecj-12528	59	211	(	(	PUNCT
ecj-12528	59	212	13.9	13.9	NUM
ecj-12528	59	213	)	)	PUNCT
ecj-12528	59	214	0.11	0.11	NUM
ecj-12528	59	215	11	11	NUM
ecj-12528	59	216	(	(	PUNCT
ecj-12528	59	217	5.5	5.5	NUM
ecj-12528	59	218	)	)	PUNCT
ecj-12528	59	219	27	27	NUM
ecj-12528	59	220	(	(	PUNCT
ecj-12528	59	221	10.8	10.8	NUM
ecj-12528	59	222	)	)	PUNCT
ecj-12528	59	223	0.067	0.067	NUM
ecj-12528	59	224	svd	svd	PROPN
ecj-12528	59	225	10	10	NUM
ecj-12528	59	226	(	(	PUNCT
ecj-12528	59	227	3.2	3.2	NUM
ecj-12528	59	228	)	)	PUNCT
ecj-12528	59	229	8	8	NUM
ecj-12528	59	230	(	(	PUNCT
ecj-12528	59	231	5.8	5.8	NUM
ecj-12528	59	232	)	)	PUNCT
ecj-12528	59	233	0.293	0.293	NUM
ecj-12528	59	234	5	5	NUM
ecj-12528	59	235	(	(	PUNCT
ecj-12528	59	236	2.5	2.5	NUM
ecj-12528	59	237	)	)	PUNCT
ecj-12528	59	238	13	13	NUM
ecj-12528	59	239	(	(	PUNCT
ecj-12528	59	240	5.2	5.2	NUM
ecj-12528	59	241	)	)	PUNCT
ecj-12528	59	242	0.228	0.228	NUM
ecj-12528	59	243	asthma	asthma	NOUN
ecj-12528	59	244	/	/	SYM
ecj-12528	59	245	copd	copd	PROPN
ecj-12528	59	246	25	25	NUM
ecj-12528	59	247	(	(	PUNCT
ecj-12528	59	248	8)	8)	NUM
ecj-12528	59	249	11	11	NUM
ecj-12528	59	250	(	(	PUNCT
ecj-12528	59	251	8)	8)	NUM
ecj-12528	59	252	1.000	1.000	NUM
ecj-12528	59	253	7	7	NUM
ecj-12528	59	254	(	(	PUNCT
ecj-12528	59	255	3.5	3.5	NUM
ecj-12528	59	256	)	)	PUNCT
ecj-12528	59	257	29	29	NUM
ecj-12528	59	258	(	(	PUNCT
ecj-12528	59	259	11.6	11.6	NUM
ecj-12528	59	260	)	)	PUNCT
ecj-12528	59	261	0.003	0.003	NUM
ecj-12528	59	262	cirrhosis	cirrhosis	NOUN
ecj-12528	59	263	1	1	NUM
ecj-12528	59	264	(	(	PUNCT
ecj-12528	59	265	0.3	0.3	NUM
ecj-12528	59	266	)	)	PUNCT
ecj-12528	59	267	0	0	NUM
ecj-12528	60	1	(	(	PUNCT
ecj-12528	60	2	0	0	NUM
ecj-12528	60	3	)	)	PUNCT
ecj-12528	60	4	1.000	1.000	NUM
ecj-12528	60	5	1	1	NUM
ecj-12528	60	6	(	(	PUNCT
ecj-12528	60	7	0.5	0.5	NUM
ecj-12528	60	8	)	)	PUNCT
ecj-12528	60	9	0	0	NUM
ecj-12528	61	1	(	(	PUNCT
ecj-12528	61	2	0	0	NUM
ecj-12528	61	3	)	)	PUNCT
ecj-12528	61	4	0.444	0.444	NUM
ecj-12528	61	5	malignancy	malignancy	NOUN
ecj-12528	61	6	6	6	NUM
ecj-12528	61	7	(	(	PUNCT
ecj-12528	61	8	1.9	1.9	NUM
ecj-12528	61	9	)	)	PUNCT
ecj-12528	61	10	8	8	NUM
ecj-12528	61	11	(	(	PUNCT
ecj-12528	61	12	5.8	5.8	NUM
ecj-12528	61	13	)	)	PUNCT
ecj-12528	61	14	0.038	0.038	NUM
ecj-12528	61	15	3	3	NUM
ecj-12528	61	16	(	(	PUNCT
ecj-12528	61	17	1.5	1.5	NUM
ecj-12528	61	18	)	)	PUNCT
ecj-12528	61	19	11	11	NUM
ecj-12528	61	20	(	(	PUNCT
ecj-12528	61	21	4.4	4.4	NUM
ecj-12528	61	22	)	)	PUNCT
ecj-12528	61	23	0.138	0.138	NUM
ecj-12528	61	24	sd	sd	NOUN
ecj-12528	61	25	,	,	PUNCT
ecj-12528	61	26	standart	standart	NOUN
ecj-12528	61	27	deviation	deviation	NOUN
ecj-12528	61	28	,	,	PUNCT
ecj-12528	61	29	dm	dm	NOUN
ecj-12528	61	30	,	,	PUNCT
ecj-12528	61	31	diabetes	diabetes	NOUN
ecj-12528	61	32	mellitus	mellitus	NOUN
ecj-12528	61	33	,	,	PUNCT
ecj-12528	61	34	ht	ht	PROPN
ecj-12528	61	35	,	,	PUNCT
ecj-12528	61	36	hypertension	hypertension	NOUN
ecj-12528	61	37	,	,	PUNCT
ecj-12528	61	38	hf	hf	INTJ
ecj-12528	61	39	,	,	PUNCT
ecj-12528	61	40	heart	heart	NOUN
ecj-12528	61	41	failure	failure	NOUN
ecj-12528	61	42	,	,	PUNCT
ecj-12528	61	43	cad	cad	PROPN
ecj-12528	61	44	,	,	PUNCT
ecj-12528	61	45	coronary	coronary	ADJ
ecj-12528	61	46	artery	artery	NOUN
ecj-12528	61	47	disease	disease	NOUN
ecj-12528	61	48	,	,	PUNCT
ecj-12528	61	49	ckf	ckf	NOUN
ecj-12528	61	50	,	,	PUNCT
ecj-12528	61	51	chronic	chronic	ADJ
ecj-12528	61	52	kidney	kidney	NOUN
ecj-12528	61	53	failure	failure	NOUN
ecj-12528	61	54	,	,	PUNCT
ecj-12528	61	55	svd	svd	PROPN
ecj-12528	61	56	,	,	PUNCT
ecj-12528	61	57	cerebrovascular	cerebrovascular	ADJ
ecj-12528	61	58	disease	disease	NOUN
ecj-12528	61	59	,	,	PUNCT
ecj-12528	61	60	copd	copd	NOUN
ecj-12528	61	61	,	,	PUNCT
ecj-12528	61	62	chronic	chronic	ADJ
ecj-12528	61	63	obstructive	obstructive	ADJ
ecj-12528	61	64	pulmonary	pulmonary	ADJ
ecj-12528	61	65	disease	disease	NOUN
ecj-12528	61	66	.	.	PUNCT
ecj-12528	62	1	[	[	X
ecj-12528	62	2	emergency	emergency	NOUN
ecj-12528	62	3	care	care	NOUN
ecj-12528	62	4	journal	journal	PROPN
ecj-12528	62	5	2024	2024	NUM
ecj-12528	62	6	;	;	PUNCT
ecj-12528	62	7	20:12528	20:12528	NUM
ecj-12528	62	8	]	]	X
ecj-12528	63	1	[	[	X
ecj-12528	63	2	page	page	NOUN
ecj-12528	63	3	95	95	NUM
ecj-12528	63	4	]	]	PUNCT
ecj-12528	63	5	non	non	ADJ
ecj-12528	63	6	-co	-co	PROPN
ecj-12528	63	7	mmerc	mmerc	PROPN
ecj-12528	63	8	ial	ial	PROPN
ecj-12528	63	9	us	us	PROPN
ecj-12528	63	10	e	e	NOUN
ecj-12528	63	11	o	o	X
ecj-12528	63	12	nly	nly	ADV
ecj-12528	63	13	in	in	ADP
ecj-12528	63	14	terms	term	NOUN
ecj-12528	63	15	of	of	ADP
ecj-12528	63	16	chronic	chronic	ADJ
ecj-12528	63	17	diseases	disease	NOUN
ecj-12528	63	18	,	,	PUNCT
ecj-12528	63	19	hypertension	hypertension	NOUN
ecj-12528	63	20	(	(	PUNCT
ecj-12528	63	21	ht	ht	PROPN
ecj-12528	63	22	)	)	PUNCT
ecj-12528	63	23	(	(	PUNCT
ecj-12528	63	24	p<0.001	p<0.001	PROPN
ecj-12528	63	25	)	)	PUNCT
ecj-12528	63	26	,	,	PUNCT
ecj-12528	63	27	diabetes	diabetes	NOUN
ecj-12528	63	28	mellitus	mellitus	NOUN
ecj-12528	63	29	(	(	PUNCT
ecj-12528	63	30	dm	dm	PROPN
ecj-12528	63	31	)	)	PUNCT
ecj-12528	63	32	(	(	PUNCT
ecj-12528	63	33	p<0.001	p<0.001	PROPN
ecj-12528	63	34	)	)	PUNCT
ecj-12528	63	35	,	,	PUNCT
ecj-12528	63	36	coronary	coronary	ADJ
ecj-12528	63	37	artery	artery	NOUN
ecj-12528	63	38	disease	disease	NOUN
ecj-12528	63	39	(	(	PUNCT
ecj-12528	63	40	cad	cad	NOUN
ecj-12528	63	41	)	)	PUNCT
ecj-12528	63	42	(	(	PUNCT
ecj-12528	63	43	p<0.001	p<0.001	PROPN
ecj-12528	63	44	)	)	PUNCT
ecj-12528	63	45	,	,	PUNCT
ecj-12528	63	46	and	and	CCONJ
ecj-12528	63	47	heart	heart	NOUN
ecj-12528	63	48	failure	failure	NOUN
ecj-12528	63	49	(	(	PUNCT
ecj-12528	63	50	hf	hf	NOUN
ecj-12528	63	51	)	)	PUNCT
ecj-12528	63	52	(	(	PUNCT
ecj-12528	63	53	p<0.001	p<0.001	X
ecj-12528	63	54	,	,	PUNCT
ecj-12528	63	55	p=0.006	p=0.006	NOUN
ecj-12528	63	56	)	)	PUNCT
ecj-12528	63	57	were	be	AUX
ecj-12528	63	58	found	find	VERB
ecj-12528	63	59	to	to	PART
ecj-12528	63	60	be	be	AUX
ecj-12528	63	61	more	more	ADV
ecj-12528	63	62	common	common	ADJ
ecj-12528	63	63	in	in	ADP
ecj-12528	63	64	deceased	deceased	ADJ
ecj-12528	63	65	and	and	CCONJ
ecj-12528	63	66	severe	severe	ADJ
ecj-12528	63	67	covid-19	covid-19	PROPN
ecj-12528	63	68	cases	case	NOUN
ecj-12528	63	69	(	(	PUNCT
ecj-12528	63	70	table	table	NOUN
ecj-12528	63	71	1	1	NUM
ecj-12528	63	72	)	)	PUNCT
ecj-12528	63	73	.	.	PUNCT
ecj-12528	64	1	when	when	SCONJ
ecj-12528	64	2	analyzed	analyze	VERB
ecj-12528	64	3	in	in	ADP
ecj-12528	64	4	terms	term	NOUN
ecj-12528	64	5	of	of	ADP
ecj-12528	64	6	laboratory	laboratory	NOUN
ecj-12528	64	7	parameters	parameter	NOUN
ecj-12528	64	8	,	,	PUNCT
ecj-12528	64	9	it	it	PRON
ecj-12528	64	10	was	be	AUX
ecj-12528	64	11	found	find	VERB
ecj-12528	64	12	that	that	SCONJ
ecj-12528	64	13	leukocyte	leukocyte	NOUN
ecj-12528	64	14	,	,	PUNCT
ecj-12528	64	15	neutrophil	neutrophil	ADJ
ecj-12528	64	16	,	,	PUNCT
ecj-12528	64	17	c	c	NOUN
ecj-12528	64	18	-	-	PUNCT
ecj-12528	64	19	reactive	reactive	ADJ
ecj-12528	64	20	protein	protein	NOUN
ecj-12528	64	21	(	(	PUNCT
ecj-12528	64	22	crp	crp	PROPN
ecj-12528	64	23	)	)	PUNCT
ecj-12528	64	24	,	,	PUNCT
ecj-12528	64	25	troponin	troponin	PROPN
ecj-12528	64	26	,	,	PUNCT
ecj-12528	64	27	sii	sii	PROPN
ecj-12528	64	28	,	,	PUNCT
ecj-12528	64	29	and	and	CCONJ
ecj-12528	64	30	siri	siri	NOUN
ecj-12528	64	31	values	value	NOUN
ecj-12528	64	32	were	be	AUX
ecj-12528	64	33	higher	high	ADJ
ecj-12528	64	34	in	in	ADP
ecj-12528	64	35	patients	patient	NOUN
ecj-12528	64	36	who	who	PRON
ecj-12528	64	37	were	be	AUX
ecj-12528	64	38	evaluated	evaluate	VERB
ecj-12528	64	39	in	in	ADP
ecj-12528	64	40	the	the	DET
ecj-12528	64	41	severe	severe	ADJ
ecj-12528	64	42	covid-19	covid-19	PROPN
ecj-12528	64	43	class	class	NOUN
ecj-12528	64	44	and	and	CCONJ
ecj-12528	64	45	died	die	VERB
ecj-12528	64	46	(	(	PUNCT
ecj-12528	64	47	p	p	NOUN
ecj-12528	64	48	values	value	NOUN
ecj-12528	64	49	p<0.001	p<0.001	X
ecj-12528	64	50	)	)	PUNCT
ecj-12528	64	51	(	(	PUNCT
ecj-12528	64	52	table	table	NOUN
ecj-12528	64	53	2	2	NUM
ecj-12528	64	54	)	)	PUNCT
ecj-12528	64	55	.	.	PUNCT
ecj-12528	65	1	results	result	NOUN
ecj-12528	65	2	of	of	ADP
ecj-12528	65	3	the	the	DET
ecj-12528	65	4	roc	roc	PROPN
ecj-12528	65	5	analysis	analysis	NOUN
ecj-12528	65	6	of	of	ADP
ecj-12528	65	7	indices	index	NOUN
ecj-12528	65	8	sii	sii	ADJ
ecj-12528	65	9	and	and	CCONJ
ecj-12528	65	10	siri	siri	NOUN
ecj-12528	65	11	parameters	parameter	NOUN
ecj-12528	65	12	were	be	AUX
ecj-12528	65	13	found	find	VERB
ecj-12528	65	14	to	to	PART
ecj-12528	65	15	have	have	VERB
ecj-12528	65	16	predictive	predictive	ADJ
ecj-12528	65	17	power	power	NOUN
ecj-12528	65	18	for	for	ADP
ecj-12528	65	19	mortality	mortality	NOUN
ecj-12528	65	20	.	.	PUNCT
ecj-12528	66	1	it	it	PRON
ecj-12528	66	2	was	be	AUX
ecj-12528	66	3	determined	determine	VERB
ecj-12528	66	4	that	that	SCONJ
ecj-12528	66	5	the	the	DET
ecj-12528	66	6	siri	siri	NOUN
ecj-12528	66	7	parameter	parameter	NOUN
ecj-12528	66	8	had	have	VERB
ecj-12528	66	9	the	the	DET
ecj-12528	66	10	power	power	NOUN
ecj-12528	66	11	to	to	PART
ecj-12528	66	12	distinguish	distinguish	VERB
ecj-12528	66	13	between	between	ADP
ecj-12528	66	14	survivors	survivor	NOUN
ecj-12528	66	15	and	and	CCONJ
ecj-12528	66	16	deceased	deceased	ADJ
ecj-12528	66	17	patients	patient	NOUN
ecj-12528	66	18	(	(	PUNCT
ecj-12528	66	19	p<0.0001	p<0.0001	NOUN
ecj-12528	66	20	,	,	PUNCT
ecj-12528	66	21	auc=0.640	auc=0.640	ADJ
ecj-12528	66	22	)	)	PUNCT
ecj-12528	66	23	,	,	PUNCT
ecj-12528	66	24	and	and	CCONJ
ecj-12528	66	25	the	the	DET
ecj-12528	66	26	mortality	mortality	NOUN
ecj-12528	66	27	rate	rate	NOUN
ecj-12528	66	28	may	may	AUX
ecj-12528	66	29	be	be	AUX
ecj-12528	66	30	higher	high	ADJ
ecj-12528	66	31	in	in	ADP
ecj-12528	66	32	patients	patient	NOUN
ecj-12528	66	33	with	with	ADP
ecj-12528	66	34	a	a	DET
ecj-12528	66	35	value	value	NOUN
ecj-12528	66	36	above	above	ADP
ecj-12528	66	37	2.057	2.057	NUM
ecj-12528	66	38	.	.	PUNCT
ecj-12528	67	1	it	it	PRON
ecj-12528	67	2	was	be	AUX
ecj-12528	67	3	observed	observe	VERB
ecj-12528	67	4	that	that	SCONJ
ecj-12528	67	5	the	the	DET
ecj-12528	67	6	sii	sii	PROPN
ecj-12528	67	7	parameter	parameter	NOUN
ecj-12528	67	8	had	have	VERB
ecj-12528	67	9	the	the	DET
ecj-12528	67	10	power	power	NOUN
ecj-12528	67	11	to	to	PART
ecj-12528	67	12	distinguish	distinguish	VERB
ecj-12528	67	13	between	between	ADP
ecj-12528	67	14	survivors	survivor	NOUN
ecj-12528	67	15	and	and	CCONJ
ecj-12528	67	16	deceased	deceased	ADJ
ecj-12528	67	17	patients	patient	NOUN
ecj-12528	67	18	(	(	PUNCT
ecj-12528	67	19	p<0.0001	p<0.0001	NOUN
ecj-12528	67	20	,	,	PUNCT
ecj-12528	67	21	auc=0.682	auc=0.682	ADJ
ecj-12528	67	22	)	)	PUNCT
ecj-12528	67	23	,	,	PUNCT
ecj-12528	67	24	and	and	CCONJ
ecj-12528	67	25	the	the	DET
ecj-12528	67	26	mortality	mortality	NOUN
ecj-12528	67	27	rate	rate	NOUN
ecj-12528	67	28	may	may	AUX
ecj-12528	67	29	be	be	AUX
ecj-12528	67	30	higher	high	ADJ
ecj-12528	67	31	in	in	ADP
ecj-12528	67	32	patients	patient	NOUN
ecj-12528	67	33	with	with	ADP
ecj-12528	67	34	a	a	DET
ecj-12528	67	35	value	value	NOUN
ecj-12528	67	36	above	above	ADP
ecj-12528	67	37	1370.353	1370.353	NUM
ecj-12528	67	38	(	(	PUNCT
ecj-12528	67	39	table	table	NOUN
ecj-12528	67	40	3	3	NUM
ecj-12528	67	41	,	,	PUNCT
ecj-12528	67	42	figure	figure	NOUN
ecj-12528	67	43	1	1	NUM
ecj-12528	67	44	)	)	PUNCT
ecj-12528	67	45	.	.	PUNCT
ecj-12528	68	1	the	the	DET
ecj-12528	68	2	sii	sii	ADJ
ecj-12528	68	3	and	and	CCONJ
ecj-12528	68	4	siri	siri	NOUN
ecj-12528	68	5	parameters	parameter	NOUN
ecj-12528	68	6	were	be	AUX
ecj-12528	68	7	found	find	VERB
ecj-12528	68	8	to	to	PART
ecj-12528	68	9	be	be	AUX
ecj-12528	68	10	effective	effective	ADJ
ecj-12528	68	11	in	in	ADP
ecj-12528	68	12	determining	determine	VERB
ecj-12528	68	13	the	the	DET
ecj-12528	68	14	severity	severity	NOUN
ecj-12528	68	15	of	of	ADP
ecj-12528	68	16	the	the	DET
ecj-12528	68	17	disease	disease	NOUN
ecj-12528	68	18	.	.	PUNCT
ecj-12528	69	1	it	it	PRON
ecj-12528	69	2	was	be	AUX
ecj-12528	69	3	determined	determine	VERB
ecj-12528	69	4	that	that	SCONJ
ecj-12528	69	5	siri	siri	NOUN
ecj-12528	69	6	values	value	NOUN
ecj-12528	69	7	above	above	ADP
ecj-12528	69	8	1.6483	1.6483	NUM
ecj-12528	69	9	may	may	AUX
ecj-12528	69	10	increase	increase	VERB
ecj-12528	69	11	the	the	DET
ecj-12528	69	12	severity	severity	NOUN
ecj-12528	69	13	level	level	NOUN
ecj-12528	69	14	of	of	ADP
ecj-12528	69	15	covid-19	covid-19	PROPN
ecj-12528	69	16	disease	disease	NOUN
ecj-12528	69	17	(	(	PUNCT
ecj-12528	69	18	p<0.0001	p<0.0001	NOUN
ecj-12528	69	19	,	,	PUNCT
ecj-12528	69	20	auc=0.689	auc=0.689	PROPN
ecj-12528	69	21	)	)	PUNCT
ecj-12528	69	22	.	.	PUNCT
ecj-12528	70	1	it	it	PRON
ecj-12528	70	2	was	be	AUX
ecj-12528	70	3	observed	observe	VERB
ecj-12528	70	4	that	that	SCONJ
ecj-12528	70	5	the	the	DET
ecj-12528	70	6	disease	disease	NOUN
ecj-12528	70	7	may	may	AUX
ecj-12528	70	8	be	be	AUX
ecj-12528	70	9	severe	severe	ADJ
ecj-12528	70	10	at	at	ADP
ecj-12528	70	11	values	value	NOUN
ecj-12528	70	12	above	above	ADP
ecj-12528	70	13	sii	sii	PROPN
ecj-12528	70	14	867.834	867.834	NUM
ecj-12528	70	15	,	,	PUNCT
ecj-12528	70	16	and	and	CCONJ
ecj-12528	70	17	the	the	DET
ecj-12528	70	18	discriminative	discriminative	NOUN
ecj-12528	70	19	power	power	NOUN
ecj-12528	70	20	of	of	ADP
ecj-12528	70	21	the	the	DET
ecj-12528	70	22	sii	sii	PROPN
ecj-12528	70	23	parameter	parameter	NOUN
ecj-12528	70	24	between	between	ADP
ecj-12528	70	25	severe	severe	ADJ
ecj-12528	70	26	and	and	CCONJ
ecj-12528	70	27	nonsevere	nonsevere	ADJ
ecj-12528	70	28	cases	case	NOUN
ecj-12528	70	29	was	be	AUX
ecj-12528	70	30	high	high	ADJ
ecj-12528	70	31	(	(	PUNCT
ecj-12528	70	32	p<0.0001	p<0.0001	NOUN
ecj-12528	70	33	,	,	PUNCT
ecj-12528	70	34	auc=0.744	auc=0.744	ADJ
ecj-12528	70	35	)	)	PUNCT
ecj-12528	70	36	(	(	PUNCT
ecj-12528	70	37	table	table	NOUN
ecj-12528	70	38	3	3	NUM
ecj-12528	70	39	,	,	PUNCT
ecj-12528	70	40	figure	figure	NOUN
ecj-12528	70	41	2	2	NUM
ecj-12528	70	42	)	)	PUNCT
ecj-12528	70	43	.	.	PUNCT
ecj-12528	71	1	discussion	discussion	NOUN
ecj-12528	71	2	the	the	DET
ecj-12528	71	3	covid-19	covid-19	PROPN
ecj-12528	71	4	disease	disease	NOUN
ecj-12528	71	5	is	be	AUX
ecj-12528	71	6	caused	cause	VERB
ecj-12528	71	7	by	by	ADP
ecj-12528	71	8	a	a	DET
ecj-12528	71	9	coronavirus	coronavirus	NOUN
ecj-12528	71	10	called	call	VERB
ecj-12528	71	11	sars	sar	NOUN
ecj-12528	71	12	-	-	PUNCT
ecj-12528	71	13	cov-2	cov-2	PUNCT
ecj-12528	71	14	and	and	CCONJ
ecj-12528	71	15	has	have	AUX
ecj-12528	71	16	spread	spread	VERB
ecj-12528	71	17	rapidly	rapidly	ADV
ecj-12528	71	18	worldwide	worldwide	ADV
ecj-12528	71	19	and	and	CCONJ
ecj-12528	71	20	affected	affect	VERB
ecj-12528	71	21	the	the	DET
ecj-12528	71	22	whole	whole	NOUN
ecj-12528	71	23	of	of	ADP
ecj-12528	71	24	humanity.6	humanity.6	PROPN
ecj-12528	71	25	early	early	ADJ
ecj-12528	71	26	intervention	intervention	NOUN
ecj-12528	71	27	has	have	VERB
ecj-12528	71	28	an	an	DET
ecj-12528	71	29	important	important	ADJ
ecj-12528	71	30	place	place	NOUN
ecj-12528	71	31	in	in	ADP
ecj-12528	71	32	the	the	DET
ecj-12528	71	33	course	course	NOUN
ecj-12528	71	34	of	of	ADP
ecj-12528	71	35	the	the	DET
ecj-12528	71	36	disease	disease	NOUN
ecj-12528	71	37	,	,	PUNCT
ecj-12528	71	38	and	and	CCONJ
ecj-12528	71	39	various	various	ADJ
ecj-12528	71	40	biomarkers	biomarker	NOUN
ecj-12528	71	41	are	be	AUX
ecj-12528	71	42	being	be	AUX
ecj-12528	71	43	developed	develop	VERB
ecj-12528	71	44	.	.	PUNCT
ecj-12528	72	1	siri	siri	NOUN
ecj-12528	72	2	and	and	CCONJ
ecj-12528	72	3	sii	sii	PRON
ecj-12528	72	4	,	,	PUNCT
ecj-12528	72	5	which	which	PRON
ecj-12528	72	6	are	be	AUX
ecj-12528	72	7	among	among	ADP
ecj-12528	72	8	the	the	DET
ecj-12528	72	9	biomarkers	biomarker	NOUN
ecj-12528	72	10	being	be	AUX
ecj-12528	72	11	developed	develop	VERB
ecj-12528	72	12	,	,	PUNCT
ecj-12528	72	13	are	be	AUX
ecj-12528	72	14	parameters	parameter	NOUN
ecj-12528	72	15	that	that	PRON
ecj-12528	72	16	can	can	AUX
ecj-12528	72	17	be	be	AUX
ecj-12528	72	18	easily	easily	ADV
ecj-12528	72	19	reached	reach	VERB
ecj-12528	72	20	with	with	ADP
ecj-12528	72	21	a	a	DET
ecj-12528	72	22	simple	simple	ADJ
ecj-12528	72	23	complete	complete	ADJ
ecj-12528	72	24	blood	blood	NOUN
ecj-12528	72	25	count	count	NOUN
ecj-12528	72	26	in	in	ADP
ecj-12528	72	27	emergency	emergency	NOUN
ecj-12528	72	28	departments	department	NOUN
ecj-12528	72	29	and	and	CCONJ
ecj-12528	72	30	hospitals.9	hospitals.9	PROPN
ecj-12528	72	31	based	base	VERB
ecj-12528	72	32	on	on	ADP
ecj-12528	72	33	these	these	DET
ecj-12528	72	34	data	datum	NOUN
ecj-12528	72	35	,	,	PUNCT
ecj-12528	72	36	we	we	PRON
ecj-12528	72	37	tried	try	VERB
ecj-12528	72	38	to	to	PART
ecj-12528	72	39	determine	determine	VERB
ecj-12528	72	40	the	the	DET
ecj-12528	72	41	effectiveness	effectiveness	NOUN
ecj-12528	72	42	of	of	ADP
ecj-12528	72	43	sii	sii	PROPN
ecj-12528	72	44	and	and	CCONJ
ecj-12528	72	45	article	article	NOUN
ecj-12528	72	46	figure	figure	VERB
ecj-12528	72	47	1	1	NUM
ecj-12528	72	48	.	.	PUNCT
ecj-12528	73	1	roc	roc	NOUN
ecj-12528	73	2	analysis	analysis	NOUN
ecj-12528	73	3	of	of	ADP
ecj-12528	73	4	indices	index	NOUN
ecj-12528	73	5	for	for	ADP
ecj-12528	73	6	predicting	predict	VERB
ecj-12528	73	7	death	death	NOUN
ecj-12528	73	8	.	.	PUNCT
ecj-12528	74	1	figure	figure	NOUN
ecj-12528	74	2	2	2	NUM
ecj-12528	74	3	.	.	PUNCT
ecj-12528	75	1	roc	roc	NOUN
ecj-12528	75	2	analysis	analysis	NOUN
ecj-12528	75	3	of	of	ADP
ecj-12528	75	4	indices	index	NOUN
ecj-12528	75	5	for	for	ADP
ecj-12528	75	6	predicting	predict	VERB
ecj-12528	75	7	disease	disease	NOUN
ecj-12528	75	8	severity	severity	NOUN
ecj-12528	75	9	.	.	PUNCT
ecj-12528	76	1	table	table	NOUN
ecj-12528	76	2	2	2	NUM
ecj-12528	76	3	.	.	PUNCT
ecj-12528	76	4	association	association	NOUN
ecj-12528	76	5	of	of	ADP
ecj-12528	76	6	laboratory	laboratory	NOUN
ecj-12528	76	7	values	value	NOUN
ecj-12528	76	8	and	and	CCONJ
ecj-12528	76	9	indices	index	NOUN
ecj-12528	76	10	with	with	ADP
ecj-12528	76	11	mortality	mortality	NOUN
ecj-12528	76	12	and	and	CCONJ
ecj-12528	76	13	severity	severity	NOUN
ecj-12528	76	14	.	.	PUNCT
ecj-12528	77	1	survival	survival	PROPN
ecj-12528	77	2	n:310	n:310	VERB
ecj-12528	77	3	death	death	NOUN
ecj-12528	77	4	n:136	n:136	NOUN
ecj-12528	77	5	p	p	NOUN
ecj-12528	77	6	non	non	ADJ
ecj-12528	77	7	-	-	ADJ
ecj-12528	77	8	severe	severe	ADJ
ecj-12528	77	9	n:198	n:198	ADJ
ecj-12528	77	10	severe	severe	ADJ
ecj-12528	77	11	n:248	n:248	NOUN
ecj-12528	77	12	p	p	PROPN
ecj-12528	77	13	hgb	hgb	PROPN
ecj-12528	77	14	(	(	PUNCT
ecj-12528	77	15	g	g	PROPN
ecj-12528	77	16	/	/	SYM
ecj-12528	77	17	dl	dl	NOUN
ecj-12528	77	18	)	)	PUNCT
ecj-12528	77	19	12.74±2.04	12.74±2.04	NUM
ecj-12528	77	20	12.46±2.06	12.46±2.06	NUM
ecj-12528	77	21	0.176	0.176	NUM
ecj-12528	77	22	12.87±2.07	12.87±2.07	NUM
ecj-12528	77	23	12.48±	12.48±	NUM
ecj-12528	77	24	2.01	2.01	NUM
ecj-12528	77	25	0.46	0.46	NUM
ecj-12528	77	26	rbc	rbc	PROPN
ecj-12528	77	27	(	(	PUNCT
ecj-12528	77	28	x103/µl	x103/µl	PROPN
ecj-12528	77	29	)	)	PUNCT
ecj-12528	77	30	37.92±5.54	37.92±5.54	NUM
ecj-12528	77	31	37.42±6.01	37.42±6.01	NUM
ecj-12528	77	32	0.391	0.391	NUM
ecj-12528	77	33	38.25±5.58	38.25±5.58	NUM
ecj-12528	77	34	37.39±	37.39±	NUM
ecj-12528	77	35	5.75	5.75	NUM
ecj-12528	77	36	0.114	0.114	NUM
ecj-12528	77	37	leukocyte	leukocyte	NOUN
ecj-12528	77	38	(	(	PUNCT
ecj-12528	77	39	x103/µl	x103/µl	PROPN
ecj-12528	77	40	)	)	PUNCT
ecj-12528	77	41	7.49±3.65	7.49±3.65	NUM
ecj-12528	77	42	9.35±4.72	9.35±4.72	NOUN
ecj-12528	77	43	<	<	NOUN
ecj-12528	77	44	0.001	0.001	NUM
ecj-12528	77	45	6.86±3.27	6.86±3.27	NUM
ecj-12528	78	1	9.02±4.42	9.02±4.42	NUM
ecj-12528	78	2	<	<	X
ecj-12528	78	3	0.001	0.001	NUM
ecj-12528	78	4	lymphocyte	lymphocyte	NOUN
ecj-12528	78	5	(	(	PUNCT
ecj-12528	78	6	x103/µl	x103/µl	PROPN
ecj-12528	78	7	)	)	PUNCT
ecj-12528	78	8	1.33±0.81	1.33±0.81	PROPN
ecj-12528	78	9	1.03±0.64	1.03±0.64	NUM
ecj-12528	78	10	<	<	X
ecj-12528	78	11	0.001	0.001	NUM
ecj-12528	78	12	4.08±0.67	4.08±0.67	NOUN
ecj-12528	78	13	1.45±0.85	1.45±0.85	PROPN
ecj-12528	78	14	<	<	X
ecj-12528	78	15	0.001	0.001	NUM
ecj-12528	78	16	monocyte	monocyte	NOUN
ecj-12528	78	17	(	(	PUNCT
ecj-12528	78	18	x103/µl	x103/µl	PROPN
ecj-12528	78	19	)	)	PUNCT
ecj-12528	78	20	0.59±0.33	0.59±0.33	NOUN
ecj-12528	79	1	0.55±0.40	0.55±0.40	ADP
ecj-12528	79	2	0.232	0.232	NUM
ecj-12528	79	3	0.61±0.34	0.61±0.34	NOUN
ecj-12528	79	4	0.56±0.36	0.56±0.36	NOUN
ecj-12528	79	5	0.150	0.150	NUM
ecj-12528	79	6	neutrophil	neutrophil	NOUN
ecj-12528	79	7	(	(	PUNCT
ecj-12528	79	8	x103/µl	x103/µl	PROPN
ecj-12528	79	9	)	)	PUNCT
ecj-12528	79	10	5.49±3.46	5.49±3.46	NUM
ecj-12528	79	11	7.70±4.35	7.70±4.35	NUM
ecj-12528	79	12	<	<	X
ecj-12528	79	13	0.001	0.001	NUM
ecj-12528	79	14	4.70±2.92	4.70±2.92	PROPN
ecj-12528	79	15	7.33±4.16	7.33±4.16	PROPN
ecj-12528	79	16	<	<	X
ecj-12528	79	17	0.001	0.001	NUM
ecj-12528	79	18	platelet(x103/µl	platelet(x103/µl	PROPN
ecj-12528	79	19	)	)	PUNCT
ecj-12528	79	20	214.82±80.23	214.82±80.23	NUM
ecj-12528	79	21	212.36±89.23	212.36±89.23	PROPN
ecj-12528	79	22	0.774	0.774	NUM
ecj-12528	79	23	209.87±74.43	209.87±74.43	NUM
ecj-12528	79	24	217.42±	217.42±	NOUN
ecj-12528	79	25	89.24	89.24	NUM
ecj-12528	79	26	0.330	0.330	NUM
ecj-12528	79	27	crp	crp	NOUN
ecj-12528	79	28	(	(	PUNCT
ecj-12528	79	29	mg	mg	PROPN
ecj-12528	79	30	/	/	SYM
ecj-12528	79	31	l	l	NOUN
ecj-12528	79	32	)	)	PUNCT
ecj-12528	80	1	67.94±79.723	67.94±79.723	NUM
ecj-12528	80	2	161.03±92.527	161.03±92.527	NUM
ecj-12528	80	3	<	<	X
ecj-12528	80	4	0.001	0.001	NUM
ecj-12528	80	5	35.42±45.71	35.42±45.71	NUM
ecj-12528	80	6	144.95±	144.95±	NUM
ecj-12528	80	7	94.51	94.51	NUM
ecj-12528	80	8	<	<	X
ecj-12528	80	9	0.001	0.001	NUM
ecj-12528	80	10	troponin	troponin	ADJ
ecj-12528	80	11	(	(	PUNCT
ecj-12528	80	12	ng	ng	PROPN
ecj-12528	80	13	/	/	SYM
ecj-12528	80	14	l	l	NOUN
ecj-12528	80	15	)	)	PUNCT
ecj-12528	81	1	34.60±227.31	34.60±227.31	PROPN
ecj-12528	82	1	313.63±2318.48	313.63±2318.48	NUM
ecj-12528	82	2	0.161	0.161	NUM
ecj-12528	82	3	39.83±280.87	39.83±280.87	NUM
ecj-12528	82	4	183.44±	183.44±	NUM
ecj-12528	82	5	1720.54	1720.54	NUM
ecj-12528	82	6	0.246	0.246	NUM
ecj-12528	82	7	siri	siri	NOUN
ecj-12528	82	8	3.37±4.18	3.37±4.18	NUM
ecj-12528	82	9	5.20±5.30	5.20±5.30	NOUN
ecj-12528	83	1	<	<	NOUN
ecj-12528	83	2	0.001	0.001	NUM
ecj-12528	83	3	2.77±3.41	2.77±3.41	NUM
ecj-12528	83	4	4.86±5.22	4.86±5.22	NOUN
ecj-12528	83	5	<	<	X
ecj-12528	83	6	0.001	0.001	NUM
ecj-12528	83	7	sii	sii	PROPN
ecj-12528	83	8	1323.77±1856.37	1323.77±1856.37	NUM
ecj-12528	83	9	2223.68±2542.62	2223.68±2542.62	NOUN
ecj-12528	83	10	<	<	NOUN
ecj-12528	83	11	0.001	0.001	NUM
ecj-12528	83	12	923.61±1162.99	923.61±1162.99	NOUN
ecj-12528	83	13	2136.76±	2136.76±	NUM
ecj-12528	83	14	2533.72	2533.72	NUM
ecj-12528	83	15	<	<	X
ecj-12528	83	16	0.001	0.001	NUM
ecj-12528	83	17	rbc	rbc	PROPN
ecj-12528	83	18	,	,	PUNCT
ecj-12528	83	19	red	red	ADJ
ecj-12528	83	20	blood	blood	NOUN
ecj-12528	83	21	cell	cell	NOUN
ecj-12528	83	22	,	,	PUNCT
ecj-12528	83	23	crp	crp	PROPN
ecj-12528	83	24	,	,	PUNCT
ecj-12528	83	25	c	c	NOUN
ecj-12528	83	26	-	-	PUNCT
ecj-12528	83	27	reactive	reactive	ADJ
ecj-12528	83	28	protein	protein	NOUN
ecj-12528	83	29	,	,	PUNCT
ecj-12528	83	30	siri	siri	NOUN
ecj-12528	83	31	,	,	PUNCT
ecj-12528	83	32	systemic	systemic	ADJ
ecj-12528	83	33	inflammatory	inflammatory	ADJ
ecj-12528	83	34	response	response	NOUN
ecj-12528	83	35	index	index	NOUN
ecj-12528	83	36	,	,	PUNCT
ecj-12528	83	37	sii	sii	PROPN
ecj-12528	83	38	,	,	PUNCT
ecj-12528	83	39	systemic	systemic	ADJ
ecj-12528	83	40	inflammatory	inflammatory	ADJ
ecj-12528	83	41	index	index	NOUN
ecj-12528	83	42	.	.	PUNCT
ecj-12528	84	1	[	[	X
ecj-12528	84	2	page	page	NOUN
ecj-12528	84	3	96	96	NUM
ecj-12528	84	4	]	]	PUNCT
ecj-12528	85	1	[	[	X
ecj-12528	85	2	emergency	emergency	NOUN
ecj-12528	85	3	care	care	NOUN
ecj-12528	85	4	journal	journal	PROPN
ecj-12528	85	5	2024	2024	NUM
ecj-12528	85	6	;	;	PUNCT
ecj-12528	85	7	20:12528	20:12528	NUM
ecj-12528	85	8	]	]	X
ecj-12528	85	9	non	non	ADJ
ecj-12528	85	10	-co	-co	PROPN
ecj-12528	85	11	mmerc	mmerc	PROPN
ecj-12528	85	12	ial	ial	PROPN
ecj-12528	85	13	us	us	PROPN
ecj-12528	85	14	e	e	NOUN
ecj-12528	85	15	o	o	NOUN
ecj-12528	85	16	nly	nly	ADV
ecj-12528	85	17	siri	siri	NOUN
ecj-12528	85	18	in	in	ADP
ecj-12528	85	19	covid-19	covid-19	PROPN
ecj-12528	85	20	disease	disease	NOUN
ecj-12528	85	21	.	.	PUNCT
ecj-12528	86	1	like	like	ADP
ecj-12528	86	2	every	every	DET
ecj-12528	86	3	disease	disease	NOUN
ecj-12528	86	4	,	,	PUNCT
ecj-12528	86	5	covid-19	covid-19	PROPN
ecj-12528	86	6	also	also	ADV
ecj-12528	86	7	shows	show	VERB
ecj-12528	86	8	different	different	ADJ
ecj-12528	86	9	severity	severity	NOUN
ecj-12528	86	10	in	in	ADP
ecj-12528	86	11	people	people	NOUN
ecj-12528	86	12	who	who	PRON
ecj-12528	86	13	are	be	AUX
ecj-12528	86	14	infected	infect	VERB
ecj-12528	86	15	with	with	ADP
ecj-12528	86	16	the	the	DET
ecj-12528	86	17	disease	disease	NOUN
ecj-12528	86	18	.	.	PUNCT
ecj-12528	87	1	the	the	DET
ecj-12528	87	2	biggest	big	ADJ
ecj-12528	87	3	reason	reason	NOUN
ecj-12528	87	4	for	for	ADP
ecj-12528	87	5	this	this	PRON
ecj-12528	87	6	is	be	AUX
ecj-12528	87	7	the	the	DET
ecj-12528	87	8	difference	difference	NOUN
ecj-12528	87	9	in	in	ADP
ecj-12528	87	10	immune	immune	ADJ
ecj-12528	87	11	status	status	NOUN
ecj-12528	87	12	between	between	ADP
ecj-12528	87	13	people	people	NOUN
ecj-12528	87	14	.	.	PUNCT
ecj-12528	88	1	covid-19	covid-19	PROPN
ecj-12528	88	2	disease	disease	NOUN
ecj-12528	88	3	is	be	AUX
ecj-12528	88	4	more	more	ADV
ecj-12528	88	5	severe	severe	ADJ
ecj-12528	88	6	than	than	ADP
ecj-12528	88	7	other	other	ADJ
ecj-12528	88	8	diseases	disease	NOUN
ecj-12528	88	9	that	that	PRON
ecj-12528	88	10	negatively	negatively	ADV
ecj-12528	88	11	affect	affect	VERB
ecj-12528	88	12	the	the	DET
ecj-12528	88	13	immune	immune	ADJ
ecj-12528	88	14	system	system	NOUN
ecj-12528	88	15	.	.	PUNCT
ecj-12528	89	1	in	in	ADP
ecj-12528	89	2	a	a	DET
ecj-12528	89	3	study	study	NOUN
ecj-12528	89	4	of	of	ADP
ecj-12528	89	5	around	around	ADV
ecj-12528	89	6	300,000	300,000	NUM
ecj-12528	89	7	covid-19	covid-19	PROPN
ecj-12528	89	8	patients	patient	NOUN
ecj-12528	89	9	,	,	PUNCT
ecj-12528	89	10	it	it	PRON
ecj-12528	89	11	was	be	AUX
ecj-12528	89	12	found	find	VERB
ecj-12528	89	13	that	that	SCONJ
ecj-12528	89	14	the	the	DET
ecj-12528	89	15	mortality	mortality	NOUN
ecj-12528	89	16	rate	rate	NOUN
ecj-12528	89	17	of	of	ADP
ecj-12528	89	18	those	those	PRON
ecj-12528	89	19	with	with	ADP
ecj-12528	89	20	comorbidities	comorbiditie	NOUN
ecj-12528	89	21	was	be	AUX
ecj-12528	89	22	12	12	NUM
ecj-12528	89	23	times	time	NOUN
ecj-12528	89	24	higher	high	ADJ
ecj-12528	89	25	and	and	CCONJ
ecj-12528	89	26	the	the	DET
ecj-12528	89	27	hospitalization	hospitalization	NOUN
ecj-12528	89	28	rate	rate	NOUN
ecj-12528	89	29	was	be	AUX
ecj-12528	89	30	6	6	NUM
ecj-12528	89	31	times	time	NOUN
ecj-12528	89	32	higher	high	ADJ
ecj-12528	89	33	than	than	ADP
ecj-12528	89	34	that	that	PRON
ecj-12528	89	35	of	of	ADP
ecj-12528	89	36	those	those	PRON
ecj-12528	89	37	without	without	ADP
ecj-12528	89	38	comorbidities.11	comorbidities.11	NOUN
ecj-12528	89	39	it	it	PRON
ecj-12528	89	40	has	have	AUX
ecj-12528	89	41	been	be	AUX
ecj-12528	89	42	reported	report	VERB
ecj-12528	89	43	that	that	SCONJ
ecj-12528	89	44	the	the	DET
ecj-12528	89	45	risk	risk	NOUN
ecj-12528	89	46	factors	factor	NOUN
ecj-12528	89	47	that	that	PRON
ecj-12528	89	48	increase	increase	VERB
ecj-12528	89	49	the	the	DET
ecj-12528	89	50	rates	rate	NOUN
ecj-12528	89	51	of	of	ADP
ecj-12528	89	52	severe	severe	ADJ
ecj-12528	89	53	disease	disease	NOUN
ecj-12528	89	54	and	and	CCONJ
ecj-12528	89	55	mortality	mortality	NOUN
ecj-12528	89	56	in	in	ADP
ecj-12528	89	57	covid-19	covid-19	PROPN
ecj-12528	89	58	are	be	AUX
ecj-12528	89	59	comorbidities	comorbiditie	NOUN
ecj-12528	89	60	such	such	ADJ
ecj-12528	89	61	as	as	ADP
ecj-12528	89	62	advanced	advanced	ADJ
ecj-12528	89	63	age	age	NOUN
ecj-12528	89	64	(	(	PUNCT
ecj-12528	89	65	age	age	NOUN
ecj-12528	89	66	>	>	X
ecj-12528	89	67	65	65	NUM
ecj-12528	89	68	)	)	PUNCT
ecj-12528	89	69	,	,	PUNCT
ecj-12528	89	70	ht	ht	PROPN
ecj-12528	89	71	,	,	PUNCT
ecj-12528	89	72	dm	dm	NOUN
ecj-12528	89	73	,	,	PUNCT
ecj-12528	89	74	cardiovascular	cardiovascular	ADJ
ecj-12528	89	75	disease	disease	NOUN
ecj-12528	89	76	,	,	PUNCT
ecj-12528	89	77	and	and	CCONJ
ecj-12528	89	78	kidney	kidney	NOUN
ecj-12528	89	79	disease.12	disease.12	NOUN
ecj-12528	89	80	in	in	ADP
ecj-12528	89	81	our	our	PRON
ecj-12528	89	82	study	study	NOUN
ecj-12528	89	83	,	,	PUNCT
ecj-12528	89	84	a	a	DET
ecj-12528	89	85	significant	significant	ADJ
ecj-12528	89	86	relationship	relationship	NOUN
ecj-12528	89	87	was	be	AUX
ecj-12528	89	88	found	find	VERB
ecj-12528	89	89	between	between	ADP
ecj-12528	89	90	comorbidities	comorbiditie	NOUN
ecj-12528	89	91	,	,	PUNCT
ecj-12528	89	92	mortality	mortality	NOUN
ecj-12528	89	93	,	,	PUNCT
ecj-12528	89	94	and	and	CCONJ
ecj-12528	89	95	disease	disease	NOUN
ecj-12528	89	96	severity	severity	NOUN
ecj-12528	89	97	.	.	PUNCT
ecj-12528	90	1	it	it	PRON
ecj-12528	90	2	can	can	AUX
ecj-12528	90	3	be	be	AUX
ecj-12528	90	4	concluded	conclude	VERB
ecj-12528	90	5	that	that	SCONJ
ecj-12528	90	6	the	the	DET
ecj-12528	90	7	mortality	mortality	NOUN
ecj-12528	90	8	rate	rate	NOUN
ecj-12528	90	9	is	be	AUX
ecj-12528	90	10	increased	increase	VERB
ecj-12528	90	11	,	,	PUNCT
ecj-12528	90	12	especially	especially	ADV
ecj-12528	90	13	in	in	ADP
ecj-12528	90	14	patients	patient	NOUN
ecj-12528	90	15	with	with	ADP
ecj-12528	90	16	diabetes	diabetes	NOUN
ecj-12528	90	17	,	,	PUNCT
ecj-12528	90	18	as	as	SCONJ
ecj-12528	90	19	their	their	PRON
ecj-12528	90	20	immune	immune	ADJ
ecj-12528	90	21	system	system	NOUN
ecj-12528	90	22	may	may	AUX
ecj-12528	90	23	be	be	AUX
ecj-12528	90	24	suppressed	suppress	VERB
ecj-12528	90	25	.	.	PUNCT
ecj-12528	91	1	since	since	SCONJ
ecj-12528	91	2	covid-19	covid-19	PROPN
ecj-12528	91	3	disease	disease	NOUN
ecj-12528	91	4	is	be	AUX
ecj-12528	91	5	a	a	DET
ecj-12528	91	6	viral	viral	ADJ
ecj-12528	91	7	disease	disease	NOUN
ecj-12528	91	8	,	,	PUNCT
ecj-12528	91	9	systemic	systemic	ADJ
ecj-12528	91	10	effects	effect	NOUN
ecj-12528	91	11	can	can	AUX
ecj-12528	91	12	be	be	AUX
ecj-12528	91	13	seen	see	VERB
ecj-12528	91	14	frequently	frequently	ADV
ecj-12528	91	15	.	.	PUNCT
ecj-12528	92	1	certain	certain	ADJ
ecj-12528	92	2	laboratory	laboratory	NOUN
ecj-12528	92	3	features	feature	NOUN
ecj-12528	92	4	have	have	AUX
ecj-12528	92	5	been	be	AUX
ecj-12528	92	6	associated	associate	VERB
ecj-12528	92	7	with	with	ADP
ecj-12528	92	8	poor	poor	ADJ
ecj-12528	92	9	outcomes	outcome	NOUN
ecj-12528	92	10	in	in	ADP
ecj-12528	92	11	covid-19	covid-19	PROPN
ecj-12528	92	12	disease	disease	NOUN
ecj-12528	92	13	.	.	PUNCT
ecj-12528	93	1	leukocyte	leukocyte	NOUN
ecj-12528	93	2	counts	count	NOUN
ecj-12528	93	3	may	may	AUX
ecj-12528	93	4	vary	vary	VERB
ecj-12528	93	5	with	with	ADP
ecj-12528	93	6	diseases.13	diseases.13	NOUN
ecj-12528	93	7	in	in	ADP
ecj-12528	93	8	our	our	PRON
ecj-12528	93	9	study	study	NOUN
ecj-12528	93	10	,	,	PUNCT
ecj-12528	93	11	although	although	SCONJ
ecj-12528	93	12	the	the	DET
ecj-12528	93	13	leukocyte	leukocyte	NOUN
ecj-12528	93	14	count	count	NOUN
ecj-12528	93	15	was	be	AUX
ecj-12528	93	16	within	within	ADP
ecj-12528	93	17	the	the	DET
ecj-12528	93	18	normal	normal	ADJ
ecj-12528	93	19	range	range	NOUN
ecj-12528	93	20	in	in	ADP
ecj-12528	93	21	both	both	DET
ecj-12528	93	22	groups	group	NOUN
ecj-12528	93	23	,	,	PUNCT
ecj-12528	93	24	it	it	PRON
ecj-12528	93	25	was	be	AUX
ecj-12528	93	26	found	find	VERB
ecj-12528	93	27	to	to	PART
ecj-12528	93	28	be	be	AUX
ecj-12528	93	29	higher	high	ADJ
ecj-12528	93	30	in	in	ADP
ecj-12528	93	31	deceased	deceased	ADJ
ecj-12528	93	32	patients	patient	NOUN
ecj-12528	93	33	than	than	ADP
ecj-12528	93	34	in	in	ADP
ecj-12528	93	35	survivors	survivor	NOUN
ecj-12528	93	36	and	and	CCONJ
ecj-12528	93	37	patients	patient	NOUN
ecj-12528	93	38	with	with	ADP
ecj-12528	93	39	severe	severe	ADJ
ecj-12528	93	40	disease	disease	NOUN
ecj-12528	93	41	than	than	ADP
ecj-12528	93	42	in	in	ADP
ecj-12528	93	43	patients	patient	NOUN
ecj-12528	93	44	with	with	ADP
ecj-12528	93	45	non	non	ADJ
ecj-12528	93	46	-	-	ADJ
ecj-12528	93	47	severe	severe	ADJ
ecj-12528	93	48	disease	disease	NOUN
ecj-12528	93	49	.	.	PUNCT
ecj-12528	94	1	lymphocyte	lymphocyte	ADJ
ecj-12528	94	2	count	count	NOUN
ecj-12528	94	3	is	be	AUX
ecj-12528	94	4	directly	directly	ADV
ecj-12528	94	5	related	relate	VERB
ecj-12528	94	6	to	to	ADP
ecj-12528	94	7	immunity	immunity	NOUN
ecj-12528	94	8	to	to	ADP
ecj-12528	94	9	the	the	DET
ecj-12528	94	10	virus	virus	NOUN
ecj-12528	94	11	.	.	PUNCT
ecj-12528	95	1	severely	severely	ADV
ecj-12528	95	2	decreased	decrease	VERB
ecj-12528	95	3	lymphocyte	lymphocyte	ADJ
ecj-12528	95	4	count	count	NOUN
ecj-12528	95	5	is	be	AUX
ecj-12528	95	6	associated	associate	VERB
ecj-12528	95	7	with	with	ADP
ecj-12528	95	8	increased	increase	VERB
ecj-12528	95	9	disease	disease	NOUN
ecj-12528	95	10	severity	severity	NOUN
ecj-12528	95	11	,	,	PUNCT
ecj-12528	95	12	morbidity	morbidity	NOUN
ecj-12528	95	13	,	,	PUNCT
ecj-12528	95	14	and	and	CCONJ
ecj-12528	95	15	mortality	mortality	NOUN
ecj-12528	95	16	.	.	PUNCT
ecj-12528	96	1	in	in	ADP
ecj-12528	96	2	the	the	DET
ecj-12528	96	3	study	study	NOUN
ecj-12528	96	4	of	of	ADP
ecj-12528	96	5	wang	wang	PROPN
ecj-12528	96	6	et	et	PROPN
ecj-12528	96	7	al	al	PROPN
ecj-12528	96	8	.	.	PROPN
ecj-12528	96	9	,	,	PUNCT
ecj-12528	96	10	decreased	decrease	VERB
ecj-12528	96	11	lymphocyte	lymphocyte	ADJ
ecj-12528	96	12	count	count	NOUN
ecj-12528	96	13	was	be	AUX
ecj-12528	96	14	associated	associate	VERB
ecj-12528	96	15	with	with	ADP
ecj-12528	96	16	severe	severe	ADJ
ecj-12528	96	17	disease	disease	NOUN
ecj-12528	96	18	and	and	CCONJ
ecj-12528	96	19	death.14	death.14	NOUN
ecj-12528	96	20	in	in	ADP
ecj-12528	96	21	our	our	PRON
ecj-12528	96	22	study	study	NOUN
ecj-12528	96	23	,	,	PUNCT
ecj-12528	96	24	lymphocyte	lymphocyte	ADJ
ecj-12528	96	25	counts	count	NOUN
ecj-12528	96	26	were	be	AUX
ecj-12528	96	27	lower	low	ADJ
ecj-12528	96	28	in	in	ADP
ecj-12528	96	29	deceased	deceased	ADJ
ecj-12528	96	30	patients	patient	NOUN
ecj-12528	96	31	compared	compare	VERB
ecj-12528	96	32	to	to	ADP
ecj-12528	96	33	survivors	survivor	NOUN
ecj-12528	96	34	.	.	PUNCT
ecj-12528	97	1	monocytes	monocyte	VERB
ecj-12528	97	2	trigger	trigger	NOUN
ecj-12528	97	3	inflammation	inflammation	NOUN
ecj-12528	97	4	through	through	ADP
ecj-12528	97	5	the	the	DET
ecj-12528	97	6	production	production	NOUN
ecj-12528	97	7	of	of	ADP
ecj-12528	97	8	cytokines	cytokine	NOUN
ecj-12528	97	9	and	and	CCONJ
ecj-12528	97	10	the	the	DET
ecj-12528	97	11	activation	activation	NOUN
ecj-12528	97	12	of	of	ADP
ecj-12528	97	13	lymphocytes.15	lymphocytes.15	NOUN
ecj-12528	97	14	in	in	ADP
ecj-12528	97	15	the	the	DET
ecj-12528	97	16	study	study	NOUN
ecj-12528	97	17	conducted	conduct	VERB
ecj-12528	97	18	by	by	ADP
ecj-12528	97	19	pan	pan	PROPN
ecj-12528	97	20	et	et	PROPN
ecj-12528	97	21	al	al	PROPN
ecj-12528	97	22	.	.	PROPN
ecj-12528	97	23	,	,	PUNCT
ecj-12528	97	24	monocyte	monocyte	NOUN
ecj-12528	97	25	levels	level	NOUN
ecj-12528	97	26	were	be	AUX
ecj-12528	97	27	found	find	VERB
ecj-12528	97	28	to	to	PART
ecj-12528	97	29	be	be	AUX
ecj-12528	97	30	significantly	significantly	ADV
ecj-12528	97	31	low	low	ADJ
ecj-12528	97	32	in	in	ADP
ecj-12528	97	33	covid-19	covid-19	PROPN
ecj-12528	97	34	patients.16	patients.16	NOUN
ecj-12528	97	35	in	in	ADP
ecj-12528	97	36	some	some	DET
ecj-12528	97	37	studies	study	NOUN
ecj-12528	97	38	,	,	PUNCT
ecj-12528	97	39	it	it	PRON
ecj-12528	97	40	has	have	AUX
ecj-12528	97	41	been	be	AUX
ecj-12528	97	42	reported	report	VERB
ecj-12528	97	43	that	that	SCONJ
ecj-12528	97	44	monocyte	monocyte	NOUN
ecj-12528	97	45	levels	level	NOUN
ecj-12528	97	46	were	be	AUX
ecj-12528	97	47	low	low	ADJ
ecj-12528	97	48	in	in	ADP
ecj-12528	97	49	patients	patient	NOUN
ecj-12528	97	50	with	with	ADP
ecj-12528	97	51	severe	severe	ADJ
ecj-12528	97	52	disease	disease	NOUN
ecj-12528	97	53	who	who	PRON
ecj-12528	97	54	were	be	AUX
ecj-12528	97	55	followed	follow	VERB
ecj-12528	97	56	up	up	ADP
ecj-12528	97	57	in	in	ADP
ecj-12528	97	58	intensive	intensive	ADJ
ecj-12528	97	59	care.17	care.17	NOUN
ecj-12528	97	60	in	in	ADP
ecj-12528	97	61	our	our	PRON
ecj-12528	97	62	study	study	NOUN
ecj-12528	97	63	,	,	PUNCT
ecj-12528	97	64	monocyte	monocyte	NOUN
ecj-12528	97	65	levels	level	NOUN
ecj-12528	97	66	were	be	AUX
ecj-12528	97	67	found	find	VERB
ecj-12528	97	68	to	to	PART
ecj-12528	97	69	be	be	AUX
ecj-12528	97	70	low	low	ADJ
ecj-12528	97	71	in	in	ADP
ecj-12528	97	72	patients	patient	NOUN
ecj-12528	97	73	who	who	PRON
ecj-12528	97	74	were	be	AUX
ecj-12528	97	75	deceased	deceased	ADJ
ecj-12528	97	76	and	and	CCONJ
ecj-12528	97	77	in	in	ADP
ecj-12528	97	78	the	the	DET
ecj-12528	97	79	group	group	NOUN
ecj-12528	97	80	with	with	ADP
ecj-12528	97	81	severe	severe	ADJ
ecj-12528	97	82	disease	disease	NOUN
ecj-12528	97	83	.	.	PUNCT
ecj-12528	98	1	the	the	DET
ecj-12528	98	2	covid-19	covid-19	PROPN
ecj-12528	98	3	disease	disease	NOUN
ecj-12528	98	4	affects	affect	VERB
ecj-12528	98	5	neutrophil	neutrophil	ADJ
ecj-12528	98	6	levels	level	NOUN
ecj-12528	98	7	.	.	PUNCT
ecj-12528	99	1	blood	blood	NOUN
ecj-12528	99	2	neutrophil	neutrophil	ADJ
ecj-12528	99	3	levels	level	NOUN
ecj-12528	99	4	usually	usually	ADV
ecj-12528	99	5	increase	increase	VERB
ecj-12528	99	6	in	in	ADP
ecj-12528	99	7	response	response	NOUN
ecj-12528	99	8	to	to	ADP
ecj-12528	99	9	infectious	infectious	ADJ
ecj-12528	99	10	agents	agent	NOUN
ecj-12528	99	11	and	and	CCONJ
ecj-12528	99	12	tissue	tissue	NOUN
ecj-12528	99	13	damage	damage	NOUN
ecj-12528	99	14	.	.	PUNCT
ecj-12528	100	1	in	in	ADP
ecj-12528	100	2	a	a	DET
ecj-12528	100	3	meta	meta	ADJ
ecj-12528	100	4	-	-	PUNCT
ecj-12528	100	5	analysis	analysis	NOUN
ecj-12528	100	6	by	by	ADP
ecj-12528	100	7	henry	henry	PROPN
ecj-12528	100	8	et	et	PROPN
ecj-12528	100	9	al	al	PROPN
ecj-12528	100	10	.	.	PROPN
ecj-12528	100	11	,	,	PUNCT
ecj-12528	100	12	neutrophil	neutrophil	ADJ
ecj-12528	100	13	counts	count	NOUN
ecj-12528	100	14	were	be	AUX
ecj-12528	100	15	found	find	VERB
ecj-12528	100	16	to	to	PART
ecj-12528	100	17	be	be	AUX
ecj-12528	100	18	higher	high	ADJ
ecj-12528	100	19	in	in	ADP
ecj-12528	100	20	deceased	deceased	ADJ
ecj-12528	100	21	patients	patient	NOUN
ecj-12528	100	22	than	than	SCONJ
ecj-12528	100	23	in	in	ADP
ecj-12528	100	24	survivors.13	survivors.13	ADJ
ecj-12528	100	25	thrombocytopenia	thrombocytopenia	NOUN
ecj-12528	100	26	has	have	AUX
ecj-12528	100	27	been	be	AUX
ecj-12528	100	28	reported	report	VERB
ecj-12528	100	29	to	to	PART
ecj-12528	100	30	be	be	AUX
ecj-12528	100	31	associated	associate	VERB
ecj-12528	100	32	with	with	ADP
ecj-12528	100	33	a	a	DET
ecj-12528	100	34	poor	poor	ADJ
ecj-12528	100	35	prognosis	prognosis	NOUN
ecj-12528	100	36	in	in	ADP
ecj-12528	100	37	covid-19	covid-19	PROPN
ecj-12528	100	38	disease.18	disease.18	PROPN
ecj-12528	100	39	in	in	ADP
ecj-12528	100	40	a	a	DET
ecj-12528	100	41	study	study	NOUN
ecj-12528	100	42	,	,	PUNCT
ecj-12528	100	43	a	a	DET
ecj-12528	100	44	low	low	ADJ
ecj-12528	100	45	platelet	platelet	NOUN
ecj-12528	100	46	count	count	NOUN
ecj-12528	100	47	was	be	AUX
ecj-12528	100	48	found	find	VERB
ecj-12528	100	49	in	in	ADP
ecj-12528	100	50	deceased	deceased	ADJ
ecj-12528	100	51	patients	patient	NOUN
ecj-12528	100	52	and	and	CCONJ
ecj-12528	100	53	severe	severe	ADJ
ecj-12528	100	54	cases.13	cases.13	NOUN
ecj-12528	100	55	in	in	ADP
ecj-12528	100	56	a	a	DET
ecj-12528	100	57	study	study	NOUN
ecj-12528	100	58	by	by	ADP
ecj-12528	100	59	lippi	lippi	PROPN
ecj-12528	100	60	et	et	PROPN
ecj-12528	100	61	al	al	PROPN
ecj-12528	100	62	.	.	PROPN
ecj-12528	100	63	,	,	PUNCT
ecj-12528	100	64	the	the	DET
ecj-12528	100	65	presence	presence	NOUN
ecj-12528	100	66	of	of	ADP
ecj-12528	100	67	thrombocytopenia	thrombocytopenia	PROPN
ecj-12528	100	68	(	(	PUNCT
ecj-12528	100	69	<	<	X
ecj-12528	100	70	31x	31x	X
ecj-12528	100	71	109	109	NUM
ecj-12528	100	72	/	/	SYM
ecj-12528	100	73	l	l	NOUN
ecj-12528	100	74	)	)	PUNCT
ecj-12528	100	75	was	be	AUX
ecj-12528	100	76	found	find	VERB
ecj-12528	100	77	to	to	PART
ecj-12528	100	78	be	be	AUX
ecj-12528	100	79	higher	high	ADJ
ecj-12528	100	80	in	in	ADP
ecj-12528	100	81	individuals	individual	NOUN
ecj-12528	100	82	with	with	ADP
ecj-12528	100	83	severe	severe	ADJ
ecj-12528	100	84	disease	disease	NOUN
ecj-12528	100	85	,	,	PUNCT
ecj-12528	100	86	and	and	CCONJ
ecj-12528	100	87	it	it	PRON
ecj-12528	100	88	was	be	AUX
ecj-12528	100	89	reported	report	VERB
ecj-12528	100	90	that	that	SCONJ
ecj-12528	100	91	the	the	DET
ecj-12528	100	92	rate	rate	NOUN
ecj-12528	100	93	of	of	ADP
ecj-12528	100	94	severe	severe	ADJ
ecj-12528	100	95	disease	disease	NOUN
ecj-12528	100	96	was	be	AUX
ecj-12528	100	97	five	five	NUM
ecj-12528	100	98	times	time	NOUN
ecj-12528	100	99	higher	high	ADJ
ecj-12528	100	100	in	in	ADP
ecj-12528	100	101	patients	patient	NOUN
ecj-12528	100	102	with	with	ADP
ecj-12528	100	103	thrombocytopenia.19	thrombocytopenia.19	PROPN
ecj-12528	100	104	in	in	ADP
ecj-12528	100	105	our	our	PRON
ecj-12528	100	106	study	study	NOUN
ecj-12528	100	107	,	,	PUNCT
ecj-12528	100	108	unlike	unlike	ADP
ecj-12528	100	109	the	the	DET
ecj-12528	100	110	studies	study	NOUN
ecj-12528	100	111	reported	report	VERB
ecj-12528	100	112	in	in	ADP
ecj-12528	100	113	the	the	DET
ecj-12528	100	114	literature	literature	NOUN
ecj-12528	100	115	,	,	PUNCT
ecj-12528	100	116	no	no	DET
ecj-12528	100	117	significant	significant	ADJ
ecj-12528	100	118	difference	difference	NOUN
ecj-12528	100	119	was	be	AUX
ecj-12528	100	120	found	find	VERB
ecj-12528	100	121	between	between	ADP
ecj-12528	100	122	the	the	DET
ecj-12528	100	123	two	two	NUM
ecj-12528	100	124	groups	group	NOUN
ecj-12528	100	125	in	in	ADP
ecj-12528	100	126	platelet	platelet	NOUN
ecj-12528	100	127	levels	level	NOUN
ecj-12528	100	128	.	.	PUNCT
ecj-12528	101	1	sii	sii	PROPN
ecj-12528	101	2	and	and	CCONJ
ecj-12528	101	3	siri	siri	NOUN
ecj-12528	101	4	are	be	AUX
ecj-12528	101	5	parameters	parameter	NOUN
ecj-12528	101	6	that	that	PRON
ecj-12528	101	7	can	can	AUX
ecj-12528	101	8	be	be	AUX
ecj-12528	101	9	used	use	VERB
ecj-12528	101	10	to	to	PART
ecj-12528	101	11	predict	predict	VERB
ecj-12528	101	12	in	in	ADP
ecj-12528	101	13	-	-	PUNCT
ecj-12528	101	14	hospital	hospital	NOUN
ecj-12528	101	15	mortality	mortality	NOUN
ecj-12528	101	16	.	.	PUNCT
ecj-12528	102	1	in	in	ADP
ecj-12528	102	2	some	some	DET
ecj-12528	102	3	malignancies	malignancy	NOUN
ecj-12528	102	4	,	,	PUNCT
ecj-12528	102	5	sii	sii	PROPN
ecj-12528	102	6	has	have	AUX
ecj-12528	102	7	been	be	AUX
ecj-12528	102	8	shown	show	VERB
ecj-12528	102	9	to	to	PART
ecj-12528	102	10	strongly	strongly	ADV
ecj-12528	102	11	predict	predict	VERB
ecj-12528	102	12	prognosis.20	prognosis.20	PROPN
ecj-12528	102	13	in	in	ADP
ecj-12528	102	14	another	another	DET
ecj-12528	102	15	study	study	NOUN
ecj-12528	102	16	,	,	PUNCT
ecj-12528	102	17	it	it	PRON
ecj-12528	102	18	was	be	AUX
ecj-12528	102	19	shown	show	VERB
ecj-12528	102	20	that	that	SCONJ
ecj-12528	102	21	it	it	PRON
ecj-12528	102	22	can	can	AUX
ecj-12528	102	23	be	be	AUX
ecj-12528	102	24	used	use	VERB
ecj-12528	102	25	to	to	PART
ecj-12528	102	26	predict	predict	VERB
ecj-12528	102	27	prognosis	prognosis	NOUN
ecj-12528	102	28	in	in	ADP
ecj-12528	102	29	pancreatitis	pancreatitis	ADJ
ecj-12528	102	30	patients.21	patients.21	NOUN
ecj-12528	102	31	there	there	PRON
ecj-12528	102	32	is	be	VERB
ecj-12528	102	33	a	a	DET
ecj-12528	102	34	study	study	NOUN
ecj-12528	102	35	in	in	ADP
ecj-12528	102	36	the	the	DET
ecj-12528	102	37	literature	literature	NOUN
ecj-12528	102	38	showing	show	VERB
ecj-12528	102	39	an	an	DET
ecj-12528	102	40	association	association	NOUN
ecj-12528	102	41	between	between	ADP
ecj-12528	102	42	increased	increase	VERB
ecj-12528	102	43	sii	sii	ADJ
ecj-12528	102	44	and	and	CCONJ
ecj-12528	102	45	poor	poor	ADJ
ecj-12528	102	46	prognosis	prognosis	NOUN
ecj-12528	102	47	in	in	ADP
ecj-12528	102	48	coronary	coronary	ADJ
ecj-12528	102	49	artery	artery	NOUN
ecj-12528	102	50	disease.22	disease.22	NOUN
ecj-12528	102	51	similarly	similarly	ADV
ecj-12528	102	52	,	,	PUNCT
ecj-12528	102	53	there	there	PRON
ecj-12528	102	54	are	be	VERB
ecj-12528	102	55	also	also	ADV
ecj-12528	102	56	studies	study	NOUN
ecj-12528	102	57	conducted	conduct	VERB
ecj-12528	102	58	for	for	ADP
ecj-12528	102	59	siri	siri	NOUN
ecj-12528	102	60	.	.	PUNCT
ecj-12528	103	1	siri	siri	NOUN
ecj-12528	103	2	has	have	AUX
ecj-12528	103	3	been	be	AUX
ecj-12528	103	4	shown	show	VERB
ecj-12528	103	5	to	to	PART
ecj-12528	103	6	predict	predict	VERB
ecj-12528	103	7	poor	poor	ADJ
ecj-12528	103	8	prognosis	prognosis	NOUN
ecj-12528	103	9	in	in	ADP
ecj-12528	103	10	stroke	stroke	NOUN
ecj-12528	103	11	and	and	CCONJ
ecj-12528	103	12	pancreatitis	pancreatitis	PROPN
ecj-12528	103	13	patients.23,24	patients.23,24	NOUN
ecj-12528	103	14	with	with	ADP
ecj-12528	103	15	these	these	DET
ecj-12528	103	16	data	datum	NOUN
ecj-12528	103	17	,	,	PUNCT
ecj-12528	103	18	the	the	DET
ecj-12528	103	19	power	power	NOUN
ecj-12528	103	20	of	of	ADP
ecj-12528	103	21	sii	sii	PROPN
ecj-12528	103	22	and	and	CCONJ
ecj-12528	103	23	siri	siri	NOUN
ecj-12528	103	24	in	in	ADP
ecj-12528	103	25	predicting	predict	VERB
ecj-12528	103	26	prognosis	prognosis	NOUN
ecj-12528	103	27	and	and	CCONJ
ecj-12528	103	28	mortality	mortality	NOUN
ecj-12528	103	29	in	in	ADP
ecj-12528	103	30	covid-19	covid-19	PROPN
ecj-12528	103	31	disease	disease	NOUN
ecj-12528	103	32	has	have	AUX
ecj-12528	103	33	aroused	arouse	VERB
ecj-12528	103	34	curiosity	curiosity	NOUN
ecj-12528	103	35	,	,	PUNCT
ecj-12528	103	36	and	and	CCONJ
ecj-12528	103	37	studies	study	NOUN
ecj-12528	103	38	have	have	AUX
ecj-12528	103	39	been	be	AUX
ecj-12528	103	40	conducted	conduct	VERB
ecj-12528	103	41	.	.	PUNCT
ecj-12528	104	1	eissa	eissa	PROPN
ecj-12528	104	2	et	et	PROPN
ecj-12528	104	3	al	al	PROPN
ecj-12528	104	4	.	.	PROPN
ecj-12528	104	5	found	find	VERB
ecj-12528	104	6	a	a	DET
ecj-12528	104	7	correlation	correlation	NOUN
ecj-12528	104	8	between	between	ADP
ecj-12528	104	9	an	an	DET
ecj-12528	104	10	increase	increase	NOUN
ecj-12528	104	11	in	in	ADP
ecj-12528	104	12	siri	siri	NOUN
ecj-12528	104	13	and	and	CCONJ
ecj-12528	104	14	an	an	DET
ecj-12528	104	15	increase	increase	NOUN
ecj-12528	104	16	in	in	ADP
ecj-12528	104	17	mortality	mortality	NOUN
ecj-12528	104	18	rates	rate	NOUN
ecj-12528	104	19	,	,	PUNCT
ecj-12528	104	20	whereas	whereas	SCONJ
ecj-12528	104	21	no	no	DET
ecj-12528	104	22	correlation	correlation	NOUN
ecj-12528	104	23	was	be	AUX
ecj-12528	104	24	found	find	VERB
ecj-12528	104	25	between	between	ADP
ecj-12528	104	26	sii	sii	PROPN
ecj-12528	104	27	and	and	CCONJ
ecj-12528	104	28	mortality.25	mortality.25	NOUN
ecj-12528	104	29	in	in	ADP
ecj-12528	104	30	the	the	DET
ecj-12528	104	31	study	study	NOUN
ecj-12528	104	32	by	by	ADP
ecj-12528	104	33	fois	fois	PROPN
ecj-12528	104	34	et	et	PROPN
ecj-12528	104	35	al	al	PROPN
ecj-12528	104	36	.	.	PROPN
ecj-12528	104	37	,	,	PUNCT
ecj-12528	104	38	both	both	CCONJ
ecj-12528	104	39	sii	sii	ADJ
ecj-12528	104	40	and	and	CCONJ
ecj-12528	104	41	siri	siri	NOUN
ecj-12528	104	42	were	be	AUX
ecj-12528	104	43	found	find	VERB
ecj-12528	104	44	to	to	PART
ecj-12528	104	45	be	be	AUX
ecj-12528	104	46	significantly	significantly	ADV
ecj-12528	104	47	increased	increase	VERB
ecj-12528	104	48	in	in	ADP
ecj-12528	104	49	covid-19	covid-19	PROPN
ecj-12528	104	50	patients	patient	NOUN
ecj-12528	104	51	who	who	PRON
ecj-12528	104	52	died.26	died.26	VERB
ecj-12528	104	53	in	in	ADP
ecj-12528	104	54	the	the	DET
ecj-12528	104	55	study	study	NOUN
ecj-12528	104	56	by	by	ADP
ecj-12528	104	57	muhammad	muhammad	PROPN
ecj-12528	104	58	et	et	PROPN
ecj-12528	104	59	al	al	PROPN
ecj-12528	104	60	.	.	PROPN
ecj-12528	104	61	,	,	PUNCT
ecj-12528	104	62	the	the	DET
ecj-12528	104	63	power	power	NOUN
ecj-12528	104	64	of	of	ADP
ecj-12528	104	65	sii	sii	PROPN
ecj-12528	104	66	in	in	ADP
ecj-12528	104	67	predicting	predict	VERB
ecj-12528	104	68	intubation	intubation	NOUN
ecj-12528	104	69	and	and	CCONJ
ecj-12528	104	70	death	death	NOUN
ecj-12528	104	71	in	in	ADP
ecj-12528	104	72	patients	patient	NOUN
ecj-12528	104	73	was	be	AUX
ecj-12528	104	74	emphasized.27	emphasized.27	ADJ
ecj-12528	104	75	in	in	ADP
ecj-12528	104	76	a	a	DET
ecj-12528	104	77	study	study	NOUN
ecj-12528	104	78	by	by	ADP
ecj-12528	104	79	usul	usul	PROPN
ecj-12528	104	80	et	et	PROPN
ecj-12528	104	81	al	al	PROPN
ecj-12528	104	82	.	.	PROPN
ecj-12528	105	1	on	on	ADP
ecj-12528	105	2	patients	patient	NOUN
ecj-12528	105	3	admitted	admit	VERB
ecj-12528	105	4	to	to	ADP
ecj-12528	105	5	the	the	DET
ecj-12528	105	6	emergency	emergency	NOUN
ecj-12528	105	7	department	department	NOUN
ecj-12528	105	8	,	,	PUNCT
ecj-12528	105	9	increased	increase	VERB
ecj-12528	105	10	sii	sii	PROPN
ecj-12528	105	11	was	be	AUX
ecj-12528	105	12	found	find	VERB
ecj-12528	105	13	to	to	PART
ecj-12528	105	14	be	be	AUX
ecj-12528	105	15	associated	associate	VERB
ecj-12528	105	16	with	with	ADP
ecj-12528	105	17	poor	poor	ADJ
ecj-12528	105	18	prognosis	prognosis	NOUN
ecj-12528	105	19	and	and	CCONJ
ecj-12528	105	20	increased	increase	VERB
ecj-12528	105	21	mortality.5	mortality.5	PROPN
ecj-12528	105	22	in	in	ADP
ecj-12528	105	23	a	a	DET
ecj-12528	105	24	study	study	NOUN
ecj-12528	105	25	conducted	conduct	VERB
ecj-12528	105	26	on	on	ADP
ecj-12528	105	27	patients	patient	NOUN
ecj-12528	105	28	hospitalized	hospitalize	VERB
ecj-12528	105	29	in	in	ADP
ecj-12528	105	30	intensive	intensive	ADJ
ecj-12528	105	31	care	care	NOUN
ecj-12528	105	32	,	,	PUNCT
ecj-12528	105	33	it	it	PRON
ecj-12528	105	34	was	be	AUX
ecj-12528	105	35	emphasized	emphasize	VERB
ecj-12528	105	36	that	that	SCONJ
ecj-12528	105	37	sii	sii	PROPN
ecj-12528	105	38	was	be	AUX
ecj-12528	105	39	an	an	DET
ecj-12528	105	40	independent	independent	ADJ
ecj-12528	105	41	marker	marker	NOUN
ecj-12528	105	42	in	in	ADP
ecj-12528	105	43	determining	determine	VERB
ecj-12528	105	44	the	the	DET
ecj-12528	105	45	prognosis	prognosis	NOUN
ecj-12528	105	46	of	of	ADP
ecj-12528	105	47	covid-19	covid-19	PROPN
ecj-12528	105	48	patients	patient	NOUN
ecj-12528	105	49	.	.	PUNCT
ecj-12528	106	1	in	in	ADP
ecj-12528	106	2	the	the	DET
ecj-12528	106	3	same	same	ADJ
ecj-12528	106	4	study	study	NOUN
ecj-12528	106	5	,	,	PUNCT
ecj-12528	106	6	siri	siri	NOUN
ecj-12528	106	7	(	(	PUNCT
ecj-12528	106	8	or	or	CCONJ
ecj-12528	106	9	:	:	PUNCT
ecj-12528	106	10	1.041	1.041	NUM
ecj-12528	106	11	,	,	PUNCT
ecj-12528	106	12	95	95	NUM
ecj-12528	106	13	%	%	NOUN
ecj-12528	106	14	ci	ci	NOUN
ecj-12528	106	15	:	:	PUNCT
ecj-12528	106	16	1.006–1.078	1.006–1.078	NUM
ecj-12528	106	17	,	,	PUNCT
ecj-12528	106	18	p=0.021	p=0.021	NUM
ecj-12528	106	19	)	)	PUNCT
ecj-12528	106	20	was	be	AUX
ecj-12528	106	21	found	find	VERB
ecj-12528	106	22	to	to	PART
ecj-12528	106	23	be	be	AUX
ecj-12528	106	24	the	the	DET
ecj-12528	106	25	most	most	ADV
ecj-12528	106	26	effective	effective	ADJ
ecj-12528	106	27	factor	factor	NOUN
ecj-12528	106	28	in	in	ADP
ecj-12528	106	29	predicting	predict	VERB
ecj-12528	106	30	hospitalization.28	hospitalization.28	NOUN
ecj-12528	106	31	in	in	ADP
ecj-12528	106	32	another	another	DET
ecj-12528	106	33	study	study	NOUN
ecj-12528	106	34	conducted	conduct	VERB
ecj-12528	106	35	on	on	ADP
ecj-12528	106	36	patients	patient	NOUN
ecj-12528	106	37	hospitalized	hospitalize	VERB
ecj-12528	106	38	in	in	ADP
ecj-12528	106	39	intensive	intensive	ADJ
ecj-12528	106	40	care	care	NOUN
ecj-12528	106	41	,	,	PUNCT
ecj-12528	106	42	similar	similar	ADJ
ecj-12528	106	43	results	result	NOUN
ecj-12528	106	44	were	be	AUX
ecj-12528	106	45	found	find	VERB
ecj-12528	106	46	,	,	PUNCT
ecj-12528	106	47	and	and	CCONJ
ecj-12528	106	48	a	a	DET
ecj-12528	106	49	significant	significant	ADJ
ecj-12528	106	50	relationship	relationship	NOUN
ecj-12528	106	51	was	be	AUX
ecj-12528	106	52	found	find	VERB
ecj-12528	106	53	between	between	ADP
ecj-12528	106	54	sii	sii	PROPN
ecj-12528	106	55	and	and	CCONJ
ecj-12528	106	56	siri	siri	NOUN
ecj-12528	106	57	and	and	CCONJ
ecj-12528	106	58	death	death	NOUN
ecj-12528	106	59	,	,	PUNCT
ecj-12528	106	60	and	and	CCONJ
ecj-12528	106	61	the	the	DET
ecj-12528	106	62	specificity	specificity	NOUN
ecj-12528	106	63	of	of	ADP
ecj-12528	106	64	sii	sii	PROPN
ecj-12528	106	65	was	be	AUX
ecj-12528	106	66	found	find	VERB
ecj-12528	106	67	to	to	PART
ecj-12528	106	68	be	be	AUX
ecj-12528	106	69	higher.29	higher.29	NOUN
ecj-12528	106	70	in	in	ADP
ecj-12528	106	71	our	our	PRON
ecj-12528	106	72	study	study	NOUN
ecj-12528	106	73	,	,	PUNCT
ecj-12528	106	74	the	the	DET
ecj-12528	106	75	mean	mean	ADJ
ecj-12528	106	76	sii	sii	ADJ
ecj-12528	106	77	and	and	CCONJ
ecj-12528	106	78	siri	siri	NOUN
ecj-12528	106	79	values	value	NOUN
ecj-12528	106	80	in	in	ADP
ecj-12528	106	81	the	the	DET
ecj-12528	106	82	deceased	deceased	ADJ
ecj-12528	106	83	and	and	CCONJ
ecj-12528	106	84	severe	severe	ADJ
ecj-12528	106	85	groups	group	NOUN
ecj-12528	106	86	were	be	AUX
ecj-12528	106	87	higher	high	ADJ
ecj-12528	106	88	than	than	ADP
ecj-12528	106	89	the	the	DET
ecj-12528	106	90	mean	mean	ADJ
ecj-12528	106	91	sii	sii	ADJ
ecj-12528	106	92	and	and	CCONJ
ecj-12528	106	93	siri	siri	NOUN
ecj-12528	106	94	values	value	NOUN
ecj-12528	106	95	in	in	ADP
ecj-12528	106	96	the	the	DET
ecj-12528	106	97	survivors	survivor	NOUN
ecj-12528	106	98	and	and	CCONJ
ecj-12528	106	99	non	non	ADJ
ecj-12528	106	100	-	-	ADJ
ecj-12528	106	101	severe	severe	ADJ
ecj-12528	106	102	groups	group	NOUN
ecj-12528	106	103	.	.	PUNCT
ecj-12528	107	1	increased	increase	VERB
ecj-12528	107	2	inflammatory	inflammatory	ADJ
ecj-12528	107	3	conditions	condition	NOUN
ecj-12528	107	4	,	,	PUNCT
ecj-12528	107	5	the	the	DET
ecj-12528	107	6	neutrophil	neutrophil	ADJ
ecj-12528	107	7	ratio	ratio	NOUN
ecj-12528	107	8	increases	increase	NOUN
ecj-12528	107	9	as	as	ADP
ecj-12528	107	10	a	a	DET
ecj-12528	107	11	product	product	NOUN
ecj-12528	107	12	of	of	ADP
ecj-12528	107	13	natural	natural	ADJ
ecj-12528	107	14	immunity	immunity	NOUN
ecj-12528	107	15	.	.	PUNCT
ecj-12528	108	1	lymphocytes	lymphocyte	NOUN
ecj-12528	108	2	provide	provide	VERB
ecj-12528	108	3	the	the	DET
ecj-12528	108	4	main	main	ADJ
ecj-12528	108	5	immunity	immunity	NOUN
ecj-12528	108	6	against	against	ADP
ecj-12528	108	7	viruses	virus	NOUN
ecj-12528	108	8	.	.	PUNCT
ecj-12528	109	1	as	as	ADP
ecj-12528	109	2	the	the	DET
ecj-12528	109	3	severity	severity	NOUN
ecj-12528	109	4	of	of	ADP
ecj-12528	109	5	the	the	DET
ecj-12528	109	6	disease	disease	NOUN
ecj-12528	109	7	increases	increase	NOUN
ecj-12528	109	8	,	,	PUNCT
ecj-12528	109	9	immunity	immunity	NOUN
ecj-12528	109	10	gradually	gradually	ADV
ecj-12528	109	11	decreases	decrease	VERB
ecj-12528	109	12	,	,	PUNCT
ecj-12528	109	13	with	with	ADP
ecj-12528	109	14	lymphocytes	lymphocyte	NOUN
ecj-12528	109	15	lost	lose	VERB
ecj-12528	109	16	in	in	ADP
ecj-12528	109	17	this	this	DET
ecj-12528	109	18	battle	battle	NOUN
ecj-12528	109	19	.	.	PUNCT
ecj-12528	110	1	since	since	SCONJ
ecj-12528	110	2	sii	sii	PROPN
ecj-12528	110	3	and	and	CCONJ
ecj-12528	110	4	siri	siri	NOUN
ecj-12528	110	5	include	include	VERB
ecj-12528	110	6	both	both	DET
ecj-12528	110	7	lymphocyte	lymphocyte	ADJ
ecj-12528	110	8	counts	count	NOUN
ecj-12528	110	9	and	and	CCONJ
ecj-12528	110	10	neutrophil	neutrophil	ADJ
ecj-12528	110	11	counts	count	NOUN
ecj-12528	110	12	,	,	PUNCT
ecj-12528	110	13	they	they	PRON
ecj-12528	110	14	can	can	AUX
ecj-12528	110	15	be	be	AUX
ecj-12528	110	16	used	use	VERB
ecj-12528	110	17	to	to	PART
ecj-12528	110	18	determine	determine	VERB
ecj-12528	110	19	the	the	DET
ecj-12528	110	20	state	state	NOUN
ecj-12528	110	21	of	of	ADP
ecj-12528	110	22	immunity	immunity	NOUN
ecj-12528	110	23	and	and	CCONJ
ecj-12528	110	24	inflammation	inflammation	NOUN
ecj-12528	110	25	.	.	PUNCT
ecj-12528	111	1	these	these	DET
ecj-12528	111	2	indices	index	NOUN
ecj-12528	111	3	indicate	indicate	VERB
ecj-12528	111	4	increasing	increase	VERB
ecj-12528	111	5	inflammation	inflammation	NOUN
ecj-12528	111	6	,	,	PUNCT
ecj-12528	111	7	and	and	CCONJ
ecj-12528	111	8	as	as	ADP
ecj-12528	111	9	the	the	DET
ecj-12528	111	10	rate	rate	NOUN
ecj-12528	111	11	of	of	ADP
ecj-12528	111	12	inflammation	inflammation	NOUN
ecj-12528	111	13	increases	increase	NOUN
ecj-12528	111	14	,	,	PUNCT
ecj-12528	111	15	the	the	DET
ecj-12528	111	16	prognosis	prognosis	NOUN
ecj-12528	111	17	worsens	worsen	VERB
ecj-12528	111	18	.	.	PUNCT
ecj-12528	112	1	the	the	DET
ecj-12528	112	2	association	association	NOUN
ecj-12528	112	3	of	of	ADP
ecj-12528	112	4	increasing	increase	VERB
ecj-12528	112	5	sii	sii	PROPN
ecj-12528	112	6	and	and	CCONJ
ecj-12528	112	7	siri	siri	NOUN
ecj-12528	112	8	with	with	ADP
ecj-12528	112	9	death	death	NOUN
ecj-12528	112	10	is	be	AUX
ecj-12528	112	11	consistent	consistent	ADJ
ecj-12528	112	12	in	in	ADP
ecj-12528	112	13	this	this	DET
ecj-12528	112	14	respect	respect	NOUN
ecj-12528	112	15	.	.	PUNCT
ecj-12528	113	1	sii	sii	PROPN
ecj-12528	113	2	and	and	CCONJ
ecj-12528	113	3	siri	siri	NOUN
ecj-12528	113	4	are	be	AUX
ecj-12528	113	5	easily	easily	ADV
ecj-12528	113	6	accessible	accessible	ADJ
ecj-12528	113	7	markers	marker	NOUN
ecj-12528	113	8	and	and	CCONJ
ecj-12528	113	9	can	can	AUX
ecj-12528	113	10	be	be	AUX
ecj-12528	113	11	used	use	VERB
ecj-12528	113	12	independently	independently	ADV
ecj-12528	113	13	to	to	PART
ecj-12528	113	14	predict	predict	VERB
ecj-12528	113	15	death	death	NOUN
ecj-12528	113	16	and	and	CCONJ
ecj-12528	113	17	poor	poor	ADJ
ecj-12528	113	18	prognosis	prognosis	NOUN
ecj-12528	113	19	in	in	ADP
ecj-12528	113	20	patients	patient	NOUN
ecj-12528	113	21	with	with	ADP
ecj-12528	113	22	covid-19	covid-19	PROPN
ecj-12528	113	23	.	.	PUNCT
ecj-12528	114	1	article	article	NOUN
ecj-12528	114	2	table	table	VERB
ecj-12528	114	3	3	3	NUM
ecj-12528	114	4	.	.	PUNCT
ecj-12528	115	1	roc	roc	NOUN
ecj-12528	115	2	analysis	analysis	NOUN
ecj-12528	115	3	results	result	NOUN
ecj-12528	115	4	of	of	ADP
ecj-12528	115	5	indices	index	NOUN
ecj-12528	115	6	for	for	ADP
ecj-12528	115	7	predicting	predict	VERB
ecj-12528	115	8	mortality	mortality	NOUN
ecj-12528	115	9	and	and	CCONJ
ecj-12528	115	10	disease	disease	NOUN
ecj-12528	115	11	severity	severity	NOUN
ecj-12528	115	12	.	.	PUNCT
ecj-12528	116	1	cut	cut	VERB
ecj-12528	116	2	-	-	PUNCT
ecj-12528	116	3	off	off	ADP
ecj-12528	116	4	auc	auc	NOUN
ecj-12528	116	5	(	(	PUNCT
ecj-12528	116	6	p	p	NOUN
ecj-12528	116	7	)	)	PUNCT
ecj-12528	116	8	sensitivity	sensitivity	NOUN
ecj-12528	116	9	(	(	PUNCT
ecj-12528	116	10	ci	ci	NOUN
ecj-12528	116	11	)	)	PUNCT
ecj-12528	116	12	specificity	specificity	NOUN
ecj-12528	116	13	(	(	PUNCT
ecj-12528	116	14	ci	ci	NOUN
ecj-12528	116	15	)	)	PUNCT
ecj-12528	116	16	ppv	ppv	NOUN
ecj-12528	116	17	(	(	PUNCT
ecj-12528	116	18	%	%	INTJ
ecj-12528	116	19	)	)	PUNCT
ecj-12528	116	20	npv	npv	NOUN
ecj-12528	116	21	(	(	PUNCT
ecj-12528	116	22	%	%	INTJ
ecj-12528	116	23	)	)	PUNCT
ecj-12528	116	24	death	death	NOUN
ecj-12528	116	25	siri	siri	NOUN
ecj-12528	116	26	>	>	X
ecj-12528	116	27	2.057	2.057	NUM
ecj-12528	116	28	0.640	0.640	NUM
ecj-12528	116	29	(	(	PUNCT
ecj-12528	116	30	0.0001	0.0001	NUM
ecj-12528	116	31	)	)	PUNCT
ecj-12528	116	32	72.06	72.06	NUM
ecj-12528	116	33	(	(	PUNCT
ecj-12528	116	34	63.72	63.72	NUM
ecj-12528	116	35	-	-	SYM
ecj-12528	116	36	79.41	79.41	NUM
ecj-12528	116	37	)	)	PUNCT
ecj-12528	116	38	50.97	50.97	NUM
ecj-12528	116	39	(	(	PUNCT
ecj-12528	116	40	45.26	45.26	NUM
ecj-12528	116	41	-	-	SYM
ecj-12528	116	42	56.66	56.66	NUM
ecj-12528	116	43	)	)	PUNCT
ecj-12528	116	44	39.20	39.20	NUM
ecj-12528	116	45	(	(	PUNCT
ecj-12528	116	46	33.11	33.11	NUM
ecj-12528	116	47	-	-	SYM
ecj-12528	116	48	45.55	45.55	NUM
ecj-12528	116	49	)	)	PUNCT
ecj-12528	116	50	80.61	80.61	NUM
ecj-12528	116	51	(	(	PUNCT
ecj-12528	116	52	74.37	74.37	NUM
ecj-12528	116	53	-	-	SYM
ecj-12528	116	54	85.90	85.90	NUM
ecj-12528	116	55	)	)	PUNCT
ecj-12528	116	56	sii	sii	PROPN
ecj-12528	116	57	>	>	X
ecj-12528	116	58	1370.353	1370.353	NUM
ecj-12528	116	59	0.682	0.682	NUM
ecj-12528	116	60	(	(	PUNCT
ecj-12528	116	61	0.0001	0.0001	NUM
ecj-12528	116	62	)	)	PUNCT
ecj-12528	116	63	55.15	55.15	NUM
ecj-12528	116	64	(	(	PUNCT
ecj-12528	116	65	46.39	46.39	NUM
ecj-12528	116	66	-	-	SYM
ecj-12528	116	67	63.68	63.68	NUM
ecj-12528	116	68	)	)	PUNCT
ecj-12528	116	69	74.19	74.19	NUM
ecj-12528	116	70	(	(	PUNCT
ecj-12528	116	71	68.94	68.94	NUM
ecj-12528	116	72	-	-	SYM
ecj-12528	116	73	78.97	78.97	NUM
ecj-12528	116	74	)	)	PUNCT
ecj-12528	116	75	48.39	48.39	NUM
ecj-12528	116	76	(	(	PUNCT
ecj-12528	116	77	40.30	40.30	NUM
ecj-12528	116	78	-	-	SYM
ecj-12528	116	79	56.54	56.54	NUM
ecj-12528	116	80	)	)	PUNCT
ecj-12528	116	81	79.04	79.04	NUM
ecj-12528	116	82	(	(	PUNCT
ecj-12528	116	83	73.90	73.90	NUM
ecj-12528	116	84	-	-	SYM
ecj-12528	116	85	83.57	83.57	NUM
ecj-12528	116	86	)	)	PUNCT
ecj-12528	116	87	severity	severity	NOUN
ecj-12528	116	88	siri	siri	NOUN
ecj-12528	116	89	>	>	X
ecj-12528	116	90	1.648	1.648	NUM
ecj-12528	116	91	0.689	0.689	NUM
ecj-12528	116	92	(	(	PUNCT
ecj-12528	116	93	0.0001	0.0001	NUM
ecj-12528	116	94	)	)	PUNCT
ecj-12528	116	95	78.63	78.63	NUM
ecj-12528	116	96	(	(	PUNCT
ecj-12528	116	97	73.0083.56	73.0083.56	NUM
ecj-12528	116	98	)	)	PUNCT
ecj-12528	116	99	51.52	51.52	NUM
ecj-12528	116	100	(	(	PUNCT
ecj-12528	116	101	44.32	44.32	NUM
ecj-12528	116	102	-	-	SYM
ecj-12528	116	103	58.66	58.66	NUM
ecj-12528	116	104	)	)	PUNCT
ecj-12528	116	105	67.01	67.01	NUM
ecj-12528	116	106	(	(	PUNCT
ecj-12528	116	107	61.28	61.28	NUM
ecj-12528	116	108	-	-	SYM
ecj-12528	116	109	72.39	72.39	NUM
ecj-12528	116	110	)	)	PUNCT
ecj-12528	116	111	65.81	65.81	NUM
ecj-12528	116	112	(	(	PUNCT
ecj-12528	116	113	57.77	57.77	NUM
ecj-12528	116	114	-	-	SYM
ecj-12528	116	115	73.23	73.23	NUM
ecj-12528	116	116	)	)	PUNCT
ecj-12528	116	117	sii	sii	NOUN
ecj-12528	116	118	>	>	X
ecj-12528	116	119	867.834	867.834	NUM
ecj-12528	116	120	0.744	0.744	NUM
ecj-12528	116	121	(	(	PUNCT
ecj-12528	116	122	0.0001	0.0001	NUM
ecj-12528	116	123	)	)	PUNCT
ecj-12528	116	124	68.95	68.95	NUM
ecj-12528	116	125	(	(	PUNCT
ecj-12528	116	126	62.79	62.79	NUM
ecj-12528	116	127	-	-	SYM
ecj-12528	116	128	74.65	74.65	NUM
ecj-12528	116	129	)	)	PUNCT
ecj-12528	116	130	70.71	70.71	NUM
ecj-12528	116	131	(	(	PUNCT
ecj-12528	116	132	63.84	63.84	NUM
ecj-12528	116	133	-	-	SYM
ecj-12528	116	134	76.94	76.94	NUM
ecj-12528	116	135	)	)	PUNCT
ecj-12528	116	136	74.67	74.67	NUM
ecj-12528	116	137	(	(	PUNCT
ecj-12528	116	138	68.52	68.52	NUM
ecj-12528	116	139	-	-	SYM
ecj-12528	116	140	80.17	80.17	NUM
ecj-12528	116	141	)	)	PUNCT
ecj-12528	116	142	64.52	64.52	NUM
ecj-12528	116	143	(	(	PUNCT
ecj-12528	116	144	57.75	57.75	NUM
ecj-12528	116	145	-	-	SYM
ecj-12528	116	146	70.87	70.87	NUM
ecj-12528	116	147	)	)	PUNCT
ecj-12528	116	148	sii	sii	PROPN
ecj-12528	116	149	,	,	PUNCT
ecj-12528	116	150	systemic	systemic	ADJ
ecj-12528	116	151	inflammation	inflammation	NOUN
ecj-12528	116	152	index	index	NOUN
ecj-12528	116	153	,	,	PUNCT
ecj-12528	116	154	siri	siri	NOUN
ecj-12528	116	155	,	,	PUNCT
ecj-12528	116	156	systemic	systemic	ADJ
ecj-12528	116	157	inflammation	inflammation	ADJ
ecj-12528	116	158	response	response	NOUN
ecj-12528	116	159	index	index	PROPN
ecj-12528	116	160	,	,	PUNCT
ecj-12528	116	161	ci	ci	NOUN
ecj-12528	116	162	,	,	PUNCT
ecj-12528	116	163	confidence	confidence	NOUN
ecj-12528	116	164	interval	interval	NOUN
ecj-12528	116	165	,	,	PUNCT
ecj-12528	116	166	auc	auc	NOUN
ecj-12528	116	167	,	,	PUNCT
ecj-12528	116	168	area	area	NOUN
ecj-12528	116	169	under	under	ADP
ecj-12528	116	170	curve	curve	NOUN
ecj-12528	116	171	,	,	PUNCT
ecj-12528	116	172	ppv	ppv	NOUN
ecj-12528	116	173	,	,	PUNCT
ecj-12528	116	174	positive	positive	ADJ
ecj-12528	116	175	predictive	predictive	ADJ
ecj-12528	116	176	value	value	NOUN
ecj-12528	116	177	,	,	PUNCT
ecj-12528	116	178	npv	npv	NOUN
ecj-12528	116	179	,	,	PUNCT
ecj-12528	116	180	negative	negative	ADJ
ecj-12528	116	181	predictive	predictive	ADJ
ecj-12528	116	182	value	value	NOUN
ecj-12528	116	183	.	.	PUNCT
ecj-12528	117	1	[	[	X
ecj-12528	117	2	emergency	emergency	NOUN
ecj-12528	117	3	care	care	NOUN
ecj-12528	117	4	journal	journal	PROPN
ecj-12528	117	5	2024	2024	NUM
ecj-12528	117	6	;	;	PUNCT
ecj-12528	117	7	20:12528	20:12528	NUM
ecj-12528	117	8	]	]	X
ecj-12528	118	1	[	[	X
ecj-12528	118	2	page	page	NOUN
ecj-12528	118	3	97	97	NUM
ecj-12528	118	4	]	]	PUNCT
ecj-12528	118	5	non	non	ADJ
ecj-12528	118	6	-co	-co	PROPN
ecj-12528	118	7	mmerc	mmerc	PROPN
ecj-12528	118	8	ial	ial	PROPN
ecj-12528	118	9	us	us	PROPN
ecj-12528	118	10	e	e	NOUN
ecj-12528	118	11	o	o	NOUN
ecj-12528	118	12	nly	nly	ADV
ecj-12528	118	13	limitations	limitation	VERB
ecj-12528	118	14	the	the	DET
ecj-12528	118	15	most	most	ADV
ecj-12528	118	16	important	important	ADJ
ecj-12528	118	17	limitation	limitation	NOUN
ecj-12528	118	18	is	be	AUX
ecj-12528	118	19	that	that	SCONJ
ecj-12528	118	20	our	our	PRON
ecj-12528	118	21	study	study	NOUN
ecj-12528	118	22	was	be	AUX
ecj-12528	118	23	conducted	conduct	VERB
ecj-12528	118	24	retrospectively	retrospectively	ADV
ecj-12528	118	25	at	at	ADP
ecj-12528	118	26	a	a	DET
ecj-12528	118	27	single	single	ADJ
ecj-12528	118	28	institution	institution	NOUN
ecj-12528	118	29	.	.	PUNCT
ecj-12528	119	1	our	our	PRON
ecj-12528	119	2	study	study	NOUN
ecj-12528	119	3	was	be	AUX
ecj-12528	119	4	performed	perform	VERB
ecj-12528	119	5	with	with	ADP
ecj-12528	119	6	laboratory	laboratory	NOUN
ecj-12528	119	7	tests	test	NOUN
ecj-12528	119	8	obtained	obtain	VERB
ecj-12528	119	9	at	at	ADP
ecj-12528	119	10	the	the	DET
ecj-12528	119	11	time	time	NOUN
ecj-12528	119	12	of	of	ADP
ecj-12528	119	13	presentation	presentation	NOUN
ecj-12528	119	14	to	to	ADP
ecj-12528	119	15	the	the	DET
ecj-12528	119	16	emergency	emergency	NOUN
ecj-12528	119	17	department	department	NOUN
ecj-12528	119	18	.	.	PUNCT
ecj-12528	120	1	no	no	DET
ecj-12528	120	2	relationship	relationship	NOUN
ecj-12528	120	3	was	be	AUX
ecj-12528	120	4	established	establish	VERB
ecj-12528	120	5	with	with	ADP
ecj-12528	120	6	the	the	DET
ecj-12528	120	7	time	time	NOUN
ecj-12528	120	8	of	of	ADP
ecj-12528	120	9	symptom	symptom	NOUN
ecj-12528	120	10	onset	onset	VERB
ecj-12528	120	11	.	.	PUNCT
ecj-12528	121	1	there	there	PRON
ecj-12528	121	2	was	be	VERB
ecj-12528	121	3	no	no	DET
ecj-12528	121	4	study	study	NOUN
ecj-12528	121	5	on	on	ADP
ecj-12528	121	6	the	the	DET
ecj-12528	121	7	stage	stage	NOUN
ecj-12528	121	8	of	of	ADP
ecj-12528	121	9	the	the	DET
ecj-12528	121	10	disease	disease	NOUN
ecj-12528	121	11	at	at	ADP
ecj-12528	121	12	which	which	PRON
ecj-12528	121	13	the	the	DET
ecj-12528	121	14	test	test	NOUN
ecj-12528	121	15	was	be	AUX
ecj-12528	121	16	taken	take	VERB
ecj-12528	121	17	.	.	PUNCT
ecj-12528	122	1	combining	combine	VERB
ecj-12528	122	2	the	the	DET
ecj-12528	122	3	indices	index	NOUN
ecj-12528	122	4	with	with	ADP
ecj-12528	122	5	clinical	clinical	ADJ
ecj-12528	122	6	findings	finding	NOUN
ecj-12528	122	7	and	and	CCONJ
ecj-12528	122	8	laboratory	laboratory	NOUN
ecj-12528	122	9	parameters	parameter	NOUN
ecj-12528	122	10	such	such	ADJ
ecj-12528	122	11	as	as	ADP
ecj-12528	122	12	blood	blood	NOUN
ecj-12528	122	13	gases	gas	NOUN
ecj-12528	122	14	may	may	AUX
ecj-12528	122	15	help	help	VERB
ecj-12528	122	16	to	to	PART
ecj-12528	122	17	better	well	ADV
ecj-12528	122	18	predict	predict	VERB
ecj-12528	122	19	the	the	DET
ecj-12528	122	20	severity	severity	NOUN
ecj-12528	122	21	and	and	CCONJ
ecj-12528	122	22	prognosis	prognosis	NOUN
ecj-12528	122	23	of	of	ADP
ecj-12528	122	24	the	the	DET
ecj-12528	122	25	disease	disease	NOUN
ecj-12528	122	26	.	.	PUNCT
ecj-12528	123	1	conclusions	conclusion	NOUN
ecj-12528	123	2	in	in	ADP
ecj-12528	123	3	our	our	PRON
ecj-12528	123	4	study	study	NOUN
ecj-12528	123	5	,	,	PUNCT
ecj-12528	123	6	sii	sii	PROPN
ecj-12528	123	7	and	and	CCONJ
ecj-12528	123	8	siri	siri	NOUN
ecj-12528	123	9	parameters	parameter	NOUN
ecj-12528	123	10	were	be	AUX
ecj-12528	123	11	found	find	VERB
ecj-12528	123	12	to	to	PART
ecj-12528	123	13	predict	predict	VERB
ecj-12528	123	14	disease	disease	NOUN
ecj-12528	123	15	severity	severity	NOUN
ecj-12528	123	16	and	and	CCONJ
ecj-12528	123	17	mortality	mortality	NOUN
ecj-12528	123	18	in	in	ADP
ecj-12528	123	19	patients	patient	NOUN
ecj-12528	123	20	with	with	ADP
ecj-12528	123	21	covid-19	covid-19	PROPN
ecj-12528	123	22	.	.	PUNCT
ecj-12528	123	23	high	high	PROPN
ecj-12528	123	24	sii	sii	PROPN
ecj-12528	123	25	and	and	CCONJ
ecj-12528	123	26	siri	siri	NOUN
ecj-12528	123	27	levels	level	NOUN
ecj-12528	123	28	were	be	AUX
ecj-12528	123	29	found	find	VERB
ecj-12528	123	30	to	to	PART
ecj-12528	123	31	be	be	AUX
ecj-12528	123	32	associated	associate	VERB
ecj-12528	123	33	with	with	ADP
ecj-12528	123	34	a	a	DET
ecj-12528	123	35	poor	poor	ADJ
ecj-12528	123	36	prognosis	prognosis	NOUN
ecj-12528	123	37	.	.	PUNCT
ecj-12528	124	1	we	we	PRON
ecj-12528	124	2	think	think	VERB
ecj-12528	124	3	that	that	SCONJ
ecj-12528	124	4	sii	sii	ADJ
ecj-12528	124	5	and	and	CCONJ
ecj-12528	124	6	siri	siri	NOUN
ecj-12528	124	7	parameters	parameter	NOUN
ecj-12528	124	8	are	be	AUX
ecj-12528	124	9	easily	easily	ADV
ecj-12528	124	10	accessible	accessible	ADJ
ecj-12528	124	11	and	and	CCONJ
ecj-12528	124	12	inexpensive	inexpensive	ADJ
ecj-12528	124	13	indices	index	NOUN
ecj-12528	124	14	in	in	ADP
ecj-12528	124	15	the	the	DET
ecj-12528	124	16	emergency	emergency	NOUN
ecj-12528	124	17	department	department	NOUN
ecj-12528	124	18	and	and	CCONJ
ecj-12528	124	19	can	can	AUX
ecj-12528	124	20	be	be	AUX
ecj-12528	124	21	used	use	VERB
ecj-12528	124	22	as	as	ADP
ecj-12528	124	23	auxiliary	auxiliary	ADJ
ecj-12528	124	24	tests	test	NOUN
ecj-12528	124	25	for	for	ADP
ecj-12528	124	26	prognosis	prognosis	NOUN
ecj-12528	124	27	prediction	prediction	NOUN
ecj-12528	124	28	.	.	PUNCT
ecj-12528	125	1	studies	study	NOUN
ecj-12528	125	2	on	on	ADP
ecj-12528	125	3	these	these	DET
ecj-12528	125	4	indices	index	NOUN
ecj-12528	125	5	are	be	AUX
ecj-12528	125	6	limited	limited	ADJ
ecj-12528	125	7	,	,	PUNCT
ecj-12528	125	8	and	and	CCONJ
ecj-12528	125	9	more	more	ADJ
ecj-12528	125	10	studies	study	NOUN
ecj-12528	125	11	are	be	AUX
ecj-12528	125	12	needed	need	VERB
ecj-12528	125	13	.	.	PUNCT
ecj-12528	126	1	references	reference	NOUN
ecj-12528	126	2	1	1	NUM
ecj-12528	126	3	.	.	PUNCT
ecj-12528	127	1	mousavi	mousavi	PROPN
ecj-12528	127	2	-	-	PUNCT
ecj-12528	127	3	nasab	nasab	PROPN
ecj-12528	127	4	sd	sd	NOUN
ecj-12528	127	5	,	,	PUNCT
ecj-12528	127	6	mardani	mardani	NOUN
ecj-12528	127	7	r	r	NOUN
ecj-12528	127	8	,	,	PUNCT
ecj-12528	127	9	azadani	azadani	ADJ
ecj-12528	127	10	hn	hn	PROPN
ecj-12528	127	11	,	,	PUNCT
ecj-12528	127	12	et	et	PROPN
ecj-12528	127	13	al	al	PROPN
ecj-12528	127	14	.	.	PROPN
ecj-12528	128	1	neutrophil	neutrophil	ADJ
ecj-12528	128	2	to	to	ADP
ecj-12528	128	3	lymphocyte	lymphocyte	ADJ
ecj-12528	128	4	ratio	ratio	NOUN
ecj-12528	128	5	and	and	CCONJ
ecj-12528	128	6	c	c	NOUN
ecj-12528	128	7	-	-	PUNCT
ecj-12528	128	8	reactive	reactive	ADJ
ecj-12528	128	9	protein	protein	NOUN
ecj-12528	128	10	level	level	NOUN
ecj-12528	128	11	as	as	ADP
ecj-12528	128	12	prognostic	prognostic	ADJ
ecj-12528	128	13	markers	marker	NOUN
ecj-12528	128	14	in	in	ADP
ecj-12528	128	15	mild	mild	ADJ
ecj-12528	128	16	versus	versus	ADP
ecj-12528	128	17	severe	severe	ADJ
ecj-12528	128	18	covid-19	covid-19	PROPN
ecj-12528	128	19	patients	patient	NOUN
ecj-12528	128	20	.	.	PUNCT
ecj-12528	129	1	gastroenterol	gastroenterol	VERB
ecj-12528	129	2	hepatol	hepatol	ADJ
ecj-12528	129	3	from	from	ADP
ecj-12528	129	4	bed	bed	NOUN
ecj-12528	129	5	to	to	PART
ecj-12528	129	6	bench	bench	VERB
ecj-12528	129	7	2020;13:361	2020;13:361	NOUN
ecj-12528	129	8	.	.	PUNCT
ecj-12528	130	1	2	2	NUM
ecj-12528	130	2	.	.	X
ecj-12528	130	3	wang	wang	PROPN
ecj-12528	130	4	c	c	PROPN
ecj-12528	130	5	,	,	PUNCT
ecj-12528	130	6	deng	deng	PROPN
ecj-12528	130	7	r	r	PROPN
ecj-12528	130	8	,	,	PUNCT
ecj-12528	130	9	gou	gou	PROPN
ecj-12528	130	10	l	l	PROPN
ecj-12528	130	11	,	,	PUNCT
ecj-12528	130	12	et	et	PROPN
ecj-12528	130	13	al	al	PROPN
ecj-12528	130	14	.	.	PROPN
ecj-12528	131	1	preliminary	preliminary	ADJ
ecj-12528	131	2	study	study	NOUN
ecj-12528	131	3	to	to	PART
ecj-12528	131	4	identify	identify	VERB
ecj-12528	131	5	severe	severe	ADJ
ecj-12528	131	6	from	from	ADP
ecj-12528	131	7	moderate	moderate	ADJ
ecj-12528	131	8	cases	case	NOUN
ecj-12528	131	9	of	of	ADP
ecj-12528	131	10	covid-19	covid-19	PROPN
ecj-12528	131	11	using	use	VERB
ecj-12528	131	12	combined	combined	ADJ
ecj-12528	131	13	hematology	hematology	NOUN
ecj-12528	131	14	parameters	parameter	NOUN
ecj-12528	131	15	.	.	PUNCT
ecj-12528	132	1	ann	ann	PROPN
ecj-12528	132	2	transl	transl	PROPN
ecj-12528	132	3	med	med	PROPN
ecj-12528	132	4	2020;8:593	2020;8:593	PROPN
ecj-12528	132	5	.	.	PUNCT
ecj-12528	133	1	3	3	X
ecj-12528	133	2	.	.	X
ecj-12528	133	3	li	li	PROPN
ecj-12528	133	4	x	x	PROPN
ecj-12528	133	5	,	,	PUNCT
ecj-12528	133	6	wang	wang	PROPN
ecj-12528	133	7	l	l	PROPN
ecj-12528	133	8	,	,	PUNCT
ecj-12528	133	9	yan	yan	PROPN
ecj-12528	133	10	s	s	PART
ecj-12528	133	11	,	,	PUNCT
ecj-12528	133	12	et	et	PROPN
ecj-12528	133	13	al	al	PROPN
ecj-12528	133	14	.	.	PROPN
ecj-12528	134	1	clinical	clinical	ADJ
ecj-12528	134	2	characteristics	characteristic	NOUN
ecj-12528	134	3	of	of	ADP
ecj-12528	134	4	25	25	NUM
ecj-12528	134	5	death	death	NOUN
ecj-12528	134	6	cases	case	NOUN
ecj-12528	134	7	with	with	ADP
ecj-12528	134	8	covid-19	covid-19	PROPN
ecj-12528	134	9	:	:	PUNCT
ecj-12528	134	10	a	a	DET
ecj-12528	134	11	retrospective	retrospective	ADJ
ecj-12528	134	12	review	review	NOUN
ecj-12528	134	13	of	of	ADP
ecj-12528	134	14	medical	medical	ADJ
ecj-12528	134	15	records	record	NOUN
ecj-12528	134	16	in	in	ADP
ecj-12528	134	17	a	a	DET
ecj-12528	134	18	single	single	ADJ
ecj-12528	134	19	medical	medical	ADJ
ecj-12528	134	20	center	center	NOUN
ecj-12528	134	21	,	,	PUNCT
ecj-12528	134	22	wuhan	wuhan	PROPN
ecj-12528	134	23	,	,	PUNCT
ecj-12528	134	24	china	china	PROPN
ecj-12528	134	25	.	.	PUNCT
ecj-12528	135	1	int	int	PROPN
ecj-12528	135	2	j	j	PROPN
ecj-12528	135	3	infect	infect	VERB
ecj-12528	135	4	dis	dis	PROPN
ecj-12528	135	5	2020;94:128	2020;94:128	NUM
ecj-12528	135	6	-	-	SYM
ecj-12528	135	7	32	32	NUM
ecj-12528	135	8	.	.	PUNCT
ecj-12528	136	1	4	4	NUM
ecj-12528	136	2	.	.	X
ecj-12528	137	1	chen	chen	PROPN
ecj-12528	137	2	n	n	CCONJ
ecj-12528	137	3	,	,	PUNCT
ecj-12528	137	4	zhou	zhou	PROPN
ecj-12528	137	5	m	m	PROPN
ecj-12528	137	6	,	,	PUNCT
ecj-12528	137	7	dong	dong	PROPN
ecj-12528	137	8	x	x	PROPN
ecj-12528	137	9	,	,	PUNCT
ecj-12528	137	10	et	et	PROPN
ecj-12528	137	11	al	al	PROPN
ecj-12528	137	12	.	.	PROPN
ecj-12528	137	13	epidemiological	epidemiological	ADJ
ecj-12528	137	14	and	and	CCONJ
ecj-12528	137	15	clinical	clinical	ADJ
ecj-12528	137	16	characteristics	characteristic	NOUN
ecj-12528	137	17	of	of	ADP
ecj-12528	137	18	99	99	NUM
ecj-12528	137	19	cases	case	NOUN
ecj-12528	137	20	of	of	ADP
ecj-12528	137	21	2019	2019	NUM
ecj-12528	137	22	novel	novel	ADJ
ecj-12528	137	23	coronavirus	coronavirus	NOUN
ecj-12528	137	24	pneumonia	pneumonia	NOUN
ecj-12528	137	25	in	in	ADP
ecj-12528	137	26	wuhan	wuhan	PROPN
ecj-12528	137	27	,	,	PUNCT
ecj-12528	137	28	china	china	PROPN
ecj-12528	137	29	:	:	PUNCT
ecj-12528	137	30	a	a	DET
ecj-12528	137	31	descriptive	descriptive	ADJ
ecj-12528	137	32	study	study	NOUN
ecj-12528	137	33	.	.	PUNCT
ecj-12528	138	1	lancet	lancet	PROPN
ecj-12528	138	2	(	(	PUNCT
ecj-12528	138	3	london	london	PROPN
ecj-12528	138	4	,	,	PUNCT
ecj-12528	138	5	england	england	PROPN
ecj-12528	138	6	)	)	PUNCT
ecj-12528	138	7	2020;395:507	2020;395:507	NUM
ecj-12528	138	8	-	-	SYM
ecj-12528	138	9	13	13	NUM
ecj-12528	138	10	.	.	PUNCT
ecj-12528	138	11	5	5	NUM
ecj-12528	138	12	.	.	X
ecj-12528	138	13	usul	usul	PROPN
ecj-12528	138	14	e	e	PROPN
ecj-12528	138	15	,	,	PUNCT
ecj-12528	138	16	san	san	PROPN
ecj-12528	138	17	i	i	PROPN
ecj-12528	138	18	,	,	PUNCT
ecj-12528	138	19	bekgöz	bekgöz	NOUN
ecj-12528	138	20	b	b	NUM
ecj-12528	138	21	,	,	PUNCT
ecj-12528	139	1	sahin	sahin	PROPN
ecj-12528	139	2	a.	a.	NOUN
ecj-12528	139	3	role	role	NOUN
ecj-12528	139	4	of	of	ADP
ecj-12528	139	5	hematological	hematological	ADJ
ecj-12528	139	6	parameters	parameter	NOUN
ecj-12528	139	7	in	in	ADP
ecj-12528	139	8	covid-19	covid-19	PROPN
ecj-12528	139	9	patients	patient	NOUN
ecj-12528	139	10	in	in	ADP
ecj-12528	139	11	the	the	DET
ecj-12528	139	12	emergency	emergency	NOUN
ecj-12528	139	13	room	room	NOUN
ecj-12528	139	14	.	.	PUNCT
ecj-12528	140	1	biomark	biomark	PROPN
ecj-12528	140	2	med	med	PROPN
ecj-12528	140	3	2020;14:1207	2020;14:1207	NUM
ecj-12528	140	4	-	-	SYM
ecj-12528	140	5	15	15	NUM
ecj-12528	140	6	.	.	NOUN
ecj-12528	141	1	6	6	NUM
ecj-12528	141	2	.	.	X
ecj-12528	142	1	danwang	danwang	PROPN
ecj-12528	142	2	c	c	PROPN
ecj-12528	142	3	,	,	PUNCT
ecj-12528	142	4	endomba	endomba	PROPN
ecj-12528	142	5	ft	ft	PROPN
ecj-12528	142	6	,	,	PUNCT
ecj-12528	142	7	nkeck	nkeck	PROPN
ecj-12528	142	8	jr	jr	PROPN
ecj-12528	142	9	,	,	PUNCT
ecj-12528	142	10	et	et	PROPN
ecj-12528	142	11	al	al	PROPN
ecj-12528	142	12	.	.	PUNCT
ecj-12528	143	1	a	a	DET
ecj-12528	143	2	meta	meta	ADJ
ecj-12528	143	3	-	-	PUNCT
ecj-12528	143	4	analysis	analysis	NOUN
ecj-12528	143	5	of	of	ADP
ecj-12528	143	6	potential	potential	ADJ
ecj-12528	143	7	biomarkers	biomarker	NOUN
ecj-12528	143	8	associated	associate	VERB
ecj-12528	143	9	with	with	ADP
ecj-12528	143	10	severity	severity	NOUN
ecj-12528	143	11	of	of	ADP
ecj-12528	143	12	coronavirus	coronavirus	NOUN
ecj-12528	143	13	disease	disease	NOUN
ecj-12528	143	14	2019	2019	NUM
ecj-12528	143	15	(	(	PUNCT
ecj-12528	143	16	covid-19	covid-19	PROPN
ecj-12528	143	17	)	)	PUNCT
ecj-12528	143	18	.	.	PUNCT
ecj-12528	144	1	biomark	biomark	PROPN
ecj-12528	144	2	res	re	NOUN
ecj-12528	144	3	2020;8:37	2020;8:37	NOUN
ecj-12528	144	4	.	.	PUNCT
ecj-12528	145	1	7	7	X
ecj-12528	145	2	.	.	X
ecj-12528	145	3	feng	feng	PROPN
ecj-12528	145	4	x	x	PROPN
ecj-12528	145	5	,	,	PUNCT
ecj-12528	145	6	li	li	PROPN
ecj-12528	145	7	s	s	PROPN
ecj-12528	145	8	,	,	PUNCT
ecj-12528	145	9	sun	sun	PROPN
ecj-12528	145	10	q	q	PROPN
ecj-12528	145	11	,	,	PUNCT
ecj-12528	145	12	et	et	PROPN
ecj-12528	145	13	al	al	PROPN
ecj-12528	145	14	.	.	PROPN
ecj-12528	145	15	immune	immune	NOUN
ecj-12528	145	16	-	-	PUNCT
ecj-12528	145	17	inflammatory	inflammatory	ADJ
ecj-12528	145	18	parameters	parameter	NOUN
ecj-12528	145	19	in	in	ADP
ecj-12528	145	20	covid-19	covid-19	PROPN
ecj-12528	145	21	cases	case	NOUN
ecj-12528	145	22	:	:	PUNCT
ecj-12528	145	23	a	a	DET
ecj-12528	145	24	systematic	systematic	ADJ
ecj-12528	145	25	review	review	NOUN
ecj-12528	145	26	and	and	CCONJ
ecj-12528	145	27	meta	meta	ADJ
ecj-12528	145	28	-	-	PUNCT
ecj-12528	145	29	analysis	analysis	NOUN
ecj-12528	145	30	.	.	PUNCT
ecj-12528	146	1	front	front	ADJ
ecj-12528	146	2	med	med	ADJ
ecj-12528	146	3	2020;7:1	2020;7:1	PROPN
ecj-12528	146	4	-	-	PUNCT
ecj-12528	146	5	14	14	NUM
ecj-12528	146	6	.	.	PUNCT
ecj-12528	146	7	8	8	NUM
ecj-12528	146	8	.	.	PUNCT
ecj-12528	147	1	peng	peng	PROPN
ecj-12528	147	2	j	j	PROPN
ecj-12528	147	3	,	,	PUNCT
ecj-12528	147	4	qi	qi	PROPN
ecj-12528	147	5	d	d	PROPN
ecj-12528	147	6	,	,	PUNCT
ecj-12528	147	7	yuan	yuan	NOUN
ecj-12528	147	8	g	g	NOUN
ecj-12528	147	9	,	,	PUNCT
ecj-12528	147	10	et	et	PROPN
ecj-12528	147	11	al	al	PROPN
ecj-12528	147	12	.	.	PUNCT
ecj-12528	148	1	diagnostic	diagnostic	ADJ
ecj-12528	148	2	value	value	NOUN
ecj-12528	148	3	of	of	ADP
ecj-12528	148	4	peripheral	peripheral	ADJ
ecj-12528	148	5	hematologic	hematologic	NOUN
ecj-12528	148	6	markers	marker	NOUN
ecj-12528	148	7	for	for	ADP
ecj-12528	148	8	coronavirus	coronavirus	NOUN
ecj-12528	148	9	disease	disease	NOUN
ecj-12528	148	10	2019	2019	NUM
ecj-12528	148	11	(	(	PUNCT
ecj-12528	148	12	covid19	covid19	NOUN
ecj-12528	148	13	):	):	PUNCT
ecj-12528	148	14	a	a	DET
ecj-12528	148	15	multicenter	multicenter	NOUN
ecj-12528	148	16	,	,	PUNCT
ecj-12528	148	17	cross	cross	ADJ
ecj-12528	148	18	-	-	ADJ
ecj-12528	148	19	sectional	sectional	ADJ
ecj-12528	148	20	study	study	NOUN
ecj-12528	148	21	.	.	PUNCT
ecj-12528	149	1	j	j	PROPN
ecj-12528	149	2	clin	clin	PROPN
ecj-12528	149	3	lab	lab	PROPN
ecj-12528	149	4	anal	anal	PROPN
ecj-12528	149	5	2020;34	2020;34	PROPN
ecj-12528	149	6	:	:	PUNCT
ecj-12528	149	7	e23475	e23475	NOUN
ecj-12528	149	8	.	.	PUNCT
ecj-12528	150	1	9	9	NUM
ecj-12528	150	2	.	.	X
ecj-12528	150	3	hu	hu	PROPN
ecj-12528	151	1	b	b	PROPN
ecj-12528	151	2	,	,	PUNCT
ecj-12528	151	3	yang	yang	PROPN
ecj-12528	151	4	xr	xr	PROPN
ecj-12528	151	5	,	,	PUNCT
ecj-12528	151	6	xu	xu	PROPN
ecj-12528	152	1	y	y	PROPN
ecj-12528	152	2	,	,	PUNCT
ecj-12528	152	3	et	et	PROPN
ecj-12528	152	4	al	al	PROPN
ecj-12528	152	5	.	.	PUNCT
ecj-12528	152	6	systemic	systemic	ADJ
ecj-12528	152	7	immune	immune	ADJ
ecj-12528	152	8	-	-	PUNCT
ecj-12528	152	9	inflammation	inflammation	NOUN
ecj-12528	152	10	index	index	NOUN
ecj-12528	152	11	predicts	predict	VERB
ecj-12528	152	12	prognosis	prognosis	NOUN
ecj-12528	152	13	of	of	ADP
ecj-12528	152	14	patients	patient	NOUN
ecj-12528	152	15	after	after	ADP
ecj-12528	152	16	curative	curative	ADJ
ecj-12528	152	17	resection	resection	NOUN
ecj-12528	152	18	for	for	ADP
ecj-12528	152	19	hepatocellular	hepatocellular	ADJ
ecj-12528	152	20	carcinoma	carcinoma	NOUN
ecj-12528	152	21	.	.	PUNCT
ecj-12528	153	1	clin	clin	PROPN
ecj-12528	153	2	cancer	cancer	NOUN
ecj-12528	153	3	res	re	VERB
ecj-12528	153	4	2014;20:6212	2014;20:6212	NUM
ecj-12528	153	5	-	-	SYM
ecj-12528	153	6	22	22	NUM
ecj-12528	153	7	.	.	PUNCT
ecj-12528	154	1	10	10	NUM
ecj-12528	154	2	.	.	PUNCT
ecj-12528	155	1	zhang	zhang	PROPN
ecj-12528	155	2	y	y	PROPN
ecj-12528	155	3	,	,	PUNCT
ecj-12528	155	4	liu	liu	PROPN
ecj-12528	155	5	f	f	PROPN
ecj-12528	155	6	,	,	PUNCT
ecj-12528	155	7	wang	wang	PROPN
ecj-12528	155	8	y.	y.	PROPN
ecj-12528	155	9	evidence	evidence	NOUN
ecj-12528	155	10	of	of	ADP
ecj-12528	155	11	the	the	DET
ecj-12528	155	12	prognostic	prognostic	ADJ
ecj-12528	155	13	value	value	NOUN
ecj-12528	155	14	of	of	ADP
ecj-12528	155	15	pretreatment	pretreatment	NOUN
ecj-12528	155	16	systemic	systemic	ADJ
ecj-12528	155	17	inflammation	inflammation	ADJ
ecj-12528	155	18	response	response	NOUN
ecj-12528	155	19	index	index	NOUN
ecj-12528	155	20	in	in	ADP
ecj-12528	155	21	cancer	cancer	NOUN
ecj-12528	155	22	patients	patient	NOUN
ecj-12528	155	23	:	:	PUNCT
ecj-12528	155	24	a	a	DET
ecj-12528	155	25	pooled	pooled	ADJ
ecj-12528	155	26	analysis	analysis	NOUN
ecj-12528	155	27	of	of	ADP
ecj-12528	155	28	19	19	NUM
ecj-12528	155	29	cohort	cohort	NOUN
ecj-12528	155	30	studies	study	NOUN
ecj-12528	155	31	.	.	PUNCT
ecj-12528	156	1	dis	dis	PROPN
ecj-12528	156	2	markers	marker	VERB
ecj-12528	156	3	2020;2020:8854267	2020;2020:8854267	NUM
ecj-12528	156	4	.	.	PUNCT
ecj-12528	157	1	11	11	NUM
ecj-12528	157	2	.	.	PUNCT
ecj-12528	158	1	stokes	stokes	PROPN
ecj-12528	158	2	ek	ek	PROPN
ecj-12528	158	3	,	,	PUNCT
ecj-12528	158	4	zambrano	zambrano	PROPN
ecj-12528	158	5	ld	ld	PROPN
ecj-12528	158	6	,	,	PUNCT
ecj-12528	158	7	anderson	anderson	PROPN
ecj-12528	158	8	kn	kn	PROPN
ecj-12528	158	9	,	,	PUNCT
ecj-12528	158	10	et	et	PROPN
ecj-12528	158	11	al	al	PROPN
ecj-12528	158	12	.	.	PROPN
ecj-12528	158	13	coronavirus	coronavirus	PROPN
ecj-12528	158	14	disease	disease	NOUN
ecj-12528	158	15	2019	2019	NUM
ecj-12528	158	16	case	case	NOUN
ecj-12528	158	17	surveillance	surveillance	NOUN
ecj-12528	158	18	united	united	PROPN
ecj-12528	158	19	states	states	PROPN
ecj-12528	158	20	,	,	PUNCT
ecj-12528	158	21	january	january	PROPN
ecj-12528	158	22	22may	22may	PROPN
ecj-12528	158	23	30	30	NUM
ecj-12528	158	24	,	,	PUNCT
ecj-12528	158	25	2020	2020	NUM
ecj-12528	158	26	.	.	PUNCT
ecj-12528	159	1	mmwr	mmwr	ADJ
ecj-12528	159	2	morb	morb	NOUN
ecj-12528	159	3	mortal	mortal	ADJ
ecj-12528	159	4	wkly	wkly	ADJ
ecj-12528	159	5	rep	rep	PROPN
ecj-12528	159	6	2020;69:759765	2020;69:759765	NUM
ecj-12528	159	7	.	.	PROPN
ecj-12528	159	8	12	12	NUM
ecj-12528	159	9	.	.	PUNCT
ecj-12528	160	1	ramos	ramos	PROPN
ecj-12528	160	2	-	-	PROPN
ecj-12528	160	3	rincon	rincon	PROPN
ecj-12528	160	4	jm	jm	PROPN
ecj-12528	160	5	,	,	PUNCT
ecj-12528	160	6	buonaiuto	buonaiuto	NOUN
ecj-12528	160	7	v	v	ADP
ecj-12528	160	8	,	,	PUNCT
ecj-12528	160	9	ricci	ricci	PROPN
ecj-12528	160	10	m	m	PROPN
ecj-12528	160	11	,	,	PUNCT
ecj-12528	160	12	et	et	PROPN
ecj-12528	160	13	al	al	PROPN
ecj-12528	160	14	.	.	PROPN
ecj-12528	161	1	clinical	clinical	ADJ
ecj-12528	161	2	characteristics	characteristic	NOUN
ecj-12528	161	3	and	and	CCONJ
ecj-12528	161	4	risk	risk	NOUN
ecj-12528	161	5	factors	factor	NOUN
ecj-12528	161	6	for	for	ADP
ecj-12528	161	7	mortality	mortality	NOUN
ecj-12528	161	8	in	in	ADP
ecj-12528	161	9	very	very	ADV
ecj-12528	161	10	old	old	ADJ
ecj-12528	161	11	patients	patient	NOUN
ecj-12528	161	12	hospitalized	hospitalize	VERB
ecj-12528	161	13	with	with	ADP
ecj-12528	161	14	covid-19	covid-19	PROPN
ecj-12528	161	15	in	in	ADP
ecj-12528	161	16	spain	spain	PROPN
ecj-12528	161	17	.	.	PUNCT
ecj-12528	162	1	journals	journal	NOUN
ecj-12528	162	2	gerontol	gerontol	PROPN
ecj-12528	162	3	ser	ser	NOUN
ecj-12528	162	4	a	a	DET
ecj-12528	162	5	2021;76	2021;76	NOUN
ecj-12528	162	6	:	:	PUNCT
ecj-12528	162	7	e28	e28	PROPN
ecj-12528	162	8	-	-	PUNCT
ecj-12528	162	9	e37	e37	NOUN
ecj-12528	162	10	.	.	PUNCT
ecj-12528	163	1	13	13	NUM
ecj-12528	163	2	.	.	PUNCT
ecj-12528	164	1	henry	henry	PROPN
ecj-12528	164	2	bm	bm	PROPN
ecj-12528	164	3	,	,	PUNCT
ecj-12528	164	4	de	de	PROPN
ecj-12528	164	5	oliveira	oliveira	PROPN
ecj-12528	164	6	mhs	mhs	PROPN
ecj-12528	164	7	,	,	PUNCT
ecj-12528	164	8	benoit	benoit	NOUN
ecj-12528	164	9	s	s	PROPN
ecj-12528	164	10	,	,	PUNCT
ecj-12528	164	11	et	et	PROPN
ecj-12528	164	12	al	al	PROPN
ecj-12528	164	13	.	.	PUNCT
ecj-12528	164	14	hematologic	hematologic	NOUN
ecj-12528	164	15	,	,	PUNCT
ecj-12528	164	16	biochemical	biochemical	ADJ
ecj-12528	164	17	and	and	CCONJ
ecj-12528	164	18	immune	immune	ADJ
ecj-12528	164	19	biomarker	biomarker	NOUN
ecj-12528	164	20	abnormalities	abnormality	NOUN
ecj-12528	164	21	associated	associate	VERB
ecj-12528	164	22	with	with	ADP
ecj-12528	164	23	severe	severe	ADJ
ecj-12528	164	24	illness	illness	NOUN
ecj-12528	164	25	and	and	CCONJ
ecj-12528	164	26	mortality	mortality	NOUN
ecj-12528	164	27	in	in	ADP
ecj-12528	164	28	coronavirus	coronavirus	NOUN
ecj-12528	164	29	disease	disease	NOUN
ecj-12528	164	30	2019	2019	NUM
ecj-12528	164	31	(	(	PUNCT
ecj-12528	164	32	covid-19	covid-19	PROPN
ecj-12528	164	33	):	):	PUNCT
ecj-12528	164	34	a	a	DET
ecj-12528	164	35	meta	meta	ADJ
ecj-12528	164	36	-	-	PUNCT
ecj-12528	164	37	analysis	analysis	NOUN
ecj-12528	164	38	.	.	PUNCT
ecj-12528	165	1	clin	clin	PROPN
ecj-12528	165	2	chem	chem	NOUN
ecj-12528	165	3	lab	lab	NOUN
ecj-12528	165	4	med	me	VERB
ecj-12528	165	5	2020;58:1021	2020;58:1021	NUM
ecj-12528	165	6	-	-	SYM
ecj-12528	165	7	8	8	NUM
ecj-12528	165	8	.	.	PUNCT
ecj-12528	165	9	14	14	NUM
ecj-12528	165	10	.	.	PUNCT
ecj-12528	166	1	wang	wang	PROPN
ecj-12528	166	2	d	d	PROPN
ecj-12528	166	3	,	,	PUNCT
ecj-12528	166	4	hu	hu	PROPN
ecj-12528	166	5	b	b	PROPN
ecj-12528	166	6	,	,	PUNCT
ecj-12528	166	7	hu	hu	PROPN
ecj-12528	167	1	c	c	X
ecj-12528	167	2	,	,	PUNCT
ecj-12528	167	3	et	et	PROPN
ecj-12528	167	4	al	al	PROPN
ecj-12528	167	5	.	.	PROPN
ecj-12528	168	1	clinical	clinical	ADJ
ecj-12528	168	2	characteristics	characteristic	NOUN
ecj-12528	168	3	of	of	ADP
ecj-12528	168	4	138	138	NUM
ecj-12528	168	5	hospitalized	hospitalize	VERB
ecj-12528	168	6	patients	patient	NOUN
ecj-12528	168	7	with	with	ADP
ecj-12528	168	8	2019	2019	NUM
ecj-12528	168	9	novel	novel	ADJ
ecj-12528	168	10	coronavirus	coronavirus	NOUN
ecj-12528	168	11	–	–	PUNCT
ecj-12528	168	12	infected	infected	ADJ
ecj-12528	168	13	pneumonia	pneumonia	NOUN
ecj-12528	168	14	in	in	ADP
ecj-12528	168	15	wuhan	wuhan	PROPN
ecj-12528	168	16	,	,	PUNCT
ecj-12528	168	17	china	china	PROPN
ecj-12528	168	18	.	.	PUNCT
ecj-12528	169	1	jama	jama	PROPN
ecj-12528	169	2	.	.	PUNCT
ecj-12528	170	1	2020;323:1061	2020;323:1061	NUM
ecj-12528	170	2	-	-	SYM
ecj-12528	170	3	9	9	NUM
ecj-12528	170	4	.	.	NOUN
ecj-12528	170	5	15	15	NUM
ecj-12528	170	6	.	.	PUNCT
ecj-12528	171	1	fan	fan	NOUN
ecj-12528	171	2	be	be	AUX
ecj-12528	171	3	.	.	PUNCT
ecj-12528	172	1	hematologic	hematologic	NOUN
ecj-12528	172	2	parameters	parameter	NOUN
ecj-12528	172	3	in	in	ADP
ecj-12528	172	4	patients	patient	NOUN
ecj-12528	172	5	with	with	ADP
ecj-12528	172	6	covid-19	covid-19	PROPN
ecj-12528	172	7	infection	infection	NOUN
ecj-12528	172	8	:	:	PUNCT
ecj-12528	172	9	a	a	DET
ecj-12528	172	10	reply	reply	NOUN
ecj-12528	172	11	.	.	PUNCT
ecj-12528	173	1	am	be	AUX
ecj-12528	173	2	j	j	PROPN
ecj-12528	173	3	hematol	hematol	PROPN
ecj-12528	173	4	2020;95	2020;95	NUM
ecj-12528	173	5	:	:	PUNCT
ecj-12528	173	6	e215	e215	PROPN
ecj-12528	173	7	.	.	PROPN
ecj-12528	173	8	16	16	NUM
ecj-12528	173	9	.	.	PUNCT
ecj-12528	174	1	pan	pan	PROPN
ecj-12528	174	2	y	y	PROPN
ecj-12528	174	3	,	,	PUNCT
ecj-12528	174	4	ye	ye	PRON
ecj-12528	174	5	g	g	NOUN
ecj-12528	174	6	,	,	PUNCT
ecj-12528	174	7	zeng	zeng	PROPN
ecj-12528	174	8	x	x	PROPN
ecj-12528	174	9	,	,	PUNCT
ecj-12528	174	10	et	et	PROPN
ecj-12528	174	11	al	al	PROPN
ecj-12528	174	12	.	.	PROPN
ecj-12528	174	13	can	can	AUX
ecj-12528	174	14	routine	routine	VERB
ecj-12528	174	15	laboratory	laboratory	NOUN
ecj-12528	174	16	tests	test	NOUN
ecj-12528	174	17	discriminate	discriminate	VERB
ecj-12528	174	18	sars	sar	NOUN
ecj-12528	174	19	-	-	PUNCT
ecj-12528	174	20	cov-2	cov-2	ADV
ecj-12528	174	21	-	-	PUNCT
ecj-12528	174	22	infected	infected	ADJ
ecj-12528	174	23	pneumonia	pneumonia	NOUN
ecj-12528	174	24	from	from	ADP
ecj-12528	174	25	other	other	ADJ
ecj-12528	174	26	causes	cause	NOUN
ecj-12528	174	27	of	of	ADP
ecj-12528	174	28	community	community	NOUN
ecj-12528	174	29	-	-	PUNCT
ecj-12528	174	30	acquired	acquire	VERB
ecj-12528	174	31	pneumonia	pneumonia	NOUN
ecj-12528	174	32	?	?	PUNCT
ecj-12528	175	1	clin	clin	PROPN
ecj-12528	175	2	transl	transl	PROPN
ecj-12528	175	3	med	med	PROPN
ecj-12528	175	4	2020;10:161	2020;10:161	PROPN
ecj-12528	175	5	-	-	PUNCT
ecj-12528	175	6	8	8	NUM
ecj-12528	175	7	.	.	PUNCT
ecj-12528	175	8	17	17	NUM
ecj-12528	175	9	.	.	PUNCT
ecj-12528	176	1	karimi	karimi	PROPN
ecj-12528	176	2	shahri	shahri	PROPN
ecj-12528	176	3	m	m	PRON
ecj-12528	176	4	,	,	PUNCT
ecj-12528	176	5	niazkar	niazkar	PROPN
ecj-12528	176	6	hr	hr	NOUN
ecj-12528	176	7	,	,	PUNCT
ecj-12528	176	8	rad	rad	PROPN
ecj-12528	176	9	f.	f.	PROPN
ecj-12528	176	10	covid-19	covid-19	PROPN
ecj-12528	176	11	and	and	CCONJ
ecj-12528	176	12	hematology	hematology	NOUN
ecj-12528	176	13	findings	finding	NOUN
ecj-12528	176	14	based	base	VERB
ecj-12528	176	15	on	on	ADP
ecj-12528	176	16	the	the	DET
ecj-12528	176	17	current	current	ADJ
ecj-12528	176	18	evidences	evidence	NOUN
ecj-12528	176	19	:	:	PUNCT
ecj-12528	176	20	a	a	DET
ecj-12528	176	21	puzzle	puzzle	NOUN
ecj-12528	176	22	with	with	ADP
ecj-12528	176	23	many	many	ADJ
ecj-12528	176	24	missing	missing	ADJ
ecj-12528	176	25	pieces	piece	NOUN
ecj-12528	176	26	.	.	PUNCT
ecj-12528	177	1	int	int	NOUN
ecj-12528	177	2	j	j	PROPN
ecj-12528	177	3	lab	lab	PROPN
ecj-12528	177	4	hematol	hematol	NOUN
ecj-12528	177	5	2021;43:160	2021;43:160	PROPN
ecj-12528	177	6	-	-	PUNCT
ecj-12528	177	7	8	8	NUM
ecj-12528	177	8	.	.	NOUN
ecj-12528	177	9	18	18	NUM
ecj-12528	177	10	.	.	X
ecj-12528	177	11	amgalan	amgalan	PROPN
ecj-12528	177	12	a	a	DET
ecj-12528	177	13	,	,	PUNCT
ecj-12528	177	14	othman	othman	ADJ
ecj-12528	177	15	m.	m.	PROPN
ecj-12528	177	16	hemostatic	hemostatic	ADJ
ecj-12528	177	17	laboratory	laboratory	NOUN
ecj-12528	177	18	derangements	derangement	NOUN
ecj-12528	177	19	in	in	ADP
ecj-12528	177	20	covid-19	covid-19	PROPN
ecj-12528	177	21	with	with	ADP
ecj-12528	177	22	a	a	DET
ecj-12528	177	23	focus	focus	NOUN
ecj-12528	177	24	on	on	ADP
ecj-12528	177	25	platelet	platelet	NOUN
ecj-12528	177	26	count	count	NOUN
ecj-12528	177	27	.	.	PUNCT
ecj-12528	178	1	platelets	platelet	VERB
ecj-12528	178	2	2020;31:740	2020;31:740	NOUN
ecj-12528	178	3	-	-	SYM
ecj-12528	178	4	5	5	NUM
ecj-12528	178	5	.	.	NOUN
ecj-12528	178	6	19	19	NUM
ecj-12528	178	7	.	.	PUNCT
ecj-12528	179	1	lippi	lippi	PROPN
ecj-12528	179	2	g	g	PROPN
ecj-12528	179	3	,	,	PUNCT
ecj-12528	179	4	plebani	plebani	PROPN
ecj-12528	179	5	m	m	PROPN
ecj-12528	179	6	,	,	PUNCT
ecj-12528	179	7	henry	henry	PROPN
ecj-12528	179	8	bm	bm	PROPN
ecj-12528	179	9	.	.	PUNCT
ecj-12528	180	1	thrombocytopenia	thrombocytopenia	PROPN
ecj-12528	180	2	is	be	AUX
ecj-12528	180	3	associated	associate	VERB
ecj-12528	180	4	with	with	ADP
ecj-12528	180	5	severe	severe	ADJ
ecj-12528	180	6	coronavirus	coronavirus	NOUN
ecj-12528	180	7	disease	disease	NOUN
ecj-12528	180	8	2019	2019	NUM
ecj-12528	180	9	(	(	PUNCT
ecj-12528	180	10	covid-19	covid-19	PROPN
ecj-12528	180	11	)	)	PUNCT
ecj-12528	180	12	infections	infection	NOUN
ecj-12528	180	13	:	:	PUNCT
ecj-12528	180	14	a	a	DET
ecj-12528	180	15	meta	meta	ADJ
ecj-12528	180	16	-	-	PUNCT
ecj-12528	180	17	analysis	analysis	NOUN
ecj-12528	180	18	.	.	PUNCT
ecj-12528	181	1	clin	clin	PROPN
ecj-12528	181	2	chim	chim	PROPN
ecj-12528	181	3	acta	acta	PROPN
ecj-12528	181	4	2020;506:145	2020;506:145	NUM
ecj-12528	181	5	-	-	SYM
ecj-12528	181	6	8	8	NUM
ecj-12528	181	7	.	.	NOUN
ecj-12528	181	8	20	20	NUM
ecj-12528	181	9	.	.	PUNCT
ecj-12528	182	1	chen	chen	PROPN
ecj-12528	182	2	jh	jh	PROPN
ecj-12528	182	3	,	,	PUNCT
ecj-12528	182	4	zhai	zhai	PROPN
ecj-12528	182	5	et	et	PROPN
ecj-12528	182	6	,	,	PUNCT
ecj-12528	182	7	yuan	yuan	PROPN
ecj-12528	182	8	yj	yj	PROPN
ecj-12528	182	9	,	,	PUNCT
ecj-12528	182	10	et	et	PROPN
ecj-12528	182	11	al	al	PROPN
ecj-12528	182	12	.	.	PUNCT
ecj-12528	183	1	systemic	systemic	ADJ
ecj-12528	183	2	immune	immune	ADJ
ecj-12528	183	3	-	-	PUNCT
ecj-12528	183	4	inflammation	inflammation	NOUN
ecj-12528	183	5	index	index	NOUN
ecj-12528	183	6	for	for	ADP
ecj-12528	183	7	predicting	predict	VERB
ecj-12528	183	8	prognosis	prognosis	NOUN
ecj-12528	183	9	of	of	ADP
ecj-12528	183	10	colorectal	colorectal	ADJ
ecj-12528	183	11	cancer	cancer	NOUN
ecj-12528	183	12	.	.	PUNCT
ecj-12528	184	1	world	world	PROPN
ecj-12528	184	2	j	j	PROPN
ecj-12528	184	3	gastroenterol	gastroenterol	PROPN
ecj-12528	184	4	2017;23:6261	2017;23:6261	NUM
ecj-12528	184	5	-	-	SYM
ecj-12528	184	6	72	72	NUM
ecj-12528	184	7	.	.	PUNCT
ecj-12528	184	8	21	21	NUM
ecj-12528	184	9	.	.	PUNCT
ecj-12528	185	1	liu	liu	PROPN
ecj-12528	185	2	x	x	PROPN
ecj-12528	185	3	,	,	PUNCT
ecj-12528	185	4	guan	guan	PROPN
ecj-12528	185	5	g	g	PROPN
ecj-12528	185	6	,	,	PUNCT
ecj-12528	185	7	cui	cui	NOUN
ecj-12528	185	8	x	x	SYM
ecj-12528	185	9	,	,	PUNCT
ecj-12528	185	10	et	et	PROPN
ecj-12528	185	11	al	al	PROPN
ecj-12528	185	12	.	.	PUNCT
ecj-12528	185	13	systemic	systemic	ADJ
ecj-12528	185	14	immune	immune	ADJ
ecj-12528	185	15	-	-	PUNCT
ecj-12528	185	16	inflammation	inflammation	NOUN
ecj-12528	185	17	index	index	NOUN
ecj-12528	185	18	(	(	PUNCT
ecj-12528	185	19	sii	sii	PROPN
ecj-12528	185	20	)	)	PUNCT
ecj-12528	185	21	can	can	AUX
ecj-12528	185	22	be	be	AUX
ecj-12528	185	23	an	an	DET
ecj-12528	185	24	early	early	ADJ
ecj-12528	185	25	indicator	indicator	NOUN
ecj-12528	185	26	for	for	ADP
ecj-12528	185	27	predicting	predict	VERB
ecj-12528	185	28	the	the	DET
ecj-12528	185	29	severity	severity	NOUN
ecj-12528	185	30	of	of	ADP
ecj-12528	185	31	acute	acute	PROPN
ecj-12528	185	32	pancreatitis	pancreatitis	PROPN
ecj-12528	185	33	:	:	PUNCT
ecj-12528	185	34	a	a	DET
ecj-12528	185	35	retrospective	retrospective	ADJ
ecj-12528	185	36	study	study	NOUN
ecj-12528	185	37	.	.	PUNCT
ecj-12528	186	1	int	int	NOUN
ecj-12528	187	1	j	j	PROPN
ecj-12528	187	2	gen	gen	PROPN
ecj-12528	187	3	med	med	PROPN
ecj-12528	187	4	2021;14:9483	2021;14:9483	PROPN
ecj-12528	187	5	-	-	PUNCT
ecj-12528	187	6	9	9	NUM
ecj-12528	187	7	.	.	NOUN
ecj-12528	187	8	22	22	NUM
ecj-12528	187	9	.	.	PUNCT
ecj-12528	188	1	candemir	candemir	PROPN
ecj-12528	188	2	m	m	PROPN
ecj-12528	188	3	,	,	PUNCT
ecj-12528	188	4	kiziltunç	kiziltunç	PROPN
ecj-12528	188	5	e	e	PROPN
ecj-12528	188	6	,	,	PUNCT
ecj-12528	188	7	nurkoç	nurkoç	PROPN
ecj-12528	188	8	s	s	PART
ecj-12528	188	9	,	,	PUNCT
ecj-12528	188	10	şahinarslan	şahinarslan	VERB
ecj-12528	188	11	a.	a.	NOUN
ecj-12528	188	12	relationship	relationship	NOUN
ecj-12528	188	13	between	between	ADP
ecj-12528	188	14	systemic	systemic	ADJ
ecj-12528	188	15	immune	immune	ADJ
ecj-12528	188	16	-	-	PUNCT
ecj-12528	188	17	inflammation	inflammation	NOUN
ecj-12528	188	18	index	index	NOUN
ecj-12528	188	19	(	(	PUNCT
ecj-12528	188	20	sii	sii	PROPN
ecj-12528	188	21	)	)	PUNCT
ecj-12528	188	22	and	and	CCONJ
ecj-12528	188	23	the	the	DET
ecj-12528	188	24	severity	severity	NOUN
ecj-12528	188	25	of	of	ADP
ecj-12528	188	26	stable	stable	ADJ
ecj-12528	188	27	coronary	coronary	ADJ
ecj-12528	188	28	artery	artery	NOUN
ecj-12528	188	29	disease	disease	NOUN
ecj-12528	188	30	.	.	PUNCT
ecj-12528	189	1	angiology	angiology	NOUN
ecj-12528	189	2	2021;72:575	2021;72:575	PROPN
ecj-12528	189	3	-	-	PUNCT
ecj-12528	189	4	81	81	NUM
ecj-12528	189	5	.	.	PUNCT
ecj-12528	189	6	23	23	NUM
ecj-12528	189	7	.	.	PUNCT
ecj-12528	190	1	zhang	zhang	PROPN
ecj-12528	190	2	y	y	PROPN
ecj-12528	190	3	,	,	PUNCT
ecj-12528	190	4	xing	xing	PROPN
ecj-12528	191	1	z	z	PROPN
ecj-12528	191	2	,	,	PUNCT
ecj-12528	191	3	zhou	zhou	PROPN
ecj-12528	191	4	k	k	PROPN
ecj-12528	191	5	,	,	PUNCT
ecj-12528	191	6	jiang	jiang	PROPN
ecj-12528	191	7	s.	s.	VERB
ecj-12528	191	8	the	the	DET
ecj-12528	191	9	predictive	predictive	ADJ
ecj-12528	191	10	role	role	NOUN
ecj-12528	191	11	of	of	ADP
ecj-12528	191	12	systemic	systemic	ADJ
ecj-12528	191	13	inflammation	inflammation	ADJ
ecj-12528	191	14	response	response	NOUN
ecj-12528	191	15	index	index	NOUN
ecj-12528	191	16	(	(	PUNCT
ecj-12528	191	17	siri	siri	NOUN
ecj-12528	191	18	)	)	PUNCT
ecj-12528	191	19	in	in	ADP
ecj-12528	191	20	the	the	DET
ecj-12528	191	21	prognosis	prognosis	NOUN
ecj-12528	191	22	of	of	ADP
ecj-12528	191	23	stroke	stroke	NOUN
ecj-12528	191	24	patients	patient	NOUN
ecj-12528	191	25	.	.	PUNCT
ecj-12528	192	1	clin	clin	PROPN
ecj-12528	192	2	interv	interv	VERB
ecj-12528	192	3	aging	age	VERB
ecj-12528	192	4	2021;16:1997	2021;16:1997	NOUN
ecj-12528	192	5	-	-	SYM
ecj-12528	192	6	2007	2007	NUM
ecj-12528	192	7	.	.	PUNCT
ecj-12528	193	1	24	24	NUM
ecj-12528	193	2	.	.	PUNCT
ecj-12528	194	1	biyik	biyik	PROPN
ecj-12528	194	2	m	m	PROPN
ecj-12528	194	3	,	,	PUNCT
ecj-12528	194	4	biyik	biyik	PROPN
ecj-12528	194	5	z	z	PROPN
ecj-12528	194	6	,	,	PUNCT
ecj-12528	194	7	asil	asil	PROPN
ecj-12528	194	8	m	m	PROPN
ecj-12528	194	9	,	,	PUNCT
ecj-12528	194	10	keskin	keskin	PROPN
ecj-12528	194	11	m.	m.	NOUN
ecj-12528	194	12	systemic	systemic	ADJ
ecj-12528	194	13	inflammation	inflammation	ADJ
ecj-12528	194	14	response	response	NOUN
ecj-12528	194	15	index	index	NOUN
ecj-12528	194	16	and	and	CCONJ
ecj-12528	194	17	systemic	systemic	ADJ
ecj-12528	194	18	immune	immune	ADJ
ecj-12528	194	19	inflammation	inflammation	NOUN
ecj-12528	194	20	index	index	NOUN
ecj-12528	194	21	are	be	AUX
ecj-12528	194	22	associated	associate	VERB
ecj-12528	194	23	with	with	ADP
ecj-12528	194	24	clinical	clinical	ADJ
ecj-12528	194	25	outcomes	outcome	NOUN
ecj-12528	194	26	in	in	ADP
ecj-12528	194	27	patients	patient	NOUN
ecj-12528	194	28	with	with	ADP
ecj-12528	194	29	acute	acute	ADJ
ecj-12528	194	30	pancreatitis	pancreatitis	NOUN
ecj-12528	194	31	?	?	PUNCT
ecj-12528	195	1	j	j	PROPN
ecj-12528	195	2	invest	invest	VERB
ecj-12528	195	3	surg	surg	PROPN
ecj-12528	195	4	2022;35:1613	2022;35:1613	NUM
ecj-12528	195	5	-	-	PUNCT
ecj-12528	195	6	20	20	NUM
ecj-12528	195	7	.	.	PUNCT
ecj-12528	196	1	25	25	NUM
ecj-12528	196	2	.	.	PUNCT
ecj-12528	197	1	eissa	eissa	PROPN
ecj-12528	197	2	m	m	PROPN
ecj-12528	197	3	,	,	PUNCT
ecj-12528	197	4	shaarawy	shaarawy	PROPN
ecj-12528	197	5	s	s	PROPN
ecj-12528	197	6	,	,	PUNCT
ecj-12528	197	7	abdellateif	abdellateif	PROPN
ecj-12528	197	8	ms	ms	PROPN
ecj-12528	197	9	.	.	PROPN
ecj-12528	198	1	the	the	DET
ecj-12528	198	2	role	role	NOUN
ecj-12528	198	3	of	of	ADP
ecj-12528	198	4	different	different	ADJ
ecj-12528	198	5	inflammatory	inflammatory	ADJ
ecj-12528	198	6	indices	index	NOUN
ecj-12528	198	7	in	in	ADP
ecj-12528	198	8	the	the	DET
ecj-12528	198	9	diagnosis	diagnosis	NOUN
ecj-12528	198	10	of	of	ADP
ecj-12528	198	11	covid-19	covid-19	PROPN
ecj-12528	198	12	.	.	PUNCT
ecj-12528	199	1	int	int	PROPN
ecj-12528	200	1	j	j	PROPN
ecj-12528	200	2	gen	gen	PROPN
ecj-12528	200	3	med	med	PROPN
ecj-12528	200	4	2021;14:7843	2021;14:7843	PROPN
ecj-12528	200	5	-	-	SYM
ecj-12528	200	6	53	53	NUM
ecj-12528	200	7	.	.	NOUN
ecj-12528	200	8	26	26	NUM
ecj-12528	200	9	.	.	PUNCT
ecj-12528	201	1	fois	fois	PROPN
ecj-12528	201	2	ag	ag	PROPN
ecj-12528	201	3	,	,	PUNCT
ecj-12528	201	4	paliogiannis	paliogiannis	PROPN
ecj-12528	201	5	p	p	X
ecj-12528	201	6	,	,	PUNCT
ecj-12528	201	7	scano	scano	PROPN
ecj-12528	201	8	v	v	NOUN
ecj-12528	201	9	,	,	PUNCT
ecj-12528	201	10	et	et	PROPN
ecj-12528	201	11	al	al	PROPN
ecj-12528	201	12	.	.	PUNCT
ecj-12528	202	1	the	the	DET
ecj-12528	202	2	systemic	systemic	ADJ
ecj-12528	202	3	inflammation	inflammation	NOUN
ecj-12528	202	4	index	index	NOUN
ecj-12528	202	5	on	on	ADP
ecj-12528	202	6	admission	admission	NOUN
ecj-12528	202	7	predicts	predict	NOUN
ecj-12528	202	8	in	in	ADP
ecj-12528	202	9	-	-	PUNCT
ecj-12528	202	10	hospital	hospital	NOUN
ecj-12528	202	11	mortality	mortality	NOUN
ecj-12528	202	12	in	in	ADP
ecj-12528	202	13	covid-19	covid-19	PROPN
ecj-12528	202	14	patients	patient	NOUN
ecj-12528	202	15	.	.	PUNCT
ecj-12528	203	1	molecules	molecule	NOUN
ecj-12528	203	2	2020;25:5725	2020;25:5725	NUM
ecj-12528	203	3	.	.	PROPN
ecj-12528	203	4	27	27	NUM
ecj-12528	203	5	.	.	PUNCT
ecj-12528	204	1	muhammad	muhammad	PROPN
ecj-12528	204	2	s	s	PROPN
ecj-12528	204	3	,	,	PUNCT
ecj-12528	204	4	fischer	fischer	PROPN
ecj-12528	204	5	i	i	PROPN
ecj-12528	204	6	,	,	PUNCT
ecj-12528	204	7	naderi	naderi	PROPN
ecj-12528	204	8	s	s	PROPN
ecj-12528	204	9	,	,	PUNCT
ecj-12528	204	10	et	et	PROPN
ecj-12528	204	11	al	al	PROPN
ecj-12528	204	12	.	.	PUNCT
ecj-12528	205	1	systemic	systemic	ADJ
ecj-12528	205	2	inflammatory	inflammatory	ADJ
ecj-12528	205	3	index	index	NOUN
ecj-12528	205	4	is	be	AUX
ecj-12528	205	5	a	a	DET
ecj-12528	205	6	novel	novel	ADJ
ecj-12528	205	7	predictor	predictor	NOUN
ecj-12528	205	8	of	of	ADP
ecj-12528	205	9	intubation	intubation	NOUN
ecj-12528	205	10	requirement	requirement	NOUN
ecj-12528	205	11	and	and	CCONJ
ecj-12528	205	12	mortality	mortality	NOUN
ecj-12528	205	13	after	after	ADP
ecj-12528	205	14	sars	sar	NOUN
ecj-12528	205	15	-	-	PUNCT
ecj-12528	205	16	cov-2	cov-2	PART
ecj-12528	205	17	infection	infection	NOUN
ecj-12528	205	18	.	.	PUNCT
ecj-12528	206	1	pathog	pathog	PROPN
ecj-12528	206	2	(	(	PUNCT
ecj-12528	206	3	basel	basel	PROPN
ecj-12528	206	4	,	,	PUNCT
ecj-12528	206	5	switzerland	switzerland	PROPN
ecj-12528	206	6	)	)	PUNCT
ecj-12528	206	7	2021;10:1	2021;10:1	PROPN
ecj-12528	206	8	-	-	SYM
ecj-12528	206	9	9	9	NUM
ecj-12528	206	10	.	.	NOUN
ecj-12528	206	11	28	28	NUM
ecj-12528	206	12	.	.	PUNCT
ecj-12528	207	1	nalbant	nalbant	PROPN
ecj-12528	207	2	a	a	PRON
ecj-12528	207	3	,	,	PUNCT
ecj-12528	207	4	demirci	demirci	PROPN
ecj-12528	207	5	t	t	PROPN
ecj-12528	207	6	,	,	PUNCT
ecj-12528	207	7	kaya	kaya	PROPN
ecj-12528	207	8	t	t	PROPN
ecj-12528	207	9	,	,	PUNCT
ecj-12528	207	10	et	et	PROPN
ecj-12528	207	11	al	al	PROPN
ecj-12528	207	12	.	.	PROPN
ecj-12528	208	1	can	can	AUX
ecj-12528	208	2	prognostic	prognostic	VERB
ecj-12528	208	3	nutritional	nutritional	ADJ
ecj-12528	208	4	index	index	NOUN
ecj-12528	208	5	and	and	CCONJ
ecj-12528	208	6	systemic	systemic	ADJ
ecj-12528	208	7	immune	immune	NOUN
ecj-12528	208	8	-	-	PUNCT
ecj-12528	208	9	inflammatory	inflammatory	ADJ
ecj-12528	208	10	index	index	NOUN
ecj-12528	208	11	predict	predict	VERB
ecj-12528	208	12	disease	disease	NOUN
ecj-12528	208	13	severity	severity	NOUN
ecj-12528	208	14	in	in	ADP
ecj-12528	208	15	covid-19	covid-19	PROPN
ecj-12528	208	16	?	?	PUNCT
ecj-12528	209	1	int	int	PROPN
ecj-12528	210	1	j	j	PROPN
ecj-12528	210	2	clin	clin	PROPN
ecj-12528	210	3	pract	pract	PROPN
ecj-12528	210	4	2021;75	2021;75	NUM
ecj-12528	210	5	:	:	PUNCT
ecj-12528	210	6	e14544	e14544	PROPN
ecj-12528	210	7	.	.	NOUN
ecj-12528	210	8	article	article	NOUN
ecj-12528	211	1	[	[	X
ecj-12528	211	2	page	page	NOUN
ecj-12528	211	3	98	98	NUM
ecj-12528	211	4	]	]	PUNCT
ecj-12528	212	1	[	[	X
ecj-12528	212	2	emergency	emergency	NOUN
ecj-12528	212	3	care	care	NOUN
ecj-12528	212	4	journal	journal	PROPN
ecj-12528	212	5	2024	2024	NUM
ecj-12528	212	6	;	;	PUNCT
ecj-12528	212	7	20:12528	20:12528	NUM
ecj-12528	212	8	]	]	X
ecj-12528	212	9	non	non	ADJ
ecj-12528	212	10	-co	-co	PROPN
ecj-12528	212	11	mmerc	mmerc	PROPN
ecj-12528	212	12	ial	ial	PROPN
ecj-12528	212	13	us	us	PROPN
ecj-12528	212	14	e	e	NOUN
ecj-12528	212	15	o	o	NOUN
ecj-12528	212	16	nly	nly	ADV